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INTRODUCTION 
In	  order	  to	  diagnose	  any	  disease,	  a	  standard	  of	  reference	  is	  required.	  This	  standard	  is	  the	  state	  of	  health	  or	  normality.	  	  In	  clinical	  practice,	  because	  previous	  measurements	  from	  the	  same	  patients	  during	  health	  are	  rarely	  available,	  it	  is	  customary	  to	  compare	  the	  test	  results	  of	  patients	  who	  are	  supposed	  or	  known	  to	  have	  a	  disease	  with	  the	  test	  results	  of	  healthy	  persons	  who	  serve	  as	  the	  control	  or	  normal	  range.	  	  Normative	  reference	  values	  for	  cardiac	  chamber	  anatomy	  and	  function	  are	  important	  for	  the	  accurate	  identification	  of	  xardiac	  chamber	  remodeling	  and/or	  dysfunction	  ,	  risk	  stratification	  and	  selection	  of	  therapy.	  Three-­‐dimensional	  echocardiography	  (3DE)	  allows	  accurate,	  unbiased	  measurement	  of	  cardiac	  chamber	  size	  and	  function	  without	  geometric	  assumptions	  regarding	  their	  shape.	  (1-­‐3)	  It	  is	  widely	  available,	  cost-­‐effective	  and	  does	  not	  expose	  patients	  to	  potentially	  harmful	  ionizing	  radiations,	  being	  ideal	  for	  serial	  assessment.	  	  Reference	  values	  for	  cardiac	  chamber	  geometry	  and	  function	  derived	  using	  two-­‐dimensional	  echocardiography	  (2DE)	  may	  not	  be	  appropriate	  for	  values	  measured	  from	  3DE	  data	  sets.	  (4,5)	  Age-­‐	  and	  gender-­‐appropriate	  reference	  values	  are	  particularly	  important	  for	  an	  earlier	  identification	  of	  cardiovascular	  diseases(6-­‐8).	  Moreover,	  since	  3DE	  is	  increasingly	  used	  in	  clinical	  practice	  to	  assess	  size	  and	  function	  of	  cardiac	  chambers,	  specific	  3DE-­‐derived	  reference	  values	  are	  desirable.	  Using	   a	   series	   of	   clinical	   studies	   in	   healthy	   subjects,	   this	   research	   project	   aims	   to:	   (i)	  determine	  the	  normative	  values	  for	  left	  ventricular	  (LV,	  Chapter	  5),(9)	  	  right	  ventricular	  (RV,	  chapter	   6),	   (10)	   left	   atrial	   (LA,	   Chapter	   7)	   and	   right	   atrial	   (RA,	   Chapter	   8)(5)	   volumes	   and	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function	   indexes	   using	   3DE	   in	   a	   large	   cohort	   of	   healthy	   subjects;	   (ii)	   compare	   the	   cardiac	  chamber	   parameters	   measured	   by	   3DE	   with	   the	   same	   values	   calculated	   using	   2DE;	   (iii)	  analyze	  the	  effects	  of	  age,	  body	  size	  and	  gender	  on	  these	  parameters.	  The	  experimental	  part	  of	  the	  thesis	  (Chapters	  4-­‐9)	  is	  preceeded	  by	  a	  general	  first	  part	  aiming	  to	  provide	  a	  comprehensive	  review	  about	  the	  concept	  of	  normality	  in	  medicine	  and	  the	  development	  of	  reference	  values	  (Chapter	  1),	  the	  history	  and	  technological	  evolution	  of	  three-­‐dimensional	  echocardiography	  (Chapter	  2)	  and	  the	  description	  of	  current	  3DE	  technology	  implemented	  in	  clinical	  and	  research	  practice	  to	  analyze	  cardiac	  chamber	  geometry	  and	  function	  (Chapter	  3).	  Finally,	  study	  project	  limitations	  and	  its	  clinical	  implications	  are	  discussed	  in	  Chapter	  9.	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  PART	  I	  	  GENERAL	  SECTION	  
	  
	  
THE	  CONCEPT	  OF	  REFERENCE	  RANGES	  IN	  MEDICINE	  AND	  THE	  
EVOLUTION	  OF	  THREE_DIMENSIONAL	  ECHOCARDIOGRAPHY	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CHAPTER 1 	  	  





1.1	  Introduction	  The	  main	  task	  of	  a	  cardiologist	  performing	  echocardiography	  is	  to	  aid	  in	  the	  investigation	  of	  patients	  by	  supplying	  quantitative	  information	  about	  the	  geometry	  and	  function	  of	  cardiac	  structures	  in	  the	  beating	  heart.	  However,	  isolated	  results	  are	  of	  scant	  interest.	  A	  meaningful	  evaluation	  requires	  comparison	  with	  other	  results	  concerning	  the	  same	  measurement	  (e.g.	  LV	  ejection	  fraction)	  from	  the	  same	  individual	  or	  from	  comparable	  individuals	  .	  Such	  values	  are	  usually	  called	  “normal	  values”,	  but	  this	  term	  implies	  a	  state	  of	  normality,	  which	  is	  hopeless	  to	  define	  in	  an	  useful	  way,	  especially	  since	  the	  term	  “normal”	  is	  ambiguous	  in	  itself.	  (11)	  
1.2	  Definition	  of	  “normality”	  Inherent	  with	  the	  concept	  of	  “normal	  range”	  is	  the	  concept	  of	  “normality”.	  The	  main	  issue	  with	  the	  concept	  of	  normality	  in	  clinical	  practice	  derives	  from	  the	  ambiguity	  among	  its	  medical	  connotation	  (where	  it	  is	  used	  as	  a	  synonim	  for	  “health”),	  its	  statistical	  connotation	  (where	  it	  is	  used	  as	  a	  synonim	  for	  “Gaussian	  distribution”),	  and	  its	  popular	  connotation	  (where	  it	  is	  used	  as	  a	  synonim	  for	  “ideal,	  usual	  or	  conventional”).	  The	  term	  “health”	  is	  said	  to	  be	  the	  “state	  of	  being	  hale,	  sound	  ,	  or	  whole,	  in	  body,	  mind,	  or	  
soul;	  especially	  the	  state	  of	  being	  free	  from	  physical	  disease	  or	  pain”	  (Merriam-Webster Online 
Dictionary, http://www.webster-dictionary.org/definition/health). By	  using	  this	  definition, a	  person	  who	  is	  in	  good	  health	  may	  indulge	  in	  physical	  and	  mental	  activities	  without	  distress	  ,	  and	  he/she	  is	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free	  from	  diseases	  that	  may	  threaten	  his	  or	  her	  well-­‐being	  or	  life. Similarly,	  the	  orthodox	  medical	  definition	  of	  normal	  ”denotes	  the	  absence	  of	  infection,	  disease,	  or	  malformation	  ,	  or	  the	  
absence	  of	  experimental	  or	  therapeutic	  manipulations”	  (Webster’s	  New	  International	  Dictionary	  of	  the	  English	  Language,	  second	  edition,	  unabridged,	  1960).	  However,	  considering	  the	  term	  “normal”	  as	  a	  synonim	  of	  “health”	  implies	  that	  every	  value	  which	  falls	  outside	  the	  “normal	  range”	  for	  that	  measurement	  will	  be	  automatically	  labeled	  as	  “disease”.	  This	  concept	  is	  obviously	  unacceptable	  in	  clinical	  practice	  Conventionally,	  a	  value/measurement	  compatible	  with	  health	  is	  called	  “normal”,	  a	  term	  that	  has	  led	  to	  confusion	  because	  of	  its	  biological	  and	  statistical	  uses.	  We	  cannot	  consider	  as	  “normal”	  only	  those	  measurements	  which	  follow	  a	  Gaussian	  distribution	  (i.e.	  distribute	  them	  in	  a	  nicely	  symmetrical,	  bell	  shaped	  curve	  around	  the	  mean	  value,	  presumably	  the	  true	  value)	  simply	  because	  measurements	  between	  “normal”	  individuals	  do	  not	  regularly	  follow	  	  a	  normal	  or	  Gaussian	  distribution	  pattern.	  (12)	  Application	  of	  statistics	  of	  normal	  distribution	  in	  such	  istances	  can	  lead	  to	  absurd	  conclusions.	  For	  example,	  Kaku	  et	  al.	  (13),	  examined	  LV	  geometry	  and	  function	  with	  three-­‐dimensional	  echocardiography	  (3DE)	  a	  large	  cohort	  of	  normal	  subjects	  and	  in	  the	  age	  group	  1-­‐19	  years	  the	  lower	  normal	  limits	  (mean	  value	  –	  2	  standard	  deviations)	  of	  the	  LV	  stroke	  volume	  was	  2	  ml	  and	  6	  ml	  in	  males	  and	  females,	  respectively.	  In	  the	  early	  days	  of	  the	  19th	  centrury,	  the	  German	  mathematician,	  physicist	  and	  astronomer	  Johann	  Carl	  F.	  Gauss	  ,	  proposed	  the	  “law	  of	  errors”.	  This	  law	  states	  that	  if	  repeated	  measures	  are	  made	  on	  the	  same	  physical	  object,	  the	  distribution	  of	  the	  random	  component	  of	  the	  errors	  can	  be	  well	  approximated	  by	  the	  Gaussian,	  or	  normal,	  distribution.	  This	  law	  implies	  that	  repeated	  measurements	  of	  the	  length	  of	  the	  same	  stick	  would	  follow	  the	  normal	  distribution;	  but	  the	  law	  certainly	  does	  not	  imply	  that	  measurements	  of	  the	  lengths	  of	  all	  the	  sticks	  to	  be	  found	  in	  a	  walking	  stick	  store	  will	  follow	  the	  same	  normal	  distribution.	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Even	  today,	  many	  scientists	  are	  strongly	  convinced	  that	  if	  a	  sample	  is	  large	  enough,	  the	  distribution	  will	  be	  “normal”	  regardless	  of	  the	  measurement	  under	  study,	  and	  that	  95%	  of	  the	  measurements	  will	  be	  included	  in	  mean	  value	  ±	  2	  standard	  deviations	  (SD).	  A	  famous	  quotations	  says	  “Everybody	  believes	  in	  the	  law	  of	  errors,	  the	  experimenters	  because	  they	  think	  it	  
is	  a	  mathematical	  theorem	  and	  the	  mathematicians	  because	  they	  think	  it	  is	  an	  experimental	  
fact”.	  (14)	  There	  is	  a	  mathematical	  theorem,	  but,	  as	  already	  stated,	  	  it	  refers	  to	  the	  random	  component	  of	  the	  errors	  made	  in	  repeated	  measurements	  of	  the	  same	  object.	  The	  experimental	  fact	  is	  that	  for	  most	  physiologic	  variables	  the	  distribution	  is	  smooth,	  unimodal	  and	  skewed,	  and	  that	  “mean	  value	  ±	  2	  standard	  deviations”	  does	  not	  cut	  off	  the	  desired	  central	  95%.	  Often,	  “normal”	  has	  been	  used	  as	  a	  synonim	  for	  “ideal”.	  Homer	  Smith	  H.	  (15)	  suggested	  that	  this	  confusion	  between	  normal	  and	  ideal	  originated	  with	  Plato	  and	  Platonic	  idealism,	  with	  its	  strong	  sense	  of	  the	  absolute:	  “The	  Ideal	  Circle	  is	  not	  inherent	  in	  the	  substantive	  circle	  
which	  we	  draw,	  but	  in	  the	  mind;	  but	  not	  in	  my	  mind	  or	  yours,	  or	  of	  any	  particular	  man,	  for	  
particular	  men	  come	  and	  go;	  since	  the	  Ideal	  Circle	  endures	  everywhere	  and	  forever,	  it	  must	  be	  
inherent	  in	  some	  universal	  unchanging	  mind	  which	  can	  only	  be	  the	  mind	  of	  God…	  The	  Ideal	  
Billygoat	  existed	  in	  the	  divine	  mind	  before	  the	  first	  actual	  billygoat	  	  was,	  or	  smelled,	  and	  will	  
continue	  to	  exist	  and	  smell	  when	  the	  last	  actual	  billygoat	  ,	  imperfect	  in	  form	  and	  odor,	  has	  
ceased	  to	  be”.	  In	  this	  quotation	  there	  are	  similarities	  with	  our	  frequently	  unquestioning,	  nearly	  mystic,	  respect	  for	  the	  “normal	  range”	  in	  this	  kind	  of	  idealism	  (e.g.	  the	  use	  of	  cardiac	  troponin	  in	  the	  screening	  of	  patients	  with	  acute	  chest	  pain).	  Normal	  ranges,	  no	  matter	  how	  imperfectly	  derived,	  attain	  through	  long	  use	  a	  patina	  of	  authority	  making	  them	  descriptive	  of	  a	  mystical	  ideal.	  The	  logical	  fallacy	  of	  confusing	  the	  “normal”	  with	  “ideal”	  is	  that	  “ideal	  persons”	  are	  theoretical	  beings,	  the	  mathematical	  combination	  of	  all	  ideal	  or	  perfect	  human	  attributes,	  
	   8	  
“existing	  only	  in	  the	  mind	  of	  God”.	  If	  our	  normal	  ranges	  were	  truly	  representative	  of	  such	  ideal	  persons,	  we	  would	  find	  “abnormalities”	  in	  every	  individual	  patient	  we	  examine.	  It	  is	  quite	  obvious	  that	  clinical	  “normal	  ranges”	  can	  not	  be	  based	  on	  such	  concepts	  and	  it	  is	  likewise	  logical	  that	  we	  do	  not	  want	  to	  use	  reference	  standards	  of	  this	  preciseness,	  similar	  to	  National	  Bureau	  of	  Standards	  reference	  standards	  of	  weight	  and	  measure.	  
	  1.3	  The	  concept	  of	  reference	  values	  Difficulty	  in	  defining	  “normality”	  in	  medicine	  has	  led	  some	  scientists	  to	  propos	  to	  abandon	  the	  terms	  “normal	  values	  and	  normal	  ranges”	  to	  adopt	  the	  more	  realistic	  terms	  “reference	  values/ranges”.	  The	  concept	  of	  reference	  values	  was	  introduced	  in	  1969	  by	  Grasbeck	  and	  Saris	  to	  describe	  fluctuation	  of	  blood	  analyte	  concentrations	  in	  well-­‐characterized	  groups	  of	  individuals.	  (16)	  Reference	  values,	  first	  introduced	  as	  a	  philosophy,	  have	  gained	  universal	  acceptance	  as	  one	  of	  the	  most	  powerful	  tools	  in	  laboratory	  medicine	  and	  clinical	  testing	  to	  aid	  in	  the	  clinical	  decision	  making	  process.	  The	  change	  from	  “normal	  values”	  to	  “reference	  values”	  is	  not	  just	  a	  semantic	  issue	  not	  related	  to	  the	  establishment	  of	  the	  scientific	  bases	  to	  interpret	  quantitative	  data	  obtained	  by	  the	  diagnostic	  modalities.	  Looking	  at	  the	  definition	  of	  reference	  values/ranges	  (e.g.	  ranges	  of	  values	  which	  include	  a	  series	  of	  quantitative	  measurements	  of	  a	  certain	  parameter	  obtained	  either	  from	  a	  single	  individual	  or	  from	  cohorts	  of	  individuals	  who	  fulfill	  well-­‐defined	  inclusion	  and	  exclusion	  criteria.	  Inclusion	  and	  exclusion	  criteria	  should	  be	  available	  for	  others	  who	  would	  like	  to	  use	  the	  same	  reference	  ranges.	  Several	  reference	  sample	  groups	  will	  be	  available	  for	  each	  measured	  parameter	  in	  order	  to	  take	  into	  account	  the	  effects	  of	  age,	  gender,	  body	  size,	  etc.)	  it	  is	  clear	  that	  this	  concept	  is	  more	  realistic	  and	  closer	  to	  the	  clinical	  practice	  	  than	  the	  concept	  of	  “normal	  values”.	  	  The	  concept	  of	  reference	  ranges	  imply	  that:	  (i).	  “Absolute	  health”	  as	  it	  has	  been	  outlined	  in	  the	  World	  Health	  Organization	  Consitution	  (“a	  state	  of	  complete	  physical,	  mental	  and	  social	  
well-­‐being	  and	  not	  merely	  the	  absence	  of	  disease	  or	  infirmity”)	  does	  not	  exist.	  (17)	  Some	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element	  of	  structural	  or	  functional,	  somatic,	  psychic	  or	  social	  “pathology”	  (however	  defined)	  is	  probably	  present	  in	  everyone	  (just	  like	  entropy	  is	  a	  characteristic	  of	  any	  thermodynamic	  system).	  Therefore,	  when	  reference	  values	  are	  derived	  from	  a	  population	  of	  heathy	  subjects,	  the	  level	  of	  “health”	  of	  enrolled	  subjects	  should	  be	  defined	  according	  to	  clear	  inclusion	  and	  exclusion	  criteria;	  (ii)	  Since	  health	  may	  be	  conceptually	  different	  in	  different	  countries,	  in	  the	  same	  country	  at	  different	  times,	  and	  in	  the	  same	  individual	  at	  different	  ages,	  	  reference	  values	  are	  not	  absolute	  but	  they	  change	  according	  to	  the	  population	  being	  examined;	  (iii)	  reference	  values	  cannot	  be	  obtained	  retrospectively	  from	  cohorts	  of	  patients	  who	  underwent	  the	  clinical	  test/measurement	  of	  what	  we	  want	  to	  define	  the	  reference	  values	  for	  clinical	  reasons	  and	  have	  	  subsequently	  been	  found	  normal	  on	  the	  basis	  of	  previous	  reference	  values.	  Conversely,	  the	  reference	  population	  from	  which	  the	  reference	  values	  will	  be	  obtained	  should	  be	  enrolled	  prospectively	  according	  to	  well	  a-­‐priori	  defined	  inclusion	  and	  exclusion	  criteria.	  The	  function	  of	  the	  normal	  range	  is	  to	  provide	  a	  base	  line	  for	  the	  interpretation	  of	  test	  results	  by	  the	  physician.	  Since	  health	  is	  the	  only	  possible	  base	  line	  to	  determine	  the	  alterations	  produced	  by	  disease,	  it	  follows	  that	  the	  normal	  range	  first	  should	  be	  established	  on	  healthy	  subjects.	  Ideally,	  the	  best	  way	  to	  establish	  reference	  values	  would	  be	  to	  obtain	  several	  measurements	  of	  the	  parameter	  to	  be	  tested	  while	  the	  subject	  under	  examination	  was	  healthy	  and	  to	  use	  the	  results	  as	  a	  comparison	  when	  a	  disease	  is	  suspected.	  This	  will	  eliminate	  the	  inter-­‐individual	  variability	  of	  measurements	  which	  is	  always	  significantly	  higher	  than	  the	  intra-­‐individual	  variability.	  However,	  this	  approach	  (subject-­‐based	  reference	  values)	  is	  only	  rarely	  available	  in	  clinical	  practice	  (e.g.	  measurement	  of	  LV	  ejection	  fraction	  before	  chemotherapy)	  and	  reference	  values	  are	  usually	  obtained	  from	  measurements	  performed	  on	  large	  cohorts	  of	  healthy	  subjects	  from	  which	  the	  upper	  and	  lower	  reference	  limits	  are	  calculated	  (e.g.	  an	  interval	  of	  the	  distribution	  of	  measurements	  comprising	  the	  central	  95%	  of	  them)	  .	  However,	  the	  inference	  that	  these	  values	  actually	  represent	  95%	  	  of	  the	  reference	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measurements	  is	  based	  on	  three	  assumptions:	  (i).	  The	  cohort	  is	  large	  enough	  that	  the	  degree	  of	  freedom	  can	  be	  ignored;	  (ii).	  The	  selection	  of	  the	  cohort	  has	  been	  adequate	  to	  be	  representative	  of	  the	  population	  from	  which	  our	  patients	  come;	  (iii).	  The	  distribution	  of	  measurements	  	  is	  normal	  (Gaussian).	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CHAPTER 2 	  	  





2.1	  Introduction	  Since	  the	  early	  days	  of	  cardiovascular	  imaging,	  the	  concept	  of	  3D	  imaging	  was	  indisputably	  perceived	  as	  a	  need	  based	  on	  the	  recognition	  that	  depicting	  the	  complex	  shape	  of	  the	  cardiovascular	  system	  in	  less	  than	  three	  dimensions	  severely	  limited	  the	  diagnostic	  value	  of	  the	  information	  obtained	  from	  medical	  imaging.	  During	  the	  last	  half	  of	  the	  twentieth	  century,	  we	  have	  witnessed	  an	  impressive	  technological	  progress	  driven	  by	  strong	  demand	  from	  the	  cardiology	  community	  that	  moved	  from	  fuzzy	  single-­‐projection	  X-­‐ray	  films	  to	  multi-­‐slices	  high	  spatial	  resolution	  tomographic	  images	  depicting	  anatomical	  details	  previously	  seen	  only	  in	  anatomy	  atlases.	  The	  possibility	  to	  visualize	  these	  details	  in	  living	  patients	  changed	  completely	  the	  way	  cardiologists	  understand	  disease	  processes	  and	  resulted	  in	  new	  standards	  in	  the	  diagnosis	  of	  diseases	  and	  patients’	  management.	  Currently,	  the	  diagnosis	  of	  most	  cardiovascular	  disease	  states	  heavily	  relies	  on	  information	  obtained	  by	  noninvasive	  imaging.	  However,	  3D	  imaging	  of	  the	  beating	  heart	  remained	  a	  challenge	  because	  of	  its	  constant	  motion.	  While	  3D	  imaging	  of	  stationary	  organs	  was	  conceptually	  easy	  to	  solve	  by	  collecting	  information	  from	  different	  parts	  or	  from	  different	  angles	  consecutively,	  imaging	  of	  the	  beating	  heart	  required	  data	  collection	  to	  occur	  virtually	  in	  real	  time.	  This	  was	  a	  real	  challenge	  for	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engineers	  and	  physicists.	  In	  fact,	  it	  can	  be	  read	  in	  textbooks	  from	  the	  early	  1970’s	  explanations	  why	  real-­‐time	  two-­‐dimensional	  (2D)	  imaging	  of	  the	  beating	  heart	  is	  an	  enormous	  	  technological	  advancement	  that	  is	  unsurpasssable	  because	  of	  the	  limitations	  imposed	  by	  the	  constant	  speed	  at	  which	  ultrasound	  waves	  travel	  inside	  the	  human	  body.	  	  Neverteless,	  despite	  the	  fact	  that	  the	  speed	  of	  sound	  has	  not	  changed	  since	  then,	  the	  combination	  of	  the	  exponential	  rise	  of	  computational	  power	  of	  computers	  with	  ingenious	  engineering	  solutions	  that	  increased	  the	  efficiency	  of	  the	  process	  of	  image	  formation	  from	  ultrasound	  reflections	  has	  meant	  that,	  during	  the	  last	  decade,	  3DE	  has	  completed	  its	  transition	  from	  a	  predominant	  research	  tool	  to	  an	  imaging	  technique	  employed	  in	  everyday	  clinical	  practice.	  (1,2,18)	  	  	  	  	  	  	  	  	  	  	  	  	  	  This	  transition	  began	  in	  2002	  with	  the	  release	  of	  a	  reasonable	  user-­‐friendly	  version	  of	  a	  matrix	  array	  transducer	  capable	  of	  real-­‐time	  3D	  imaging	  together	  with	  software	  which	  allows	  	  rapid	  slicing	  and	  quantification	  of	  3DE	  data	  sets.	  	  
	  
	  
Figure	  2.1.	  Progress	  in	  ultrasound	  technology.	  From	  the	  early	  M-­‐mode	  (1D),	  when	  one	  single	  ultrasound	  beam	  produced	  a	  time-­‐depth	  display	  of	  cardiac	  structures,	  through	  two-­‐dimensional	  echocardiography	  (2D),	  when	  a	  real-­‐time	  tomographic	  display	  of	  the	  beating	  heart	  was	  made	  available,	  to	  current	  three-­‐dimensional	  technology	  (3D),	  with	  which	  a	  real-­‐time	  pyramidal	  acquisition	  of	  data	  is	  available.	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Figure	  2.2.	  Temporal	  evolution	  of	  three-­‐dimensional	  echocardiography	  technology	  (see	  text	  for	  details).	  Abbreviations:	  RT3DE,	  real-­‐time	  three-­‐dimensional	  echocardiography;	  TEE,	  transesophageal;	  TT,	  transthoracic.	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2.2	  Extrinsic	  tracking	  (“positional”	  and	  “free-­‐hand”	  scanning)	  The	  first	  attempt	  in	  imaging	  the	  human	  heart	  in	  3D	  by	  ultrasound	  was	  made	  by	  Dekker	  et	  al.(19)	  in	  1974,	  who	  used	  a	  mechanical	  articulated	  arm	  that	  measured	  probe	  displacement	  during	  the	  acquisition	  of	  multiple	  2DE	  views	  to	  perform	  freehand	  transthoracic	  scanning.	  This	  marked	  the	  birth	  of	  static	  surface	  rendering,	  the	  earliest	  3D	  echocardiographic	  technique.	  
	  This	  work	  demonstrated	  the	  possibility	  of	  producing	  a	  3D	  data	  set,	  but	  the	  technology	  was	  impractical	  for	  clinical	  use.	  Trying	   to	   improve	   the	   tracking	   method,	   Moritz	   and	   Shreve(20)	   developed	   an	   acoustic	  locator	  (the	  so.called	  “spark-­‐gap)	  whereby	  an	  acoustic	  element	  was	  attached	  to	  the	  ultrasoud	  probe	  and	  sent	  regular	  audio	  pulses	  that	  were	  detected	  by	  a	  fixed	  antenna	  to	  be	  included	  in	  a	  Cartesian	  locator	  grid.	  
	  
	  
Figure	  2.3.	  The	  mechanical	  arm.	  Schematic	  drawing	  of	  the	  scanning	  bed	  and	  the	  device	  (left	  panel)	  and	  actual	  picture	  of	  the	  arm	  with	  the	  probe	  (right	  panel).	  A	  large	  external	  beam	  device	  gives	  spatial	  data	  regarding	  an	  ultrasound	  probe	  to	  enable	  three-­‐dimensional	  reconstruction.	  The	  ultrasound	  probe	  is	  highlighted	  by	  a	  red	  circle.	   	  
	  
	  
Figure	  2.4.	  Acoustic	  locators	  or	  “spark-­‐gaps”.	  The	  ultrasound	  probe	  position	  is	  tracked	  by	  a	  means	  similar	  to	  radar	  technology.	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In	   1977,	   Raab	   et	   al.	   (21)	   reported	   about	   an	   electromagnetic	   sensor	   which	   could	   be	  attached	   to	   the	   ultrasound	   probe	   allowing	   continuous	   monitoring	   of	   its	   position	   in	   space.	  Although	  this	  technique	  was	  quite	  advanced	  for	  1977,	  it	  was	  not	  used	  systematically	  until	  the	  mid	  1990s	  (Figure	  2.5).	  Several	  other	  Authors	  published	  early	  attempts	  to	  produce	  3DE	  data	  sets	  during	  this	  time	  period.	  (22-­‐24)	  Further	  development	  of	  these	  techniques	  led	  to	  what	  has	  been	   termed	   “free-­‐hand	   scanning”.	   With	   this	   modality,	   a	   highly	   developed	   magnetic-­‐field	  system	  orients	   sequentially	   acquired	   2DE	   imaging	   planes	   by	   tracking	   the	  movement	   of	   the	  ultrasound	  probe	  as	  it	  is	  manipulated	  by	  the	  operator.	   	  	  	  	  	  	  	  	  
2.3	  Gated	  sequential	  acquisition	  One	  crucial	  developmental	  aspect	  for	  the	  success	  of	  3D	  reconstruction	  from	  multiplane	  acquisition	   was	   the	   registration	   of	   the	   different	   planes,	   so	   that	   they	   could	   be	   combined	  together	  to	  create	  a	  3D	  image	  of	  the	  heart.	  This	  was	  achieved	  by	  sequential	  gated	  acquisition,	  wherein	   different	   cut	   planes	   were	   acquired	   one-­‐by-­‐one	   with	   gating	   designed	   to	   minimize	  artifacts.	  To	  minimize	  spatial	  misalignment	  of	  slices	  because	  of	  respiration,	  respiratory	  gating	  was	  used,	  such	  that	  only	  cardiac	  cycles	  coinciding	  with	  a	  certain	  phase	  of	  the	  respiratory	  cycle	  were	   captured.	   Similarly,	   to	   minimize	   temporal	   misalignment	   because	   of	   heart	   rate	  variability,	   ECG	   gating	   was	   used,	   such	   that	   only	   cardiac	   cycles	   within	   preset	   limits	   of	   R-­‐R	  
	  	  
Figure	  2.5.	  Freehand	  scanning.	  A	  modified	  ultrasound	  probe	  is	  tracked	  in	  3D	  space	  using	  an	  electromagnetic	  locator	  system	  (left	  panel).	  Schematic	  drawing	  of	  the	  receiver	  and	  transmitting	  device	  and	  the	  Cartesian	  coordinate	  system	  for	  tracking	  the	  location	  of	  the	  trasnducer	  (right	  panel).	  Images	  then	  may	  be	  reconstructed	  off-­‐line	  to	  create	  3D	  data	  sets.	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interval	   were	   included.	   This	   methodology	   became	   standard	   in	   both	   transthoracic	   and	  transesophageal	  multiplane	   imaging	   aimed	   at	   3D	   reconstruction	   and	  was	  widely	   used	  until	  real-­‐time	  3D	  imaging	  became	  possible.	  To	   achieve	   effective	   multiplane	   acquisition,	   new	   techniques	   were	   developed	   that	  operated	  under	  the	  assumption	  that	  both	  the	  patient	  and	  the	  housing	  of	  the	  ultrasound	  probe	  remained	  in	  a	  relatively	  fixed	  position.	  The	  ultrasound	  probe	  was	  held	  by	  a	  device	  that	  moved	  the	  probe	  in	  a	  specified,	  preprogrammed	  fashion	  within	  the	  housing	  of	  a	  mechanical	  device.	  	  Examples	  were	  linear,	  fan-­‐like	  and	  rotational	  acquisition	  methods.	  	  	  	  	  	  	  	  	  	  	  
In	   the	   early	   1990s,	   the	   use	   of	   linear	   step-­‐by-­‐step	   motion	   acquisition,	   wherein	   the	  transducer	   was	   mechanically	   advanced	   between	   acquisitions	   using	   a	   motorized	   driving	  device	  become	  commercially	  available.	  (25)	  
	  	  
Figure	  2.6.	  Gated	  sequential	  imaging.	  Transducer	  motion	  modalities	  to	  generate	  3DE	  images	  using	  gated	  sequential	  imaging.	  Linear	  (left	  panel):	  multiple	  parallel	  equi-­‐distantly	  spaced	  2D	  images	  can	  be	  obtained	  by	  progressive	  computer-­‐controlled	  linear	  motion	  of	  the	  transducer	  in	  prespecified	  depths.	  Fan-­‐like	  (central	  panel):	  multiple	  two-­‐dimensional	  images	  are	  obtained	  in	  a	  fan-­‐like	  array	  by	  tilting	  the	  transducer	  in	  specified	  arc	  angles	  to	  create	  a	  pyramidal	  data	  set.	  Rotational	  (right	  panel):	  multiple	  two-­‐dimensional	  images	  are	  obtained	  by	  rotating	  the	  transducer	  180°	  and	  obtaining	  images	  at	  pedetermined	  	  intervals	  (e.g.	  every	  3°	  or	  6°)	  to	  create	  a	  conical	  data	  set.	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However,	  this	  simple	  solution	  was	  not	  applicable	  for	  transthoracic	  echocardiography,	  because	   of	   the	   need	   to	   find	   intercostal	   acoustic	   windows	   for	   each	   acquisition	   step.	   This	  approach	   was	   implemented	   in	   a	   pull-­‐back	   transesophageal	   echocardiography	   transducer,	  known	  as	  “lobster	  tail”	  probe	  (Figure	  2.7,	  Right	  panel).	  In	  the	  handle	  of	  the	  transducer	  there	  was	   a	   motorized	   unit	   that	   incrementally	   pulled	   crystals	   in	   a	   parallel	   fashion	   at	   1	   mm	  increments	  gated	  to	  electrocardiogram	  (ECG)	  and	  respiration.	  The	  first	  transesophageal	  3DE	  study	  was	  performed	  in	  the	  early	  90’s	  using	  this	  device.	  (26)	  	  
2.3.1	  Transoesophageal	  rotational	  imaging	  An	   alternative	   approach	   to	   linear	   scanning	   was	   to	   keep	   the	   transducer	   in	   a	   fixed	  position	   corresponding	   to	   an	   optimal	   acoustic	   window,	   and	   rotate	   the	   imaging	   plane	   by	  internally	   steering	   the	   imaging	   element	   in	   different	   direction	   This	   concept	   of	   rotational	  scanning	   in	   combination	   with	   gated	   sequential	   scanning	   was	   implemented	   into	  transoesophageal	  technology	  and	  resulted	  in	  a	  probe	  that	  has	  subsequently	  become	  the	  main	  source	   of	   multiplane	   images	   used	   for	   3D	   reconstruction,	   both	   for	   research	   and	   clinical	  practice.	  (27,28)	  	  	  	  	  
	  	  
Figure	  2.7.	  Motorized	  linear-­‐motion	  device	  used	  to	  acquire	  parallel	  cut	  planes	  for	  reconstructing	  3D	  images	  using	  linear	  step-­‐by-­‐step	  transducer	  motion	  (left	  panel).	  Pull	  back	  transoesophageal	  probe	  that	  employed	  the	  same	  approach	  of	  linear	  motion	  (right	  panel)	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This	   approach	   provided	   3D	   reconstructions	   of	   reasonably	   good	   quality	   due	   to	   the	   high	  quality	   of	   the	   original	   2D	   images	   and	   the	   fact	   that	   the	   transoesophageal	   probe	   is	   relatively	  well	   “anchored”	   in	   its	  position	   throughout	   image	  acquisition,	   especially	   in	   sedated	  patients.	  Nevertheless,	   cardiac	   structures,	   such	  as	   valve	   leaflets	   appeared	   jagged	  as	   a	   result	   of	   stitch	  artifacts	  (Figure	  2.8,	  right	  panel),	  reflecting	  the	  contributions	  of	  individual	  imaging	  planes	  that	  could	  not	  be	  perfectly	  aligned	  during	  reconstruction,	  despite	  the	  ECG	  and	  respiratory	  gating.	  Multiple	  studies	  demonstrated	  the	  clinical	  usefulness	  of	  this	  approach	  mostly	  in	  the	  context	  of	  the	  evaluation	  of	  valvular	  heart	  disease.	  
2.3.2	  Transthoracic	  rotational	  imaging	  An	  early	  transthoracic	  implementation	  of	  rotational	  approach	  consisted	  of	  a	  motorized	  device	   that	   contained	   a	   conventional	   transducer,	   which	   was	   mechanically	   rotated	   several	  degrees	   at	   a	   time,	   resulting	   in	   first	   transthoracic	   gated	   sequential	   multiplane	   acquisitions	  suitable	  for	  3D	  reconstruction	  of	  the	  heart.	  (29-­‐31)	  	  	  	  	  
	  	  
Figure	  2.8.	  Rotational	  approach	  implemented	  into	  a	  transoesophageal	  multiplane	  transducer	  (left	  
panel).	  Schematic	  drawing	  of	  sequential	  ultrasound	  images	  obtained	  by	  progressive	  rotation	  of	  the	  transducer	  in	  a	  prespecified	  fashion	  (central	  panel).	  Example	  of	  a	  3D	  image	  of	  the	  mitral	  valve	  with	  anterior	  leaflet	  prolapse	  from	  multiplane	  images	  acquired	  using	  this	  transducer	  (right	  panel)	  
	  
	  
Figure	  2.9.	  Motorized	  device	  that	  housed	  an	  external	  stepper	  motor	  that	  mechanically	  rotated	  a	  built-­‐in	  transthoracic	  transducer.	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 Despite	  the	  previously	  unseen	  transthoracic	  3DE	  images	  that	  excited	  so	  many,	   it	  quickly	  became	   clear	   that	   this	  methodology	   was	   destined	   to	   remain	   limited	   to	   the	   research	   arena	  because	   image	  acquisition	  was	   too	   time-­‐consuming	  and	   tedious	   for	  clinical	  use.	   In	  addition,	  the	  quality	  of	  the	  reconstructed	  images	  was	  limited.	  	  With	  each	  of	  these	  methods,	  once	  the	  numerous	  2D	  “planes”	  have	  been	  obtained	  according	  to	  prescribed	  transducer	  movements,	  the	  images	  had	  to	  be	  realigned	  and	  digitally	  reformatted	  into	  rectangular	  pixels	  that	  were	  then	  stacked.	  Gaps	  between	  adjacent	  images	  were	  filled	  by	  interpolation.	  A	  cubic	  volume	  of	  “voxels”	  was	  then	  derived	  from	  the	  stacked	  images	  that	  could	  then	  be	  volume	  rendered	  or	  “sliced”	  in	  any	  plane	  of	  interest.	   	  	  	  	  	  	  	  	  	  	  A	  profound	  limitation	  to	  each	  of	  these	  techniques	  was	  that	  they	  fundamentally	  relied	  on	  the	  acquisition	  of	  multiple	  2D	  images.	  Image	  quality	  was	  therefore	  highly	  dependent	  on	  concordance	  between	  adjacent	  images.	  The	  inherent	  need	  to	  interpolate	  data	  became	  problematic	  if	  the	  adjacent	  images	  were	  themselves	  discordant	  due	  to	  voluntary	  or	  involuntary	  patient	  movement.	  Problems	  inherent	  to	  irregular	  heart	  rate	  and	  lung	  artifact	  were	  minimized	  by	  using	  cardiac	  and	  respiratory	  gating	  to	  prespecified	  heart	  rates	  and	  
	  	  
Figure	  2.10.	  Reconstruction	  of	  a	  3D	  data	  set	  from	  multiple	  2D	  images.	  The	  collection	  of	  images	  (typically	  15	  to	  60	  cardiac	  cycles,	  with	  10	  to	  15	  frames/heart	  beat)	  were	  re-­‐sampled	  in	  a	  cubical	  data	  set	  and	  ultimately	  rendered	  into	  a	  3D	  image	  or	  sliced	  according	  to	  planes	  of	  interest	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phases	  of	  the	  respiratory	  cycle.	  Images	  were	  therefore	  acquired	  over	  a	  varying	  period	  of	  time,	  often	  up	  to	  2	  to	  3	  minutes,	  and	  even	  longer	  in	  the	  presence	  of	  atrial	  fibrillation.	  This	  was	  because,	  from	  a	  practical	  standpoint,	  the	  image	  mismatch	  was	  too	  profound	  if	  the	  R-­‐R	  gating	  was	  set	  to	  vary	  by	  more	  than	  roughly	  150	  msec.	  If	  a	  patient	  with	  atrial	  fibrillation	  was	  gated	  at	  150-­‐msec	  variation,	  the	  acquisition	  could	  take	  up	  to	  10	  minutes.	  In	  this	  setting,	  it	  was	  unlikely	  that	  either	  the	  patient	  or	  the	  physician	  obtaining	  the	  data	  could	  remain	  stationary	  for	  this	  length	  of	  time.	  Actually,	  to	  obtain	  a	  satisfactory	  3D	  reconstruction	  with	  this	  technology,	  it	  was	  required	  a	  very	  skilled	  operator,	  a	  very	  cooperative	  patient,	  an	  operatorr	  skilled	  with	  3D	  reconstruction	  and	  a	  bit	  of	  luck.	  If	  succesful,	  although	  image	  quality	  was	  suboptimal	  for	  small	  discrete	  structure	  like	  valve	  morphology	  analysis,	  even	  at	  this	  time,	  data	  sets	  were	  useful	  for	  ventricular	  volume	  assessment.	  	  However,	  the	  presence	  of	  the	  locator	  device,	  which,	  limited	  significantly	  the	  portability	  of	  the	  ultrasound	  system,	  the	  need	  of	  avoiding	  any	  metallic	  close	  to	  the	  system	  and	  the	  patient,	  the	  long	  reconstrunction	  times	  and	  the	  unpredictability	  of	  the	  final	  results	  have	  further	  hindered	  more	  widespread	  use	  of	  this	  technique	  in	  clinical	  practice.	  
2.4	  Early	  transthoracic	  real-­‐time	  3D	  imaging	  The	   collective	   experience	   and	   the	   limitations	  of	   the	   gated	   sequential	   acquisition	   and	  offline	   3D	   reconstruction	   gradually	   led	   developers	   to	   the	   understanding	   that	   scanning	  volumes	   rather	   than	   isolated	   cut	   planes	   would	   intrinsically	   address	   many	   of	   the	   previous	  issues.	  This	  revolutionary	  idea	  led	  von	  Ramm	  et	  al.(32,33)	  to	  develop	  the	  first	  real-­‐time	  3DE	  system	   at	   Duke	   university.	   This	   system	   was	   equipped	   with	   a	   phased-­‐array	   transducer,	   in	  which	  piezoelectric	  elements	  were	  arranged	  in	  multiple	  rows,	  rather	  than	  one	  row,	  allowing	  fast	   sequential	   scanning	   of	  multiple	   planes.	   The	   phased	   array	   technology,	   that	   has	   been	   an	  integral	   part	   of	   the	   2D	   transducers	   for	   decades,	   was	  modified	   to	   electronically	   change	   the	  direction	  of	  the	  beam	  not	  only	  within	  a	  single	  plane	  to	  create	  a	  fan-­‐shaped	  scan,	  but	  also	  in	  the	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lateral	  direction	  to	  generate	  a	  series	  of	  such	  scans.	  Importantly	  this	  was	  achieved	  without	  any	  mechanical	  motion,	  allowing	  the	  speeds	  necessary	  for	  volumetric	  real-­‐time	  imaging.	  	  The	   first	   generation	   of	   real-­‐time	   3D	   transducers	   was	   bulky	   due	   to	   unprecedented	  number	   of	   electrical	   connections	   to	   the	   individual	   crystals,	   despite	   the	   relatively	   small	  number	  of	  elements	  in	  each	  row.	  This	  sparse	  array	  matrix	  transducer	  consisted	  of	  256	  non-­‐simultaneously	   firing	   elements	   and	   had	   large	   footprint,	  which	   did	   not	   allow	   good	   coupling	  with	   the	   chest	   wall	   for	   optimal	   acoustic	   windows,	   and	   produced	   3D	   images	   that	   were	  suboptimal	   in	  any	  selected	  plane,	  when	  compared	   to	   the	  quality	  of	   standard	  at	   the	   time	  2D	  echocardiographic	   images.	  Nevertheless,	   the	  mere	  fact	  of	  successful	  real-­‐time	  3D	  imaging	  of	  an	  entire	  volume	  of	  heart	  using	  one	  cardiac	  cycle	  was	  a	  huge	  technological	  breakthrough.	  	  	  	  	  	  	  	  	  	  This	  represented	  a	  major	  transition	  from	  the	  thin	  slice	  sector	  imaging	  obtainable	  with	  2DE.	   Despite	   volumetric	   acquisition	   was	   a	   very	   positive	   development,	   the	   images	   were	  displayed	  as	  2D	  (Figure	  2.11).	   	  The	  2D	   images	  were	  derived	   from	  the	  3D	  data	  set	  but	  were	  displayed	  as	  2D	  orthogonal	  cut	  planes.	  However,	   the	   road	   was	   paved	   and	   in	   November	   2002,	   at	   the	   time	   of	   the	   American	  Heart	  Association	  meeting,	  Philips	  released	  the	  first	  generation	  of	  real-­‐time	  3DE.	  
	  
Figure	  2.11.	  The	  first	  real-­‐time	  3D	  echocardiography	  system	  (C-­‐scan,	  Volumetrics,	  Inc)	  equipped	  with	  a	  sparse	  matrix	  array	  transducer	  (left	  panel).	  	  In	  the	  right	  panel	  the	  images	  which	  can	  be	  obtained	  with	  that	  system	  are	  shown:	  apical	  views	  of	  the	  heart	  on	  the	  right	  (4-­‐chamber	  on	  top,	  and	  2-­‐chamber	  of	  the	  left	  ventricle	  	  on	  the	  bottom),	  and	  short	  axis,	  or	  C	  scans,	  of	  the	  LV	  derived	  from	  perpendicular	  cuts	  through	  the	  apical	  views	  on	  the	  left.	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CHAPTER 3 	  	  





3.1	  Introduction	  The	  milestone	  in	  the	  development	  of	  current	  3DE	  technology	  has	  been	  the	  development	  of	  fully-­‐sampled	  matrix	  array	  transthoracic	  transducers	  based	  on	  advanced	  digital	  processing	  and	  improved	  image	  formation	  algorithms	  which	  allowed	  the	  operators	  to	  obtain	  on	  cart	  transthoracic	  real-­‐time	  volumetric	  imaging	  with	  short	  acquisition	  time,	  high	  spatial	  and	  temporal	  resolution.	  Further	  technological	  developments	  (i.e.	  advances	  in	  miniaturization	  of	  the	  electronics	  and	  in	  element	  interconnection	  technology)	  made	  possible	  to	  insert	  a	  full	  matrix	  array	  into	  the	  tip	  of	  a	  transoesophageal	  probe	  and	  provide	  transoesophageal	  real-­‐time	  volumetric	  imaging.	  	  In	  addition	  to	  transducer	  engineering,	  improved	  computer	  processing	  power	  and	  the	  availability	  of	  dedicated	  software	  packages	  for	  both	  on-­‐	  and	  off-­‐line	  analysis	  have	  allowed	  3DE	  to	  become	  a	  practical	  clinical	  tool.	  
3.2	  Comparison	  between	  2DE	  and	  3DE	  ultrasound	  transducers	  	  The	  backbone	  of	  the	  3DE	  technology	  is	  the	  transducer.	  (34)	  	  A	  conventional	  2DE	  phased	  array	  transducer	  is	  composed	  by	  128	  piezoelectric	  elements,	  electrically	  isolated	  from	  each	  other,	  arranged	  in	  a	  single	  row.	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  Each	  ultrasound	  wave	  front	  is	  generated	  by	  firing	  individual	  elements	  in	  a	  specific	  sequence	  with	  a	  delay	  in	  phase	  with	  respect	  to	  the	  transmit	  initiation	  time.	  Each	  element	  adds	  and	  subtracts	  pulses	  to	  generate	  a	  single	  ultrasound	  wave	  with	  a	  specific	  direction	  that	  constitutes	  a	  radially	  propagating	  scan	  line.	  	  
Since	  the	  piezoelectric	  elements	  area	  arranged	  in	  a	  single	  row,	  the	  ultrasound	  beam	  can	  be	  steered	  in	  two	  dimensions	  -­‐	  vertical	  (axial)	  and	  lateral	  (azimuthal)	  -­‐	  while	  resolution	  in	  the	  z	  axis	  (elevation)	  is	  fixed	  by	  the	  thickness	  of	  the	  tomographic	  slice	  (Figure	  3.2,	  left	  panel),	  which,	  in	  turn,	  is	  related	  to	  the	  vertical	  dimension	  of	  piezoelectric	  elements.	  Currently,	   3DE	   matrix-­‐array	   transducers	   are	   composed	   of	   about	   3000	   individually	  
	  
	  
Figure	  3.1.	  	  Two-­‐	  and	  three-­‐dimensional	  transducers.	  Schematic	  
drawing	  showing	  the	  differences	  between	  a	  two-­‐	  (left	  panel)	  and	  	  a	  
three-­‐dimensional	  (right	  panel)	  transducer	  
	  
	  
Figure	  3.2.	  Two-­‐dimensional	  beamforming.	  Schematic	  drawing	  of	  beamforming	  using	  a	  
conventional	  2DE	  phased	  array	  transducer.	  During	  transmission	  (left	  panel),	  focused	  
beams	  of	  ultrasound	  are	  produced	  by	  pulsing	  each	  piezoelectric	  element	  with	  pre-­‐
calculated	  time	  delays	  (i.e.	  phasing).	  During	  reception	  (right	  panel),	  focusing	  is	  achieved	  
by	  applying	  selective	  delays	  at	  echo	  signals	  received	  by	  the	  different	  piezoelectric	  
elements	  in	  order	  to	  create	  isophase	  signals	  that	  will	  be	  summed	  in	  a	  coherent	  way.	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connected	   and	   simultaneously	   active	   (fully	   sampled)	   piezoelectric	   elements	  with	   operating	  frequencies	  ranging	  from	  2	  to	  4	  MHz	  and	  5	  to	  7	  MHz	  for	  transthoracic	  and	  transoesophageal	  transducers,	   respectively.	   To	   steer	   the	   ultrasound	   beam	   in	   3D,	   a	   3D	   array	   of	   piezoelectric	  elements	  needs	  to	  be	  used	  in	  the	  probe,	  therefore	  piezoelectric	  elements	  are	  arranged	  in	  rows	  and	   columns	   to	   form	   of	   a	   rectangular	   grid	   (matrix	   configuration)	   within	   the	   transducer	  (Figure	   3.2,	   right	   panel).	   The	   electronically	   controlled	   phasic	   firing	   of	   the	   elements	   in	   that	  matrix	  generates	  a	  scan	  line	  that	  propagates	  radially	  (y	  or	  axial	  direction)	  and	  can	  be	  steered	  both	   laterally	   (x	  or	  azimuthal	  direction)	  and	   in	  elevation	   (z	  direction)	   in	  order	   to	  acquire	  a	  volumetric	   pyramid	   of	   data	   (Figure	   3.2,	   right	   panel).	  Matrix	   array	   probes	   can	   also	   provide	  real-­‐time	  multiple	  simultaneous	  2D	  views,	  at	  high	  frame	  rate,	  oriented	  in	  predefined	  or	  user-­‐selected	  plane	  orientations.	   	  	  	  	  	  	  	  	  	  	  	  	  	  The	   main	   technological	   breakthrough	   which	   allowed	   manufacturers	   to	   develop	   fully	  sampled	   matrix	   transducers	   has	   been	   the	   miniaturization	   of	   electronics	   that	   allowed	   the	  development	  of	   individual	   electrical	   interconnections	   for	  every	  piezoelectric	   element	  which	  could	  be	  independently	  controlled,	  both	  in	  transmission	  and	  in	  reception.	  	  Beamforming	   is	  a	   technique	  used	  to	  process	  signals	   in	  order	   to	  produce	  directionally	  or	  
	  
	  
Figure	  3.3.	  Multiplane	  acquisition	  using	  the	  matrix	  array	  transducer.	  Bi-­‐plane	  acquisition	  showing	  a	  parasternal	  long-­‐axis	  view	  (reference	  view)	  and	  a	  simultaneous	  short	  axis	  view	  taken	  at	  the	  level	  of	  the	  dotted	  yellow	  line	  on	  the	  reference	  view	  (left	  panel).	  Tri-­‐plane	  acquisition	  (right	  
panel)	  showing	  simultaneously	  a	  4-­‐	  (left	  upper	  corner),	  2-­‐camber	  (right	  	  upper	  corner)	  views	  and	  an	  apical	  long-­‐axis	  view	  (left	  lower	  corner).	  The	  angles	  of	  the	  2-­‐chamber	  and	  the	  long-­‐axis	  views	  are	  adjustable	  during	  the	  acquisition	  to	  optimize	  the	  views.	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spatially	   selected	   signals	   sent	   or	   received	   from	  arrays	   of	   sensors.	   In	   2DE,	   all	   the	   electronic	  components	   for	  the	  beamforming	  (high-­‐voltage	  transmitters,	   low-­‐noise	  receivers,	  analog-­‐to-­‐digital	  converter,	  digital	  controllers,	  digital	  delay	  lines)	  are	  in	  the	  system	  and	  consume	  a	  lot	  of	  power	   (around	   100W	   and	   1,500	   cm2	   of	   personal	   computer	   electronics	   board	   area).	   If	   the	  same	  beamforming	  approach	  would	  have	  been	  used	  for	  matrix	  array	  transducers	  used	  in	  3DE,	  it	  would	  require	  around	  4kW	  power	  consumption	  and	  a	  huge	  PC	  board	  area	  to	  accommodate	  all	  the	  needed	  electronics.	  To	  reduce	  both	  power	  consumption	  and	  the	  size	  of	  the	  connecting	  cable,	   several	   miniaturized	   circuit	   boards	   are	   incorporated	   into	   the	   transducer,	   allowing	  partial	  beamforming	  to	  be	  performed	  in	  the	  probe.	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
This	  unique	  circuit	  design	  results	  in	  an	  active	  probe	  which	  allows	  microbeamforming	  of	  the	  signal	  with	  low	  power	  consumption	  (<1	  W)	  and	  avoids	  to	  connect	  every	  piezoelectric	  element	   to	   the	  ultrasound	  machine.	  The	  3000	   channel	   circuit	   boards	  within	   the	   transducer	  
	  	  
Figure	  3.4.	  Three-­‐dimensional	  beamforming.	  Beamforming	  with	  3D	  matrix	  array	  transducers	  has	  been	  splitted	  in	  two:	  the	  transducer	  and	  the	  ultrasound	  machine	  levels.	  At	  the	  transducer	  level,	  interconnection	  technology	  and	  integrated	  analog	  circuits	  (DELAY)	  control	  transmit	  and	  receive	  signals	  using	  different	  subsection	  of	  the	  matrix	  (patches)	  to	  perform	  analog	  pre-­‐beamforming	  and	  fine	  steering.	  Signals	  from	  each	  patch	  are	  summed	  to	  reduce	  the	  number	  of	  digital	  lines	  in	  the	  coaxial	  cable	  that	  connects	  the	  transducer	  to	  the	  ultrasound	  system	  from	  3000	  to	  the	  conventional	  128-­‐256	  channels.	  At	  the	  ultrasound	  machine	  level,	  analog-­‐to-­‐digital	  (A/D)	  convertors	  amplify,	  filter	  and	  digitize	  the	  elements	  signals	  which	  are	  then	  focused	  (coarse	  steering)	  using	  digital	  delay	  (DELAY)	  circuitry	  and	  summed	  together	  (SUM)	  to	  form	  the	  received	  signal	  from	  a	  desired	  object.	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control	   the	   fine	  steering	  by	  delaying	  and	  summing	  signals	  within	  subsections	  of	   the	  matrix,	  known	  as	  patches	   (Figure	  3.4).	  This	  microbeamforming	  allows	   to	  reduce	   the	  number	  of	   the	  digital	  channels	  to	  be	  put	  into	  the	  cable	  that	  connects	  the	  probe	  to	  the	  ultrasound	  system	  from	  3000	  (which	  would	  make	  the	  cabling	  too	  heavy	  for	  practical	  use)	  to	  the	  conventional	  128-­‐256	  allowing	  the	  same	  size	  of	  the	  2D	  cable	  to	  be	  used	  with	  3D	  probes.	  Coarse	  steering	  is	  controlled	  by	   the	   ultrasound	   system	  where	   the	   analog-­‐to-­‐digital	   conversion	   occurs	   using	   digital	   delay	  lines	  (Figure	  3.4).	  	  However,	   the	   electronics	   inside	   the	   probe	   produce	   heat	   whose	   amount	   is	   directly	  proportional	   to	  mechanical	   index	   used	   during	   imaging,	   therefore	   the	   engineering	   of	   active	  3DE	  transducer	  should	  include	  thermal	  management.	  	  Finally,	  new	  and	  advanced	  crystal	  manufacturing	  processes	  allows	  production	  of	  single	  crystal	   materials	   with	   homogeneous	   solid	   state	   technology	   and	   unique	   piezoelectric	  properties.	   These	   new	   transducers	   result	   in	   reduced	   heating	   production	   by	   increasing	   the	  efficiency	  of	  the	  transduction	  process	  which	  improves	  the	  conversion	  of	  transmit	  power	  into	  ultrasound	   energy	   and	   of	   received	   ultrasound	   energy	   into	   electrical	   power.	   Increased	  efficiency	   of	   the	   transduction	   process	   together	  with	   a	  wider	   bandwidth	   result	   in	   increased	  ultrasound	   penetration	   and	   resolution	   which	   improve	   image	   quality	   with	   the	   additional	  benefits	  of	  reducing	  artifacts,	  lowering	  power	  consumption	  and	  increase	  Doppler	  sensitivity.	  Further	  developments	  in	  transducer	  technology	  have	  resulted	  in	  a	  reduced	  transducer	  footprint,	   improved	   side-­‐lobe	   suppression,	   increased	   sensitivity	   and	   penetration,	   and	   the	  implementation	   of	   harmonic	   capabilities	   that	   can	   be	   used	   for	   both	   gray-­‐scale	   and	   contrast	  imaging.	  The	  last	  generation	  of	  matrix	  transducers	  are	  significantly	  smaller	  than	  the	  previous	  ones	   and	   the	   quality	   of	   2D	   and	   3D	   imaging	   has	   improved	   significantly,	   allowing	   a	   single	  transducer	  to	  acquire	  both	  2D	  and	  3DE	  studies,	  as	  well	  as	  of	  acquiring	  the	  whole	  LV	  cavity	  in	  a	  single	  beat.	  
	   28	  
	  3.2	  Three-­‐dimensional	  echocardiography	  physics	  3DE	   is	   an	   ultrasound	   technique	   and	   the	   physical	   limitation	   of	   the	   constant	   speed	   of	  ultrasounds	  in	  human	  body	  tissues	  (approximately	  1,540	  m/s	  in	  myocardial	  tissue	  and	  blood)	  cannot	  be	  overcome.	  The	   speed	  of	   sound	   in	  human	   tissues	  divided	  by	   the	  distance	  a	   single	  pulse	  has	  to	  travel	  forth	  and	  back	  (determined	  by	  the	  image	  depth)	  results	  in	  the	  maximum	  number	  of	  pulses	  that	  can	  be	  fired	  each	  second	  without	  producing	  interferences.	  Based	  on	  the	  acquired	  pyramidal	  angular	  width	  and	  the	  desired	  beam	  spacing	   in	  each	  dimension	  (spatial	  resolution),	   this	  number	   is	  related	  to	  the	  volumes	  per	  second	  that	  can	  be	   imaged	  (temporal	  resolution).	  Therefore,	  similar	  to	  2DE	  imaging,	  in	  3DE	  imaging	  there	  is	  an	  inverse	  relationship	  between	  volume	  rate	  (temporal	  resolution),	  acquisition	  volume	  size	  and	  the	  number	  of	  scan	  lines	   (spatial	   resolution).	   Any	   increase	   in	   one	   of	   these	   factors	  will	   cause	   a	   decrease	   in	   the	  other	  two.	  The	  relation	  between	  volume	  rate,	  number	  of	  parallel	  receive	  beams,	  sector	  width,	  depth,	  and	  line	  density	  can	  be	  described	  	  by	  the	  following	  equation:	  1,540	  x	  No.	  of	  parallel	  received	  beams	  Volume	  rate	   =	  	  2	  x	  Volume	  width2	  x	  Lateral	  resolution2	  x	  Volume	  depth	  	  therefore	  the	  volume	  rate	  can	  be	  adjusted	  to	  the	  specific	  needs	  by	  either	  changing	  the	  volume	  width	  or	  depth.	  The	  3D	  system	  allows	  the	  user	  to	  control	  the	   lateral	  resolution	  by	  changing	  the	   density	   of	   the	   scan	   lines	   in	   the	   pyramidal	   sector	   too.	   However,	   a	   decrease	   in	   spatial	  resolution	   also	   affects	   the	   contrast	   of	   the	   image.	   Volume	   rate	   can	   also	   be	   increased	   by	  increasing	  the	  number	  of	  parallel	  receive	  beams,	  but	  in	  this	  way	  the	  signal-­‐to-­‐noise	  ratio	  and	  the	  image	  quality	  will	  be	  affected.	  To	  put	  all	  this	  in	  perspective	  let	  us	  assume	  that	  we	  want	  to	  image	  up	  to	  16	  cm	  depth	  in	  the	  body	   and	   acquire	   a	   60°	   x	   60°	   degrees	   pyramidal	   volume.	   Since	   the	   speed	   of	   sound	   is	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approximately	  1540	  m/s	  and	  each	  pulse	  has	   to	  propagate	  16	  cm	  x	  2	   (to	  go	   forth	  and	  come	  back	   to	   the	   transducer),	   1540/0.32=	   4812	   pulses	  may	   be	   fired	   per	   second	  without	   getting	  interference	  between	  the	  pulses.	  Assuming	  that	  1°	  beam	  spacing	  in	  both	  X	  and	  Z	  dimension	  is	  a	  sufficient	  spatial	   resolution	  we	  would	  need	  3600	  beams	  (60	  x	  60)	   to	  spatially	   resolve	   the	  60°	  x	  60°	  pyramidal	  volume.	  As	  a	  result	  we	  will	   	  get	  a	   temporal	  resolution	  (volume	  rate)	  of	  4812/3600=	  1.3	  Hz,	  which	  is	  practically	  useless	  in	  clinical	  echocardiography.	  The	  example	  above	  shows	  how	  the	  fixed	  speed	  of	  sound	  in	  body	  tissues	  has	  been	  a	  major	  challenge	   to	   the	   development	   of	   3DE	   imaging.	   Manufacturers	   have	   developed	   several	  techniques	   such	   as	   parallel	   receive	   beamforming,	   multibeat	   imaging	   and	   real-­‐time	   zoom	  acquisition	  to	  cope	  with	  this	  challenge	  but	  in	  practice	  this	  is	  usually	  achieved	  by	  selecting	  the	  appropriate	  acquisition	  modality	   for	  different	   imaging	  purposes	   (see	  sub-­‐chapter	  3.4	   Image	  acquisition	  and	  display).	  Parallel	   receive	   beamforming	   or	   multiline	   acquisition	   is	   a	   technique	   where	   the	   system	  transmits	   one	  wide	   beam	   and	   receives	  multiple	   narrow	   beams	   in	   parallel.	   In	   this	   way	   the	  volume	  rate	  (temporal	  resolution)	  is	  increased	  by	  a	  factor	  equal	  to	  the	  number	  of	  the	  received	  beams.	  Each	  beamformer	  focuses	  along	  a	  slightly	  different	  direction	  that	  was	  insonated	  by	  the	  broad	  transmit	  pulse.	  As	  an	  example,	  to	  obtain	  a	  90°	  x	  90°,	  16-­‐cm	  depth	  pyramidal	  volume	  at	  25	  vps,	  the	  system	  needs	  to	  receive	  200,000	  lines/s.	  Since	  the	  emission	  rate	  is	  around	  5000	  pulsed/s,	   the	   system	   should	   receive	   42	   beams	   in	   parallel	   for	   each	   emitted	   pulse.	  However,	  increasing	  the	  number	  of	  parallel	  beams	  to	  increase	  temporal	  resolution	  leads	  to	  an	  increase	  in	  size,	  costs	  and	  power	  consumption	  of	  the	  beamforming	  electronics,	  and	  deterioration	  in	  the	  signal-­‐to-­‐noise	  ratio	  and	  contrast	   resolution.	  With	   this	   technique	  of	  processing	   the	  received	  data,	  multiple	  scan	  lines	  can	  be	  sampled	  in	  the	  amount	  of	  time	  a	  conventional	  scanner	  would	  take	  for	  a	  single	  line,	  at	  the	  expense	  of	  reduced	  signal	  strength	  and	  resolution,	  as	  the	  receive	  beam	  are	  steered	  farther	  and	  farther	  away	  from	  the	  center	  of	  the	  transmit	  beam.	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  Another	  technique	  to	  increase	  the	  size	  of	  the	  pyramidal	  volume	  and	  maintain	  the	  volume	  rate	  (or	  the	  reverse,	  e.g.	  maintain	  volume	  rate	  and	  increase	  the	  pyramidal	  volume)	  is	  the	  multibeat	  acquisition.	   With	   this	   technique,	   a	   number	   of	   ECG-­‐gated	   subvolumes	   acquired	   from	  consecutive	  cardiac	  cycles	  are	  stitched	  together	  to	  build	  up	  the	  final	  pyramidal	  volume.	  	  	  	  	  	  	  	  	  
	  
Figure	  3.5.	  Parallel	  receive	  beamforming.	  Schematic	  representation	  of	  the	  parallel	  receive	  or	  multiline	  beamforming	  technique	  receiving	  16	  (left	  panel)	  or	  64	  (central	  panel)	  beams	  for	  each	  transmit	  pulse	  (dashed	  red	  line).	  The	  right	  panel	  shows	  the	  degradation	  of	  the	  power	  and	  resolution	  of	  the	  signal	  	  (from	  red	  maximal	  to	  bright	  yellow	  minimal)	  from	  the	  parallel	  receiving	  beams	  steered	  farther	  away	  from	  the	  center	  of	  the	  transmit	  beam.	  	  
	  	  
Figure	  3.6.	  Multibeat	  acquisition.	  Two-­‐	  (panel	  A)	  and	  three-­‐dimensional	  volume	  rendered	  (panel	  B)	  imaging	  of	  the	  mitral	  valve	  from	  the	  ventricular	  perspective.	  The	  latter	  has	  been	  obtained	  from	  a	  4-­‐beat	  full-­‐volume	  acquisition	  illustrated	  in	  panel	  C.	  The	  4	  pyramidal	  subvolumes	  (the	  colors	  show	  the	  relationships	  between	  the	  pyramidal	  subvolumes,	  the	  ECG	  beats	  and	  the	  way	  the	  3D	  data	  set	  has	  been	  built	  up	  in	  the	  lower	  part	  of	  the	  figure.	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Multibeat	  acquisition	  will	  be	  effective	  only	  if	  the	  different	  subvolumes	  will	  be	  constant	  in	  position	   and	   size,	   therefore	   any	   transducer	   movement,	   cardiac	   translation	   motion	   due	   to	  respiration,	  change	  in	  cardiac	  cycle	  length	  will	  create	  subvolume	  malalignment	  and	  stitching	  artifacts.	  	  	  	  	  	  	  	  	  Finally,	  the	  quality	  of	  the	  images	  of	  the	  cardiac	  structures	  which	  can	  be	  obtained	  by	  a	  3DE	  data	  set	  will	  be	  affected	  by	  the	  point	  spread	  function	  of	  the	  system.	  The	  point	  spread	  function	  describes	  the	  imaging	  system	  response	  to	  a	  point	  input.	  A	  point	  input,	  represented	  as	  a	  single	  pixel	  in	  the	  “ideal”	  image,	  will	  be	  reproduced	  as	  something	  other	  than	  a	  single	  pixel	  in	  the	  “real”	  image.	  	  	  	  	  	  	  	  	  	  
	  	  
Figure	  3.7.	  Stitching	  artifacts.	  Volume-­‐rendered	  image	  displayed	  with	  respiratory	  gating	  artifacts.	  The	  blue	  lines	  highlight	  the	  misalignment	  of	  the	  pyramidal	  subvolumes	  	  
	  
Figure	  3.8.	  Point	  spread	  function.	  A.	  Graphical	  representation	  of	  the	  extent	  of	  degradation	  (blur)	  of	  a	  point	  passing	  through	  a	  optical	  system.	  B.	  Effect	  of	  the	  point	  spread	  function	  on	  the	  final	  image	  of	  a	  circular	  object	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  The	  degree	  of	  spreading	  (blurring)	  of	  	  any	  point	  object	  varies	  according	  to	  the	  dimension	  employed.	  In	  current	  3DE	  systems	  it	  will	  be	  around	  0.5	  mm	  in	  the	  axial	  (y)	  dimension,	  around	  2.5	  mm	  in	  the	  lateral	  (x)	  dimension,	  and	  around	  3	  mm	  in	  the	  elevation	  (z)	  dimension.	  As	  a	  result	  we	  will	  obtain	  the	  best	  images	  (less	  degree	  of	  blurring,	  i.e.	  distortion)	  when	  using	  the	  axial	  dimension	  and	  the	  worst	  (greatest	  degree	  of	  spreading)	  when	  we	  use	  the	  elevation	  dimension.	  	  These	  concepts	  have	  an	  immediate	  practical	  application	  in	  the	  choice	  of	  the	  best	  approach	  to	  image	  a	  cardiac	  structure.	  According	  to	  the	  point	  spread	  function	  of	  3DE	  the	  best	  results	  is	  expected	   to	   be	   obtained	   by	   using	   the	   parasternal	   approach	   because	   structures	   are	   mostly	  imaged	   by	   the	   axial	   and	   lateral	   dimensions.	   Conversely,	   the	  worst	   result	   is	   expected	   to	   be	  obtained	  by	  the	  apical	  approach	  which	  mostly	  uses	  the	  lateral	  and	  elevation	  dimensions.	  	  
3.3	  Image	  acquisition	  and	  display	  Currently,	   3D	   data	   set	   acquisition	   can	   be	   easily	   implemented	   into	   standard	  echocardiographic	  examination	  by	  either	  switching	  among	  2D	  and	  3D	  probes	  or,	  with	  newest	  all-­‐in-­‐one-­‐probes,	  by	   switching	  between	  2D	  and	  3D	  modalities	   available	   in	   the	   same	  probe.	  The	   latter	  probes	  are	  also	   capable	   to	  provide	   single-­‐beat	   full-­‐volume	  acquisition,	   as	  well	   as	  real-­‐time	  3D	  color	  Doppler	  imaging.	  	  	  	  At	  present,	  three	  different	  methods	  for	  3D	  data	  set	  acquisition	  are	  available:	  (2)	  	  
• multiplane	  imaging	  
• “real-­‐time”	  (or	  “live”)	  3D	  imaging	  
• multi-­‐beat	  ECG-­‐gated	  	  imaging	  
In	  the	  multiplane	  mode,	  multiple,	  simultaneous	  2D	  views	  can	  be	  acquired	  at	  high	  frame	  rate	   using	   predefined	   or	   user-­‐selected	   plane	   orientations	   and	   displayed	   using	   the	   split	  screen	  option	  (Figure	  3.3).	  The	  first	  view	  on	  the	  left	  is	  usually	  the	  reference	  plane	  that	  is	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orientated	   by	   adjusting	   the	   probe	   position	   while	   the	   other	   views	   represents	   views	  obtained	   from	   the	   reference	   view	   by	   simply	   tilting	   and/or	   rotating	   the	   imaging	   planes.	  Multiplane	   imaging	   is	   a	   real	   time	   acquisition	   and	   secondary	   imaging	   planes	   orientation	  can	  only	  be	  adjusted	  during	  acquisition.	  Doppler	  colour	  flow	  can	  be	  superimposed	  on	  2D	  images	   and	   in	   some	   systems	   both	   tissue	   Doppler	   and	   speckle	   tracking	   analysis	   can	   be	  performed.	  Although	  strictly	  not	  a	  3D	  acquisition,	  this	  imaging	  mode	  is	  useful	  in	  situations	  where	   assessment	   of	   multiple	   views	   from	   the	   same	   cardiac	   cycle	   is	   useful	   (e.g.	   atrial	  fibrillation	   or	   other	   irregular	   arrhythmias,	   stress	   echo,	   evaluation	   of	   intervenricular	  dyssynchrony)	  	  	  In	   the	   real-­‐time	   mode,	   a	   pyramidal	   3D	   volumetric	   data	   set	   is	   obtained	   from	   each	  cardiac	  cycle	  and	  visualized	  live,	  beat	  after	  beat	  as	  during	  2D	  scanning.	  As	  the	  data	  set	  is	  updated	  in	  real-­‐time,	  image	  orientation	  and	  plane	  can	  be	  changed	  by	  rotating	  or	  tilting	  the	  probe.	  Analysis	  can	  be	  done	  with	  limited	  post-­‐processing	  and	  the	  data	  set	  can	  be	  rotated	  (independent	   of	   the	   transducer	   position)	   to	   view	   the	   heart	   from	   different	   orientations.	  Heart	  dynamics	   is	  shown	  in	  a	  realistic	  way,	  with	  instantaneous	  on-­‐line	  volume	  rendered	  reconstruction.	   It	   allows	   fast	   acquisition	   of	   dynamic	   pyramidal	   data	   structures	   from	   a	  single	   acoustic	   view	   that	   can	   encompass	   the	   entire	   heart	  without	   the	   need	   of	   reference	  system,	   ECG	   and	   respiratory	   gating.	   Real-­‐time	   imaging	   is	   time-­‐saving	   both	   for	   data	  acquisition	  and	  analysis.	  Although	  this	  acquisition	  mode	  overcomes	  rhythm	  disturbances	  or	   respiratory	  motion	   limitations,	   it	   still	   suffers	   of	   relatively	   poor	   temporal	   and	   spatial	  resolution.	  Real-­‐time	  imaging	  can	  be	  acquired	  in	  the	  following	  modes:	  i. Live	   3D.	   Once	   the	   desired	   cardiac	   structure	   has	   been	   imaged	   in	   2DE	   it	   can	   be	  converted	   to	  a	  3D	   image	  by	  pressing	  a	   specific	  button	   in	   the	  control	  panel	  of	   the	  ultrasound	   system.	   The	   3D	   system	   automatically	   switch	   to	   a	   narrow	   sector	  acquisition	   (approximately	   30°	   x	   60°	   pyramidal	   volume)	   to	   preserve	   spatial	   and	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temporal	  resolution.	  The	  size	  of	  the	  pyramidal	  volume	  can	  be	  increased	  to	  visualize	  larger	   structures,	   but	   both	   scan	   line	  density	   (spatial	   resolution)	   and	   volume	   rate	  (temporal	  resolution)	  will	  drop	  down.	  3D	  live	  imaging	  mode	  is	  used	  to:	  (i).	   	  Guide	  full-­‐volume	   acquisition;	   (ii).	   Visualize	   small	   structures	   (aortic	   valve,	  masses	   etc);	  (iii).	  Record	  short-­‐lived	  events	  (i.e.	  bubble	  passage);	  (iv).	  Acquire	  full	  volume	  data	  sets	  in	  patients	  with	  irregular	  cardiac	  rhythm/dyspnea;	  (v).	  monitor	  interventional	  procedures.	  ii. Live	  3D	  colour.	  Colour	  flow	  can	  be	  superimposed	  on	  a	  live	  3D	  data	  set	  to	  visualize	  blood	  flow	  in	  real	  time.	  Temporal	  resolution	  is	  usually	  very	  low.	  iii. 3D	  zoom.	  This	  imaging	  mode	  is	  an	  extension	  of	  live	  3D	  and	  allows	  a	  focussed	  real	  time	   view	   of	   a	   structure	   of	   interest.	   A	   crop	   box	   is	   placed	   on	   a	   2D	   single-­‐	   or	  multiplane	   image	   to	   allow	   the	   operator	   to	   adjust	   lateral	   and	   elevation	   width	   to	  include	  the	  structure	  of	  interest	  in	  the	  final	  data	  set,	  then	  the	  system	  automatically	  crops	   the	   adjacent	   structures	   to	   provide	   a	   real	   time	   display	   of	   the	   structure	   of	  interest	  with	  high	  spatial	  and	  temporal	  resolution.	  The	  draw-­‐back	  of	  the	  3D	  zoom	  mode	   is	   that	   the	  operator	   loses	   the	  relationships	  of	   the	  structure	  of	   interest	  with	  surrounding	  structures.	  Mainly	  used	  during	  transoesophageal	  studies	   for	  detailed	  anatomical	  analysis	  of	  the	  structure	  of	  interest	  iv. Full-­‐volume.	   The	   full-­‐volume	   mode	   has	   the	   largest	   acquisition	   volume	   possible	  (usually	  90°	  x	  90°	  degrees).	  Real-­‐time	  (or	  “single-­‐beat”)	   full-­‐volume	  acquisition	  is	  affected	  by	  low	  spatial	  and	  temporal	  resolution	  and	  it	  is	  used	  for	  quantification	  of	  cardiac	   chambers	   when	   multibeat	   ECG	   gated	   acquisition	   is	   not	   possible	   (e.g	  irregular	  cardiac	  rhythm,	  patient	  unable	  to	  cooperate	  for	  breath-­‐holding)	  	  
In	   contrast	   to	   real-­‐time/live	   3D	   imaging,	   multi-­‐beat	   acquisition	   is	   realized	   through	  sequential	   acquisitions	   of	   narrow	   smaller	   volumes	   obtained	   from	   several	   ECG-­‐gated	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consecutive	   heart	   cycles	   (from	   2	   to	   6)	   that	   are	   subsequently	   stitched	   together	   to	   create	   a	  single	   volumetric	   data	   set	   (Figure	   3.6).	   Once	   acquired,	   the	   data	   set	   cannot	   be	   changed	   by	  manipulating	  the	  probe	  like	  in	  live	  3D	  imaging	  and	  analysis	  requires	  off-­‐line	  slicing,	  rotation	  and	   cropping	   of	   the	   acquired	   data	   set.	   It	   provides	   large	   data	   sets	   with	   high	   temporal	   and	  spatial	   resolution	   that	  can	  be	  used	   for	  quantitating	  cardiac	  chamber	  size	  and	   function	  or	   to	  assess	  spatial	  relationships	  among	  cardiac	  structures.	  However,	  this	  3D	  imaging	  mode	  has	  the	  disadvantage	  of	  the	  ECG-­‐gating,	  as	  the	  images	  are	  acquired	  over	  several	  cardiac	  cycles	  and	  the	  final	  data	  set	  is	  available	  to	  be	  visualized	  by	  the	  operator	  only	  after	  the	  last	  cardiac	  cycle	  has	  been	  acquired,	   it	   is	   a	   “near	  real-­‐time”	   imaging,	   and	   it	   is	  prone	   to	   artifacts	  due	   to	  patient	  or	  respiratory	  motion	  or	  irregular	  cardiac	  rhythms.	  	  Multibeat	  imaging	  can	  be	  acquired	  with	  or	  without	  color	   flow	  mapping	  and	  usually	  more	  cardiac	  cycles	  are	   required	   for	  3D	  color	  data	  sets.	  3D	  data	  sets	  can	  be	  sectioned	  in	  several	  planes	  and	  rotated	  in	  order	  to	  visualize	  the	  cardiac	  structure	  of	  interest	  from	  any	  desired	  perspective,	  irrespective	  of	  its	  orientation	  and	  position	  within	  the	  heart.	  This	  allows	  the	  operator	  to	  easily	  obtain	  unique	  visualizations,	  that	  may	  be	  difficult	  or	  impossible	  to	  achieve	  using	  conventional	  2DE	  (e.g.	  en-­‐face	  views	  of	  the	  tricuspid	  valve	  or	  cardiac	  defects).	  	  Three	  main	  actions	  are	  undertaken	  by	  the	  operator	  to	  obtain	  the	  desired	  view	  from	  a	  3D	  volumetric	  data	  set:	  cropping,	  slicing	  and	  rotating.	  Similarly	  to	  what	  the	  anatomists	  or	  the	  surgeons	  do	  to	  expose	  an	  anatomic	  structure	  within	  a	  3DE	  data	  set,	  the	  operator	  should	  remove	  the	  surrounding	  chamber	  walls.	  This	  process	  of	  virtually	  removing	  the	  irrelevant	  neighbouring	  tissue	  is	  called	  cropping,	  and	  can	  be	  performed	  either	  during	  or	  after	  acquisition.	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  In	  contrast	  with	  2DE	  images,	  displaying	  a	  cropped	  image	  requires	  also	  data	  set	  rotation	  (Figure	  3.9)	  and	  the	  definition	  of	  the	  viewing	  perspective	  (i.e.	  since	  the	  same	  3D	  structure	  can	  be	  visualized	  en	  face	  either	  from	  above	  or	  below,	  as	  well	  as	  from	  any	  desired	  view	  angle)(2).	  Slicing	  refers	  to	  a	  virtual	  “cutting”	  of	  the	  3D	  data	  set	  into	  one	  or	  more	  (up	  to	  twelve)	  2D	  (tomographic)	  grey-­‐scale	  images.	  	  	  	  	  	  	  	  	  	  
	  	  
Figure	  3.9.	  Data	  set	  cropping	  and	  rotation.	  	  To	  display	  the	  mitral	  valve	  from	  the	  left	  atrial	  perspective	  (surgical	  view)	  a	  full-­‐volume	  pyramidal	  data	  set	  has	  been	  cropped	  to	  remove	  part	  of	  the	  left	  ventricle	  from	  above	  and	  part	  of	  the	  left	  atrium	  from	  below.	  Then,	  remaining	  data	  set	  has	  been	  rotated	  to	  the	  desired	  perspective	  and	  to	  put	  the	  cardiac	  structures	  in	  an	  anatomical	  sound	  position	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  Finally,	  irrespective	  of	  its	  acquisition	  window,	  a	  cropped	  or	  a	  sliced	  image	  should	  be	  displayed	  according	  to	  the	  anatomical	  orientation	  of	  the	  heart	  within	  the	  human	  body	  and	  this	  is	  usually	  obtained	  by	  rotating	  the	  selected	  images.	  Acquisition	  of	  volumetric	  images	  generates	  the	  technical	  problem	  of	  rendering	  the	  depth	  perception	  on	  a	  flat,	  2D	  monitor.	  3D	  graphic	  reproduction	  has	  been	  made	  possible	  using	  computer	  graphics	  techniques.	  First,	  data	  are	  segmented	  to	  delineate	  the	  3D	  surface	  of	  structures	  of	  interest.	  Data	  segmentation	  algorithms	  separate,	  within	  the	  3D	  data	  set,	  the	  object	  to	  be	  rendered	  from	  the	  surrounding	  structures:	  blood,	  pericardial	  fluid,	  air.	  	  Since	  these	  structures	  have	  different	  physical	  properties	  and	  different	  ability	  to	  reflect	  ultrasounds,	  segmentation	  is	  obtained	  by	  setting	  a	  threshold	  of	  echo	  intensity	  (For	  example,	  any	  voxel	  with	  echo	  intensity	  equal	  or	  lower	  than	  blood	  will	  not	  be	  processed	  further).	  Once	  segmented,	  the	  
	  	  
Figure	  3.10	  Data	  set	  slicing.	  A	  full-­‐volume	  data	  set	  (Panel	  A)	  can	  be	  sliced	  in	  several	  ways.	  Two	  longitudinal	  (4-­‐chamber	  and	  the	  orthogonal	  view)	  plus	  3	  transversal	  slices	  at	  different	  levels	  of	  the	  left	  ventricle	  (yellow	  lines)	  (Panel	  B).	  Nine	  transversal	  slices	  of	  the	  left	  ventricle	  from	  the	  mitral	  valve	  (MV)	  to	  the	  apical	  (Apex)	  level	  (Panel	  C).	  	  Three	  longitudinal	  slices	  (4-­‐	  and	  2-­‐chamber	  plus	  the	  long-­‐axis	  apical	  views)	  and	  nine	  transversal	  views	  (Panel	  D).	  The	  position	  of	  the	  lowest	  and	  the	  highest	  transversal	  planes	  are	  adjustable	  by	  the	  operator	  and	  the	  slices	  in	  between	  are	  automatically	  repositioned	  to	  be	  equidistant.	  The	  position	  of	  longitudinal	  planes	  are	  adjustable	  as	  well	  both	  during	  acquisition	  and	  post	  processing.	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3D	  data	  set	  can	  be	  displayed	  using	  three	  rendering	  techniques:	  wireframe	  rendering,	  surface	  rendering	  and	  volume	  rendering.	  	  
For	  the	  purposes	  of	  cardiac	  chamber	  quantification	  only	  the	  wireframe	  and	  surface	  rendering	  are	  relevant.	  Volume	  rendering	  is	  used	  to	  visualized	  structures	  with	  complex	  morphology	  like	  the	  heart	  valves	  which	  require	  greater	  anatomical	  detail	  for	  clinically	  meaningful	  imaging.	  In	  the	  volume	  rendering	  modality,	  various	  color	  maps	  are	  applied	  to	  convey	  the	  depth	  perception	  to	  the	  observer.	  Generally,	  lighter	  shades	  (e.g.	  bronze,)	  are	  used	  for	  structures	  closer	  to	  the	  observer,	  while	  darker	  shades	  (e.g.	  blue)	  are	  used	  for	  deeper	  structures	  (Figure	  3.11,	  right	  panel).	  	  Surface	  rendering	  modality	  (Figure	  3.11,	  central	  panel)	  displays	  the	  3D	  surface	  of	  cardiac	  structures,	  identified	  either	  by	  manual	  tracing	  or	  by	  using	  automated	  border	  detection	  algorithms	  on	  multiple	  2D	  cross-­‐sectional	  images	  of	  the	  structure/cavity	  of	  interest.	  This	  stereoscopic	  approach	  is	  useful	  for	  the	  assessment	  of	  shape	  and	  for	  a	  better	  appreciation	  of	  geometry	  and	  dynamic	  function	  during	  the	  cardiac	  cycle.	  	  Wireframe	  rendering	  (Figure	  4.11,	  left	  panel)	  is	  the	  simplest	  of	  the	  available	  techniques.	  It	  identifies	  equidistant	  points	  on	   the	  surface	  of	  a	  3D	  object	  obtained	   from	  manual	   tracing,	  or	  using	  semiautomatic	  border	  detection	  algorithms,	  to	  trace	  the	  endocardial	  contour	   in	  cross-­‐sectional	   images	  and	  then	  connect	   these	  points	  using	   lines	  (wires)	   to	  create	  a	  mesh	  of	   little	  
	  
	  
Figure	  4.11.	  3D	  display	  techniques	  of	  the	  left	  ventricle.	  Wireframe	  (left	  panel),	  surface	  (central	  
panel)	  and	  volume	  (right	  panel)	  rendering	  (see	  text	  for	  details).	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polygonal	   tiles.	   Smoothing	   algorithms	   are	   used	   to	   smooth	   angles	   and	   give	   a	   realistic	  appearance	   to	   the	  structure	  of	   interest.	  This	  rendering	   technique	  processes	  a	  relatively	   low	  amount	  of	   data	   and	   it	   is	   used	   for	   relatively	   flat	   endocardial	   boundaries	   such	   as	   the	   cardiac	  chamber	   walls.	   This	   stereoscopic	   approach	   is	   useful	   for	   the	   assessment	   of	   shape	   and	   for	  better	  visualization	  of	  chambers	  volume	  and	  function	  during	  the	  cardiac	  cycle.	  	  The	  surface-­‐rendering	  technique	  is	  very	  similar	  to	  the	  wireframe	  technique	  but	  identifies	  many	  more	  points	  on	  the	  surface	  of	  the	  structure	  of	  interest	  and	  the	  lines	  joining	  the	  points	  become	   indistinguishable.	   It	  displays	   in	  detail	   the	  surfaces	  of	   the	  analyzed	  object	   facing	   the	  observer	  as	  a	  solid	  structure	  (Figure	  3.11,	  central	  panel).	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DEVELOPMENT	  OF	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CHAPTER 4 	  	  





4.1	  Background	  Correct	  quantification	  of	  cardiac	  chamber	  size	  and	  geometry	  coupled	  with	  the	  assessment	  of	  ventricular	  mass	  and	  function	  are	  critically	  important	  for	  patient	  evaluation	  and	  represent	  the	  most	  frequent	  indication	  for	  an	  echocardiographic	  study.	  2DE	   assessment	   of	   cardiac	   chamber	   volumes	   and	   function	   relies	   on	   geometric	  assumptions	  and	  is	  subject	  to	  plane	  positioning	  errors,	  leading	  to	  chamber	  foreshortening	  and	  subsequent	  underestimation	  of	  volumes.	  Moreover,	  since	  cardiac	  chambers	  like	  the	  RV	  has	  a	  complex	   asymmetric	   geometry	   which	   cannot	   be	   fitted	   into	   simple	   geometric	   models,	   and	  separate	  inflow	  and	  outflow	  which	  cannot	  be	  adequately	  visualized	  with	  any	  single	  2D	  view,	  its	   volumes	   and	   ejection	   fraction	   cannot	   be	   reliably	   calculated	   with	   conventional	   2DE.	   All	  these	   reasons	   may	   explain	   why	   standardization	   of	   measures	   with	   2DE	   has	   been	   less	  successful	   compared	   to	   other	   imaging	   techniques	   and	   	   echocardiography	   is	   sometimes	  perceived	  as	  less	  reliable	  and	  an	  excessively	  operator-­‐dependent	  technique.	  (35)	  	  The	  advent	  of	  3DE	  represents	  a	  major	  innovation	  in	  cardiovascular	  ultrasound(1).	  3DE	  is	  the	  only	  imaging	  technique	  based	  on	  volumetric	  scanning	  able	  to	  show	  moving	  structures	  in	  the	   beating	   heart,	   in	   contrast	   to	   cardiac	   magnetic	   resonance	   (CMR)	   and	   computed	  tomography,	   which	   are	   based	   on	   post-­‐acquisition	   3D	   reconstruction	   from	   multiple	  tomographic	   images	   and	   displaying	   only	   3D	   rendered	   snapshots.	   Presently,	   3D	   data	   set	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acquisition	  can	  be	  easily	  implemented	  into	  standard	  echocardiographic	  examination	  by	  either	  switching	  among	  2D	  and	  3D	  probes	  or,	  with	  newest	  all-­‐in-­‐one-­‐probes,	  by	  switching	  between	  the	  2D	  and	  3D	  modes	  available	  in	  the	  same	  probe.	  3DE	  overcomes	  geometric	  assumptions	  and	  enables	   an	   accurate	   quantitative	   and	   reproducible	   evaluation	   of	   cardiac	   chambers	   thus	  offering	   solid	   elements	   for	   patient	   management.	   Multiple	   studies	   have	   shown	   that	   3DE	  measurements	  of	  cardiac	  chamber	  volumes	  and	  function	  are	  significantly	  more	  accurate	  and	  reliable	  than	  2DE	  when	  compared	  with	  CMR	  imaging	  as	  the	  reference	  technique.	  (1)	  Recently,	  joint	   European	   Association	   of	   Echocardiography	   (EAE)/American	   Society	   of	  Echocardiography	  (ASE)	  recommendations	  have	  been	  published,	  aiming	  to	  provide	  clinicians	  with	  a	  systematic	  approach	  to	  3D	  image	  acquisition	  and	  analysis.	  (2)	  	  However,	   the	   implementation	   of	   3DE	   for	   cardiac	   chamber	   volume	   and	   function	  measurements	  in	  the	  routine	  of	  the	  echocardiographic	  laboratories	  requires	  the	  availability	  of	  reliable	  reference	  values.	  (2)	  At	  present,	  normative	  data	  about	  3DE	  cardiac	  chamber	  volumes	  and	  function	  parameter	  are	  very	  limited.	  (1,3)	  	  Accordingly,	   we	   designed	   this	   prospective,	   observational	   study	   to:	   (i)	   determine	   the	  normative	  values	  for	  	  cardiac	  chamber	  volumes	  and	  function	  parameters	  using	  3DE	  in	  a	  large	  cohort	   of	   healthy	   subjects;	   (ii)	   compare	   the	   cardiac	   chamber	  parameters	  measured	  by	  3DE	  with	   the	   same	   values	   calculated	   using	   2DE;	   (iii)	   analyze	   the	   effects	   of	   age,	   body	   size	   and	  gender	  on	  these	  parameters.	  
4.2	  Methods	  
5.2.1	  Study	  population	  	  Between	   October	   2011	   and	   September	   2013,	   263	   healthy	   volunteers	   with	   a	   wide	   age	  range	   were	   prospectively	   recruited	   among	   hospital	   employees,	   fellows	   in	   training,	   their	  parents,	  and	  people	  who	  underwent	  medical	  visits	  for	  driving	  or	  working	  license	  and	  met	  the	  inclusion	  criteria.	  The	  size	  of	   the	  study	  has	  been	  chosen	  according	  to	  Altman	  et	  al.(36)	  who	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Figure	  4.1.	  Enrollment	   flow	  chart.	  2DE:	  two-­‐dimensional	  echocardiography;	  3DE:	  three-­‐dimensional	  echocardiography.	  
 
Recruited	  healthy	  volunteers	  (n=263)	  
Subjects	  excluded	  due	  to:	  -­‐ Inadequate	  acoustic	  window	  for	  2DE	  and	  3DE	  evaluation	  (n=6)	  -­‐ Abnormal	  echocardiographic	  study	  (n=13)	  
Enrolled	  healthy	  volunteers	  (n=244)	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TABLE	  4.1	  –	  Demographic	  Characteristics	  of	  the	  enrolled	  healthy	  volunteers	  	   	   All	  (n=244)	   Men	  (n=103)	   Women	  (n=141)	   	  p	  	  Value	  Age	  (years)	   43	  ±	  14	   42	  ±	  14	   44	  ±	  14	   NS	  Age	  range	  (years)	   18	  -­‐	  75	   18	  –	  74	   18	  -­‐	  75	   NS	  Heart	  rate	  (bpm)	   68	  ±	  12	   67	  ±	  12	   69	  ±	  11	   NS	  Height	  (cm)	   170	  ±	  9	   178	  ±	  6	   165	  ±	  7	   <	  0.001	  Weight	  (kg)	   67	  ±	  11	   76	  ±	  9	   61	  ±	  8	   <	  0.001	  Body	  mass	  index	  (kg/m2)	   23.1	  ±	  2.8	   24.1	  ±	  2.4	   22.3	  ±	  2.8	   <	  0.001	  Body	  surface	  area	  (m2)	   1.78	  ±	  0.18	   1.93	  ±	  0.13	   1.67	  ±	  0.13	   <	  0.001	  Systolic	  blood	  pressure	  (mmHg)	   121	  ±	  13	   126	  ±	  11	   117	  ±	  14	   <	  0.001	  Diastolic	  blood	  pressure	  (mmHg)	   74	  ±	  8	   77	  ±	  8	   71	  ±	  8	   <	  0.001	  
*	  p	  values	  refer	  to	  gender	  differences	  
 For	  the	  development	  of	  the	  reference	  values	  for	  the	  RV,	  data	  collected	  at	  the	  University	  of	  Padua	  were	  merged	  with	   those	   prospectively	   collected	   in	   2	   Italian	   tertiary	   centers	   (Centro	  Cardiologico	  Monzino,	  Milan;	  University	  Federico	  II,	  Naples)	  having	  a	   large	  expertise	  in	  3DE	  for	   RV	   quantification	   (>400	   studies/year/center	   for	   both	   clinical	   and	   research	   purposes).	  Participating	  centers	  were	  asked	  to	  provide	  samples	  with	  a	  fairly	  uniform	  distribution	  among	  genders	  and	  age	  (from	  18	  to	  90	  years).	  	  
4.2.2	  Data	  set	  acquisition.	  	  Using	  a	  standardized	  protocol,	  all	  examinations	  were	  perfomed	  by	  three	  cardiologists	  with	  experience	  in	  research	  echocardiography	  (DM,	  LDB,	  LPB)1	  using	  a	  commercially-­‐available	  Vivid	  E9	  ultrasound	  machine	  (GE	  Vingmed	  Ultrasound,	  Norway)	  equipped	  with	  M5S	  and	  4V	  probes	  for	  2D	  and	  3DE,	  respectively.	  All	  patients	  were	  examined	  in	  the	  left	  lateral	  position	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  1	  DM=	  dott.ssa	  Denisa	  Muraru,	  LDB	  =	  dott.ssa	  Lucia	  Dal	  Bianco,	  LPB=	  dott.	  Luigi	  Paolo	  Badano	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using	  grey	  scale	  second-­‐harmonic	  2D	  imaging	  technique,	  with	  the	  adjustment	  of	  image	  contrast,	  frequency,	  depth,	  and	  sector	  size	  for	  adequate	  frame	  rate	  and	  optimal	  endocardial	  border	  visualization.	  Care	  was	  taken	  to	  avoid	  cardiac	  chamber	  foreshortening	  in	  both	  apical	  views,	  and	  image	  acquisition	  was	  done	  during	  breath	  holding	  to	  minimize	  respiratory	  movements.	  Conventional	  transthoracic	  echocardiography	  included:	  (i).	  2D	  guided	  M-­‐mode	  tracings	  of	  LV	  wall	  thickness	  and	  cavity	  diameter	  to	  calculate	  LV	  mass;	  (ii).	  Zoom	  imaging	  of	  LV	  outflow	  tract	  obtained	  from	  parasternal	  2D	  long-­‐axis	  view;	  (iii).	  Spectral	  recordings	  of	  LV	  outflow	  tract	  flow	  sampled	  using	  a	  pulsed-­‐wave	  Doppler	  sample	  volume	  positioned	  just	  proximal	  to	  the	  aortic	  valve	  so	  that	  the	  location	  of	  the	  velocity	  recording	  could	  match	  the	  LV	  outflow	  tract	  measurement;	  (iv).	  Apical	  4-­‐	  and	  2-­‐chamber	  view	  recordings	  for	  LV	  volumes,	  taking	  care	  of	  maximising	  LV	  length	  and	  obtaining	  the	  highest	  frame	  rate	  by	  reducing	  depth	  in	  order	  to	  exclude	  atria;	  (v).	  Apical	  4-­‐	  and	  2-­‐chamber	  view	  recordings	  for	  LA	  volumes,	  taking	  care	  of	  maximising	  LA	  length	  and	  obtaining	  the	  highest	  frame	  rate	  by	  reducing	  the	  scanning	  sector	  angle	  in	  order	  to	  exclude	  the	  right	  atrium;	  (vi).	  RV	  focused	  4-­‐chamber	  apical	  view,	  taking	  care	  of	  maximising	  RV	  area	  and	  length;	  and	  (vii).	  RA	  focused	  4-­‐chamber	  view	  taking	  care	  of	  maximising	  RA	  length	  and	  area.	  (38)	  All	  tracings	  and	  recordings	  contained	  at	  least	  3	  cardiac	  cycles	  to	  allow	  averaging	  of	  measurements.	  Separate	  3DE	  full-­‐volume	  LV,	  LA,	  RV	  and	  RA	  data	  sets	  obtained	  by	  stitching	  together	  4	  or	  6	  consecutive	   ECG-­‐gated	   subvolumes	  were	   acquired	   by	   the	   same	   examiner	   at	   the	   end	   of	   the	  conventional	  2DE	  and	  Doppler	  study.	  Using	  multi-­‐slice	  display	  of	  the	  3D	  data	  set,	  special	  care	  was	   taken	   to	   visualize	   all	   cardiac	   chamber	   segments	   and	   to	   exclude	   any	   stitching	   artifacts	  between	   subvolumes.	  Data	   sets	  were	   stored	  digitally	   in	   raw-­‐data	   format	   and	   exported	   to	   a	  separate	  workstation	  for	  analysis.  
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4.2.3	  Data	  set	  post-­‐processing	  and	  quantitative	  analyses	  Image	   quality	   check,	   post-­‐processing	   and	   analysis	   were	   performed	   by	   2	   independent	  observers	   (DM,	   LPB)2,	   having	   a	   3-­‐year	   long	   experience	  with	   the	   software	   packages	   used	   in	  this	  project.	  
4.2.3.1	   Left	   ventricular	   data	   set	   analysis.	   LV	   mass	   was	   calculated	   using	   measurement	  performed	   on	   2DE	   guided	   M-­‐mode	   tracings(39)	   according	   to	   the	   ASE	   leading-­‐edge	  convention(40).	  To	  calculate	  LV	  stroke	  volume	  (SV),	  LV	  outflow	  tract	  diameter	  was	  measured	  in	   the	  zoom	  parasternal	   long-­‐axis	  view	   in	  mid-­‐systole	   from	   the	  white-­‐black	   interface	  of	   the	  septal	  endocardium	  to	  the	  anterior	  mitral	  leaflet,	  parallel	  to	  the	  aortic	  valve	  plane	  and	  within	  0.5-­‐1.0	  cm	  of	   the	  valve	  orifice.	  End-­‐diastole	  and	  end-­‐systole	  were	   identified	   from	  2DE	  cine-­‐loops	  using	   frame-­‐by-­‐frame	  analysis	  of	   the	  apical	  4-­‐	  and	  2-­‐chamber	  LV	  views	  as	   the	   largest	  and	  smallest	  cavity	  during	  the	  cardiac	  cycle,	  respectively.	  Then,	  manual	  tracing	  of	  endocardial	  border	   was	   performed	   in	   both	   frames,	   paying	   attention	   to	   include	   the	   papillary	   muscles	  within	  the	  LV	  cavity.	  LV	  end-­‐diastolic	  (EDV)	  and	  end-­‐systolic	  (ESV)	  volumes	  were	  calculated	  using	  the	  biplane	  disc-­‐summation	  algorithm	  (modified	  Simpson’s	  rule)	  and	  ejection	   fraction	  (EF)	  was	  calculated	  as	  1-­‐	  ESV/EDV.	  2DE	  end-­‐diastolic	  sphericity	  index	  was	  calculated	  from	  LV	  EDV	  and	  LV	   longitudinal	  axis	   (calculated	  as	   the	  average	  between	  LV	   longitudinal	  axes	   in	  4-­‐	  and	  2-­‐chamber	  views),	  by	  applying	  the	  same	  formula	  as	  with	  3DE	  (see	  below).	  Quantification	  of	  3D	  LV	  volumes	  and	  EF	  was	  performed	  using	  a	  commercially-­‐available	  software	  (4D	  AutoLVQ,	  GE	  Vingmed,	  Norway),	  previously	  validated	  against	  CMR,	  (41)	  by	  completing	  the	  following	  steps:	  	  	  
(i) Automatic	  slicing	  of	  LV	  full-­‐volume	  data	  set.	  The	  end-­‐diastolic	  frames	  needed	  for	  contour	  detection	  were	  automatically	  displayed	  in	  quad-­‐view:	  apical	  four-­‐,	  two-­‐chamber,	  long-­‐axis	  views	  and	  LV	  short-­‐axis	  plane.	  Each	  longitudinal	  view	  was	  colour-­‐	  coded	  and	  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  2	  DM=	  dott.	  Denisa	  Muraru;	  LPB=	  dott.	  Luigi	  P.	  Badano	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indicated	  on	  the	  short-­‐axis	  image	  at	  60°	  between	  each	  plane.	  Both	  reference	  frames	  in	  the	  end-­‐systole	  and	  end-­‐	  diastole	  could	  be	  also	  manually	  selected,	  if	  necessary.	  








(iii)	  LV	  reference	  point	  identification.	  To	  subsequently	  identify	  a	  fitting	  geometric	  model,	  the	  software	  required	  manual	  input	  of	  only	  three	  single	  points	  for	  each	  of	  the	  three	  LV	  apical	  planes	  (two	  points	  at	  mitral	  annulus	  borders,	  and	  one	  at	  the	  apex	  showed	  as	  green	  dots	  in	  Figure	  4.3)	  first	  in	  end-­‐diastolic	  frames,	  and	  then	  for	  corresponding	  end-­‐systolic	  frames.	  Manual	  positioning	  of	  the	  points	  was	  simultaneously	  shown	  on	  the	  LV	  short-­‐axis	  view	  for	  
	  
	  
Figure	  4.2	  Left	  ventricular	  data	  set	  alignment.	  The	  3	  longitudinal	  planes	  (e.g.	  4-­‐,	  2-­‐chamber	  and	  long-­‐axis	  views)	  are	  manual	  aligned	  by	  pivoting	  and	  translating	  the	  respective	  plane	  in	  order	  that	  the	  corresponding	  intersection	  line	  of	  all	  planes	  was	  placed	  in	  the	  middle	  of	  the	  LV	  cavity,	  crossing	  the	  LV	  apex	  and	  the	  centre	  of	  mitral	  valve	  opening	  in	  each	  view.	  The	  spatial	  orientation	  of	  	  each	  longitudinal	  plane	  is	  visualized	  on	  the	  short	  axis	  plane	  on	  the	  roght	  lower	  panel	  and	  can	  be	  readjusted	  to	  optimize	  it.	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After	  completing	  steps	  1	  –	  4	  for	  end-­‐diastolic	  views,	  only	  3	  –	  4	  sequence	  was	  required	  for	  end-­‐systolic	  frames,	  since	  adjustments	  done	  in	  steps	  1	  –	  2	  were	  automatically	  carried	  out	  subsequently	  in	  end-­‐systolic	  views.	  
	  	  
Figure	  4.3	  Identification	  of	  reference	  point	  and	  of	  endocardial	  border.	  Reference	  points	  at	  mitral	  annulus	  and	  LV	  apex	  (green	  dots	  on	  the	  left	  upper	  panel)	  are	  manually	  identified	  to	  allow	  the	  software	  to	  provide	  an	  automatic	  identification	  of	  the	  endocardial	  border	  (green	  line).	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(v)	  Final	  quantitative	  analysis	  and	  data	  display.	  Using	  the	  initial	  contours	  in	  both	  end-­‐systole	  and	  end-­‐diastole,	  a	  corresponding	  dynamic	  surface-­‐rendered	  LV	  cast	  was	  derived.	  Final	  data	  panel	  automatically	  displayed	  LVEDV,	  LVESV,	  LVEF,	  stroke	  volume,	  cardiac	  output,	  and	  heart	  rate	  values.	  A	  volume	  –	  time	  plot	  was	  also	  provided.	  
Manual	  editing	  of	  the	  semi-­‐automatically	  generated	  endocardial	  contours	  was	  routinely	  applied	  in	  order	  to	  include	  the	  LV	  outflow,	  as	  well	  as	  papillary	  muscles	  and	  trabeculae	  within	  the	  LV	  cavity	  since	  this	  approach	  was	  found	  to	  reduce	  the	  bias	  in	  comparison	  with	  CMR.	  (41,42)	  	  In	  addition,	  this	  software	  enabled	  automatic	  calculation	  of	  LV	  sphericity	  index	  and	  LV	  mass	  measurements.	  LV	  sphericity	  index	  is	  a	  quantitative	  parameter	  reflecting	  LV	  shape	  and	  it	  is	  calculated	  as	  the	  ratio	  between	  the	  LV	  EDV	  divided	  by	  the	  volume	  of	  a	  sphere,	  whose	  diameter	  is	  equal	  to	  the	  longitudinal	  LV	  axis	  measured	  at	  end-­‐diastole(43).	  	  For	  LV	  mass	  calculation,	  after	  LV	  endocavitary	  volume	  quantitation	  the	  software	  automatically	  detected	  also	  the	  epicardial	  LV	  contours	  in	  end-­‐diastole	  and	  in	  end-­‐systole.	  Both	  endo-­‐	  and	  epicardial	  contours	  were	  verified	  by	  the	  operator	  and	  manually	  adjusted	  to	  fit	  
	  
	  
Figure	  4.4.	  Measurement	  of	  left	  ventricular	  volumes	  by	  3D	  echocardiography.	  Left	  ventricular	  beutel	  size	  is	  generated	  through	  semi-­‐automated	  identification	  of	  endocardial	  surface	  and	  volume	  measurement	  is	  based	  on	  beutel	  voxel	  count	  .	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4.2.3.2	  Right	  ventricular	  data	  set	  analysis.	  Offline	  analyses	  of	  all	  RV	  data	  sets	  were	  carried	  out	  using	  a	  single	  commercially-­‐available	  software	  package	  (TomTec	  4D	  RV	  Analysis,	  Unterschleissheim,	  D)	  by	  one	  experienced	  investigator	  in	  each	  center.	  This	  vendor-­‐independent	  software	  was	  validated	  against	  CMR	  and	  its	  workflow	  has	  been	  extensively	  described	  elsewhere.	  (44-­‐46) This	  software	  uses	  border-­‐detection	  algorithms	  to	  obtain	  a	  dynamic	  surface-­‐rendered	  RV	  cast	  (beutel)	  which	  enables	  the	  evaluation	  of	  RV	  geometry	  and	  contraction	  from	  any	  perspective.	  	  Adequate	  identification	  of	  3	  pre-­‐defined	  RV	  planes	  is	  required	  in	  order	  to	  proceed	  with	  RV	  quantitative	  analysis	  workflow:	  RV	  apical	  4-­‐chamber	  plane	  (RV	  inflow),	  saggital	  plane	  (the	  plane	  orthogonal	  to	  the	  4-­‐chamber	  plain,	  that	  includes	  the	  RV	  outflow	  tract)	  and	  coronal	  plane	  (transversal	  plane	  displaying	  the	  crescentic	  RV	  cavity	  in	  short-­‐axis).	  	  	  
	  
	  
Figure	  4.5.	  Measurement	  of	  left	  ventricular	  mass	  by	  3D	  echocardiography.	  Semi-­‐automated	  identification	  of	  endocardial	  and	  epicardial	  surfaces	  allows	  measurement	  of	  endo-­‐	  and	  epi-­‐cardial	  volumes.	  Then,	  LV	  mass	  was	  automatically	  computed	  by	  multiplying	  myocardial	  volume	  (epicardial	  volume	  -­‐	  endocardial	  volume)	  multiplied	  by	  the	  specific	  weigth	  of	  the	  myocardial	  tissue	  (1.05	  g/ml).	   	  
	   53	  





Figure	  4.5.	  Three-­‐dimensional	  analysis	  of	  the	  right	  ventricle.	  Semi-­‐automated	  dedicated	  software	  for	  right	  ventricular	  volumes	  and	  function	  quantitation	  based	  of	  3D	  data	  set.	  After	  manual	  initialization	  on	  standard	  2D	  views	  of	  the	  right	  ventricle	  (coronal,	  A;	  sagittal,	  B;	  4-­‐chamber,	  C),	  the	  software	  identifies	  the	  cavity	  contour	  in	  three	  dimensions	  and	  provides	  a	  surface	  reconstruction	  of	  the	  right	  ventricular	  cavity	  (cast,	  D).	  	  











4.2.3.3	  Left	  atrial	  data	  set	  analysis.	  2DE	  LA	  images	  were	  analyzed	  using	  EchoPAC	  v112.1.3,	  (GE	  Vingmed,	  Horten,	  Norway).	   The	   LV	   end-­‐systolic	   frame	   corresponding	   to	   the	   largest	   LA	  area,	  just	  before	  the	  mitral	  valve	  opening,	  was	  identified	  in	  the	  dedicated	  4CH	  and	  2CH	  views.	  Then,	  endocardial	  border	  was	  manually	  traced	  in	  the	  same	  frames	  paying	  attention	  to	  exclude	  the	   area	   between	   the	   mitral	   leaflets	   and	   annulus,	   pulmonary	   veins	   and	   atrial	   appendix	   to	  obtain	  LA	  area.	  	  	  	  	  	  	  	  	  	   	  	  Figure	  4.7.	  Two-­‐dimensional	  echocardiography	  assessment	  of	  left	  atrial	  
size.	  A)	  Dedicated	  4-­‐chamber	  view;	  B)	  Dedicated	  2-­‐chamber	  view.	  IAS:	  interatrial	  septum;	  MV:	  mitral	  valve.	  
	  	  
Figure	  4.6.	  Results	  of	  right	  ventricular	  quantitative	  analysis.	  Surface	  rendering	  of	  the	  right	  ventricle	  obtained	  by	  transthoracic	  three-­‐dimensional	  echocardiography	  (Panel	  A).	  Time-­‐volume	  curve	  showing	  right	  volume	  changes	  during	  cardiac	  cycle	  (Panel	  B).	  Results	  of	  the	  quantitative	  analysis	  are	  shown	  in	  Panel	  C.	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Maximal	   LA	   volume	   (Vmax)	   was	   automatically	   calculated	   by	   the	   software,	   considering	  both	  4-­‐	  and	  2-­‐chamber	  analyses,	  using	  the	  biplane	  discs’	  summation	  method.(38)	  The	  same	  process	  was	   used	   to	   calculate	   the	  minimum	  LA	   volume	   (Vmin)	   and	   pre	  A	   volume	   (VpreA),	  corresponding	  to	  the	  end-­‐diastolic	  frame,	  just	  after	  mitral	  valve	  closure,	  and	  to	  the	  peack	  of	  P	  wave	  frame,	  respectively.	  3DE	   LA	   analysis	   was	   performed	   using	   a	   dedicated	   software	   designed	   for	   volumetric	  analysis	  of	   the	  LA	   (LA	  analysis,	  Tomtec	   Imaging	  Systems,	  Unterschleissheim,	  Germany)	  and	  recently	  validated	  against	  CMR.(48)	  At	  the	  beginning	  of	   the	  3DE	  analysis	  workflow,	  LA	  data	  set	  was	  automatically	  sliced	  4-­‐,	  2-­‐chamber	  and	  long-­‐axis	  apical	  planes,	  and	  a	  short-­‐axis	  plane.	  	  The	  end-­‐systolic,	  pre	  A	  and	  end-­‐diastolic	   frames	  were	  marked	   in	   the	  corresponding	  cardiac	  cycle.	  Then,	  rapid	  manual	  data	  set	  alignment	  was	  performed	  by	  translating	  and	  rotating	  the	  4-­‐chamber	   plane	   in	   order	   to	   obtain	   orthogonal	   non-­‐foreshortened	   planes	   of	   the	   LA	   in	   all	   3	  apical	  planes.	  In	  each	  apical	  plane,	  the	  LA	  blood-­‐tissue	  interface	  was	  manually	  initialized	  on	  2	  frames	   identifying	   LA	   Vmax,	   and	   Vmin.	   These	   initialized	   LA	   endocardial	   boundaries	   were	  used	   to	   reconstruct	   the	   LA	   endocardial	   surface.	   A	   3DE	   surface	   of	   the	   LA	   volume	  was	   then	  generated	  for	  each	  frame	  throughout	  the	  cardiac	  cycle	  resulting	   in	  a	  dynamic	  cast	  of	   the	  LA	  cavity	  .	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  For	   each	   consecutive	   frame,	   the	   voxel	   count	   inside	   the	   3DE	   LA	   surface	   was	   used	   to	  measure	  LA	  volume,	  resulting	  in	  a	  smooth	  interpolated	  time-­‐volume	  curve	  from	  which	  Vmax,	  Vmin	  and	  VpreA	  can	  be	  easily	  obtained.	  	  
	  
	  
Figure	  4.9.	  Three-­‐dimensional	  echocardiography	  (3DE)	  assessment	  of	  left	  atrial	  size	  (LA)	  and	  
function.	  Transversal	  (A)	  and	  longitudinal	  (B)	  visualization	  of	  3D	  LA	  surface	  superimposed	  on	  gray	  scale	  3DE	  data	  set,	  and	  time-­‐volume	  curve	  depicting	  LA	  volume	  changes	  during	  the	  cardiac	  cycle	  (C).	  From	  this	  time-­‐volume	  curve	  curve	  the	  values	  from	  maximal	  (Vmax),	  minimal	  (Vmin)	  and	  pre-­‐A	  (VpreA)	  LA	  volumes	  can	  be	  obtained,	  from	  which	  passive	  (PassEV),	  active	  (ActEV)	  and	  total	  (TotEV)	  emptying	  volumes	  has	  been	  calculated	  (see	  text).	  	  
	  
Figure	  4.8.	  Three-­‐dimensional	  echocardiography	  quantification	  of	  left	  atrial	  volumes	  and	  
function.	  The	  3D	  LA	  surface	  is	  displayed	  at	  3	  different	  phases	  of	  the	  cardiac	  cycle,	  namely	  the	  minimum,	  maximum	  and	  pre	  A	  LA	  volumes,	  along	  with	  the	  electrocardiogram	  and	  mitral	  valve	  inflow	  pulsed	  Doppler	  to	  show	  temporization	  of	  LA	  volume	  changes.	  3D:	  three-­‐dimensional;	  LA:	  left	  atrium.	  
	   57	  
From	   LA	   volumes	  we	   calculated:	   total	   emptying	   volume	   (EV),	   which	   represents	   the	   LA	  reservoir	   function,	  as	   the	  difference	  between	  Vmax	  and	  Vmin;	  passive	  EV,	  which	  represents	  conduit	   function,	   as	   the	   difference	   between	   Vmax	   and	   VpreA;	   and	   active	   EV¸	   which	  corresponds	   to	   LA	   booster	   function,	   as	   the	   difference	   between	   VpreA	   and	   Vmin.(49)	  Accordingly,	   total	   emptying	   fraction	   (EmptFr)	   was	   total	   EV/Vmax,	   passive	   EmptFr	   was	  passive	  EV/Vmax	  and	  active	  EmptFr	  was	  active	  EV/VpreA.	  In	  addition,	  we	  calculated	  the	  LA	  expansion	  index	  as	  [(Vmax-­‐Vmin)/Vmin]	  x100%	  as	  an	  index	  of	  LV	  filling	  pressure	  
4.2.3.4	  Right	  atrial	  data	  set	  analysis.	  	  2DE	  images	  were	  analyzed	  using	  EchoPAC	  v110.1.3,	  (GE-­‐Healthcare,	  Horten,	  Norway).	  The	  RV	  end-­‐systolic	  frame	  corresponding	  to	  the	  largest	  RA	  area,	  just	  before	  the	  tricuspid	  valve	  opening,	  was	  identified	  in	  the	  dedicated	  apical	  4-­‐chamber	  view.	  Supero-­‐inferior	  and	  medio-­‐lateral	  diameters	  were	  measured	  according	  to	  current	  guidelines.	  (50)	  Then	  endocardial	  border	  was	  manually	  traced	  in	  the	  same	  frame	  paying	  attention	  to	  exclude	  the	  area	  between	  the	  tricuspid	  leaflets	  and	  annulus	  to	  obtain	  RA	  area.	  	  	  	  	  	  	  	  	  	   	  Maximal	  RA	  volume	  (Vmax)	  was	  automatically	  calculated	  by	  the	  software	  using	  the	  area-­‐length	  method.	  (38)	  Using	  the	  same	  procedure	  we	  also	  measured	  the	  minimal	  RA	  volume	  (Vmin)	  as	  the	  smallest	  RA	  cavity	  during	  the	  cardiac	  cycle,	  just	  before	  tricuspid	  valve	  closure,	  
	  
	  
Figure	  4.10.	  Two-­‐dimensional	  echocardiography	  (2DE)	  
assessment	  of	  right	  atrial	  (RA)	  size.	  A.	  RA	  supero-­‐inferior	  (SI)	  	  and	  medio-­‐lateral	  (ML)	  diameters	  measured	  on	  a	  dedicated	  4-­‐chamber	  view.	  B.	  RA	  area	  tracing.	  IAS,	  interatrial	  septum;	  TA,	  tricuspid	  annulus.	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and	  pre	  A	  volume	  (VpreA)	  as	  the	  RA	  volume	  corresponding	  at	  P	  wave	  peak	  on	  the	  ECG	  tracing.	  	  3DE	   RA	   analysis	   was	   performed	   using	   a	   dedicated	   software	   designed	   for	   volumetric	  analysis	   of	   the	   left	   atrium	   (LA	   analysis,	   Tomtec	   Imaging	   Systems,	   Unterschleissheim,	  Germany)	   and	   recently	   validated	   against	   CMR.	   (48)	   At	   the	   beginning	   of	   the	   3D	   analysis	  workflow,	  RA	  data	  set	  was	  automatically	  sliced	  4-­‐,	  2-­‐chamber,	  and	  long-­‐axis	  apical	  planes	  and	  a	   short-­‐axis	   plane.	   Rapid	   manual	   data	   set	   alignment	   was	   performed	   by	   translating	   and	  rotating	  the	  4-­‐chamber	  plane	  in	  order	  to	  obtain	  orthogonal	  non-­‐foreshortened	  planes	  of	  the	  RA	   in	   all	   3	   apical	   views.	   In	   each	   apical	   view,	   the	   RA	   blood-­‐tissue	   interface	   was	   manually	  initialized	   on	   2	   frames	   identifying	   RA	   Vmax,	   and	   Vmin.	   These	   initialized	   RA	   endocardial	  boundaries	   were	   used	   to	   reconstruct	   the	   RA	   endocardial	   surface.	   A	   surface	   rendered	   3D	  beutel	   of	   the	   RA	   volume	   was	   then	   generated	   for	   each	   frame	   throughout	   the	   cardiac	   cycle	  resulting	  in	  a	  dynamic	  cast	  of	  the	  RA	  cavity.	  	  	  	  	  	  	  	  	  	  For	  each	  consecutive	  frame,	  the	  voxel	  count	  inside	  the	  RA	  beutel	  was	  used	  to	  measure	  RA	  volume,	   resulting	   in	  a	   smooth	   interpolated	   time-­‐volume	  curve	   from	  which	  Vmax,	  Vmin	  and	  VpreA	  can	  be	  easily	  obtained.	  	  
	  
	  
Figure	  4.11.	  3DE	  dynamic	  quantitation	  of	  right	  atrial	  (RA)	  volumes	  
and	  function.	  The	  RA	  beutel	  is	  displayed	  at	  3	  different	  phases	  of	  the	  cardiac	  cycle,	  namely	  the	  minimum,	  maximum	  and	  preA	  RA	  volumes	  along	  with	  the	  electrocardiogram	  to	  show	  temporization	  of	  RA	  function	  phases.	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Similar	   to	   measurements	   performed	   for	   the	   LA,	   from	   RA	   volumes	   we	   calculated	   total	  emptying	  volume	  (EV),	  which	  represents	  the	  RA	  reservoir	  function,	  as	  the	  difference	  between	  Vmax	   and	   Vmin;	   passive	   EV,	  which	   represents	   conduit	   function,	   as	   the	   difference	   between	  Vmax	  and	  VpreA;	  and	  active	  EV¸	  which	  corresponds	  to	  RA	  booster	  function,	  as	  the	  difference	  between	   VpreA	   and	   Vmin	   (49,51).	   Accordingly,	   total	   emptying	   fraction	   (EmptFr)	  was	   total	  EV/Vmax,	  passive	  EmptFr	  was	  passive	  EV/Vmax	  and	  active	  EmptFr	  was	  active	  EV/VpreA. 
	  
4.2.4	  Statistical	  analysis.	  	  Normal	  distribution	  of	  study	  variables	  was	  checked	  using	   the	  Kolmogorov-­‐Smirnov	   test.	  Continuous	  variables	  were	  summarized	  as	  mean±SD	   if	  normally	  distributed.	  Variables	  were	  compared	  between	  men	  and	  women	  using	   the	  unpaired	   t-­‐test.	  3DE	  and	  2DE	  measurements	  obtained	   from	  the	  same	  subject	  were	  compared	  using	   the	  paired	   t-­‐test.	  Pearson	  correlation	  was	  used	  to	  analyze	  the	  relationships	  between	  chamber	  size	  size	  and	  age	  and	  body	  size.	  	  Inter-­‐observer	  variablity	  for	  3D	  LV	  volumes	  and	  mass	  was	  analyzed	  in	  15	  random	  subjects	  by	  2	  independent	  observers.	  Intra-­‐observer	  variability	  was	  analyzed	  in	  another	  group	  of	  15	  
	  
	  
Figure	  4.12.	  Three-­‐dimensional	  echocardiography	  (3DE)	  assessment	  of	  the	  right	  
atrial	  (RA)	  size	  and	  function.	  Longitudinal	  visualization	  of	  a	  	  surface	  rendered	  RA	  beutel	  superimposed	  on	  gray	  scale	  3DE	  data	  set	  (upper	  panel),	  and	  time-­‐volume	  curve	  depicting	  RA	  volume	  changes	  during	  the	  cardiac	  cycle	  (lower	  panel).	  From	  this	  time-­‐volume	  curve	  the	  values	  for	  maximal,	  minimal	  and	  pre-­‐A	  RA	  volumes	  can	  be	  obtained	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subjects	  by	  the	  same	  observer	  repeating	  the	  measurements	  1	  week	  later.	  For	  each	  parameter,	  reproducibility	  was	  reported	  as	  mean	  difference	  and	  coefficient	  of	  repeatability	  (1.96	  SD	  of	  the	  differences	  between	  the	  two	  measurements)	  by	  Bland-­‐Altman	  analysis,	  and	  as	  intraclass	  correlation	  coefficient	  (ICC).	  All	  analyses	  were	  carried	  out	  using	  SPSS	  19.0	  (SPSS	  Inc,	  Chicago,	  IL,	  USA)	  and	  MedCalc	  10.0.1.0	  Mariakerke,	  Belgium).	  Differences	  among	  variables	  were	  considered	  significant	  at	  p<0.05.	  Upper	  and	  lower	  limits	  of	  normality	  were	  computed	  as	  the	  mean	  value	  plus	  or	  minus	  2SD.	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CHAPTER 5 	  	  





5.1	  Background	  Noninvasive	   assessment	   of	   LV	   geometry	   and	   function	   ranks	   among	   the	   principal	  parameters	   assessed	  with	   echocardiography.	   Suitability	   for	  device	   implantation,	   indications	  to	   cardiac	   surgery	   or	   to	   treatment	   initiation	   in	   asymptomatic	   patients	   with	   LV	   systolic	  dysfunction	  are	  among	  the	  most	  critical	  decisions	  that	  rely	  on	  an	  accurate	  LV	  quantification.	  (52,53)	  	  LV	   volume	   measurement	   by	   2DE	   is	   highly	   experience-­‐dependent,	   uses	   only	   partial	  information	  contained	  in	  few	  predefined	  cross-­‐sections	  to	  assess	  global	  myocardial	  function,	  and	  relies	  on	  geometrical	  assumptions	  that	  may	  not	  be	  necessarily	  valid	   in	  all	  patients.	  2DE	  has	  also	  shown	  limited	  test-­‐retest	  reproducibility	  for	  LV	  volumes	  and	  EF	  quantification.	  (54)	  Geometric	   assumptions	   render	   the	   measurements	   of	   LV	   volume	   and	   EF	   particularly	  inaccurate	   in	   those	   patients	   in	  whom	   these	   parameters	   are	  most	   needed	   (i.e.	   patients	  with	  previous	  myocardial	  infarction	  or	  cardiomyopathies,	  whose	  LVs	  are	  asymmetric	  or	  distorted).	  	  	  	  	  3D	  LV	  data	   set	   analysis	   can	  now	  be	  performed	  using	   computerized	   automated	  or	   semi-­‐automated	   endocardial	   surface	   detection	   softwares,	   which	   do	   not	   rely	   on	   geometric	  assumptions	   and	   require	   only	   minimal	   human	   intervention,	   therefore	   improving	  measurement	   reproducibility	   (Figure	  4.4).	   After	   identification	   of	   few	   anatomical	   landmarks	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(i.e.	  apex	  and	  mitral	  annulus	  reference	  points),	  the	  3D	  LV	  cast	  can	  be	  automatically	  segmented	  into	   the	   standard	   16	   or	   17	   segments.	   The	   volume	   of	   the	   entire	   LV	   cavity,	   as	   well	   as	   the	  separate	  subvolumes	  corresponding	  to	  each	  of	  16	  or	  17	  segments	  can	  be	  measured	  frame-­‐by-­‐frame	  and	  plotted	  against	  time	  .	  	  	   	  	  	  	  	  	  	  	  	  	  3DE	  has	  been	  extensively	  validated	  against	  CMR	  (Table	  5.1)	  and	  has	  been	  demonstrated	  to	  be	  more	  time-­‐saving,	  reproducible	  and	  accurate	  than	  conventional	  2DE	  for	  LV	  volumes	  and	  EF	  measurement.	  The	  possibility	  of	  re-­‐aligning	  planes	  and	  optimally	  adjusting	  the	  LV	  chamber	  size	  to	  its	  maximum	  longitudinal	  axis	  length	  is	  an	  important	  advantage	  offered	  by	  3DE	  over	  conventional	  2DE.	  (55)	  Foreshortening	  of	  LV	  longitudinal	  axis	  is	  a	  major	  cause	  of	  volume	  underestimation	  by	  2DE,	  which	  accounts	  for	  the	  larger	  bias	  observed	  in	  comparison	  with	  3DE.	  	  However,	  despite	  eliminating	  LV	  apical	  foreshortening	  and	  geometric	  assumptions,	  3DE	  still	  yields	  a	  systematic	  underestimation	  of	  LV	  volumes	  as	  shown	  in	  a	  meta-­‐analysis	  of	  95	  studies	  having	  CMR	  as	  reference.	  (56)	  A	  significant	  underestimation	  has	  been	  reported	  for	  LV	  ESV	  (-­‐4.7	  ml)	  and	  EDV	  (-­‐9.9	  ml),	  whereas	  LV	  EF	  measurement	  revealed	  an	  excellent	  accuracy	  (-­‐0,13%),	  probably	  due	  to	  a	  constant	  underestimation	  of	  both	  volumes.	  
	  
	  
Figure	  5.1.	  Left	  ventricular	  cast	  segmentation.	  The	  endocardial	  surface	  can	  be	  subdivided	  in	  16	  (right	  panel)	  or	  17	  (left	  panel)	  color-­‐coded	  areas	  corresponding	  to	  the	  left	  ventricular	  segmentation.	  Each	  segment	  can	  be	  assimilated	  to	  a	  pyramid	  with	  the	  base	  on	  the	  endocardium	  and	  the	  apex	  at	  the	  gravity	  center	  of	  the	  ventricle	  and	  time	  variations	  of	  the	  segmental	  pyramidal	  volume	  can	  be	  measured	  during	  cardiac	  cycle	  and	  displayed	  on	  a	  volume-­‐time	  graph.	  The	  time	  to	  minimal	  volume	  of	  each	  segment	  can	  be	  measured	  on	  the	  corresponding	  time-­‐volume	  curves	  and	  the	  standard	  deviation	  of	  the	  time	  to	  minimal	  volume	  of	  the	  16/17	  segments	  has	  been	  reported	  as	  an	  index	  of	  intraventricular	  dyssynchrony.	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TABLE	  5.1	  -­‐	  Differences	  between	  left	  ventricular	  volumes	  and	  function	  assessed	  by	  three-­‐dimensional	  echocardiography	  and	  conventional	  two-­‐dimensional	  echocardiography	  in	  comparison	  with	  cardiac	  magnetic	  resonance.	  
 	   	   Mean	  difference	  ±SD	  from	  CMR	  
Author	   Parameter	   3DE	   2DE	  Jenkins	  et	  al.	  (57)	   End-­‐diastolic	  volume	  (ml)	  End-­‐systolic	  volume	  (ml)	  Ejection	  fraction	  (%)	   -­‐4±9	  -­‐3±18	  0±7	   -­‐54±33	  -­‐28±28	  -­‐1±13	  Kuhl	  et	  al.	  (58)	   End-­‐diastolic	  volume	  (ml)	  End-­‐systolic	  volume	  (ml)	  Ejection	  fraction	  (%)	   -­‐13.6±18.9	  -­‐12.8±20.5	  0.9±4.4	   -­‐	  -­‐	  -­‐	  Caiani	  et	  al.	  (59)	   End-­‐diastolic	  volume	  (ml)	  End-­‐systolic	  volume	  (ml)	  Ejection	  fraction	  (%)	   -­‐4.1±29	  	  -­‐3.5±33	  -­‐8	  ±14	   -­‐23±86	  -­‐19±60	  +3.7±16	  Shiota	  et	  al.	  (60)	   End-­‐diastolic	  volume	  (ml)	  End-­‐systolic	  volume	  (ml)	  Ejection	  fraction	  (%)	   -­‐43±65	  -­‐37±67	  1±4%	   -­‐	  -­‐	  -­‐	  Zeidan	  et	  al.	  (61)	   End-­‐diastolic	  volume	  (ml)	  End-­‐systolic	  volume	  (ml)	  Ejection	  fraction	  (%)	   -­‐6±11	  -­‐4±9	  2±5%	   -­‐	  -­‐	  -­‐	  Chan	  et	  al.	  (62)	  	   End-­‐diastolic	  volume	  (ml)	  End-­‐systolic	  volume	  (ml)	   -­‐10.4±26.4	  -­‐0.9±18.8	   -­‐	  -­‐	  Corsi	  et	  al.	  (63)	   End-­‐diastolic	  volume	  (ml)	  End-­‐systolic	  volume	  (ml)	  Ejection	  fraction	  (%)	   2.9±12	  2.8±7	  -­‐1±5	   -­‐	  -­‐	  -­‐	  Sugeng	  et	  al.	  (64)	   End-­‐diastolic	  volume	  (ml)	  End-­‐systolic	  volume	  (ml)	  Ejection	  fraction	  (%)	   -­‐4	  -­‐1	  2	   -­‐	  -­‐	  -­‐	  Nikitin	  et	  al.	  (65)	   End-­‐diastolic	  volume	  (ml)	  End-­‐systolic	  volume	  (ml)	  Ejection	  fraction	  (%)	   7±28	  3±22	  -­‐1±10	   -­‐	  -­‐	  -­‐	  Jacobs	  et	  al.	  (66)	   End-­‐diastolic	  volume	  (ml)	  End-­‐systolic	  volume	  (ml)	  Ejection	  fraction	  (%)	   -­‐14±17	  -­‐6.5±16	  -­‐1±6	   -­‐23±29	  -­‐15±24	  1±9	  Gutierrez-­‐Chico	  et	  al.(67)	  	  	   End-­‐diastolic	  volume	  (ml)	  End-­‐systolic	  volume	  (ml)	  Ejection	  fraction	  (%)	   -­‐3±1	  2±7	  0±6	   -­‐	  -­‐	  -­‐	  Van	  den	  Bosch	  et	  al.	  (68)	   End-­‐diastolic	  volume	  (ml)	  End-­‐systolic	  volume	  (ml)	  Ejection	  fraction	  (%)	   -­‐3±12	  -­‐12±31	  -­‐1±7	   -­‐	  -­‐	  -­‐	  Pouleur	  et	  al.	  (69)	   End-­‐diastolic	  volume	  (ml)	  End-­‐systolic	  volume	  (ml)	  Ejection	  fraction	  (%)	   -­‐20±31	  -­‐12±31	  1±11	   -­‐	  -­‐	  -­‐	  Qi	  et	  al.(70)	  	   End-­‐diastolic	  volume	  (ml)	  End-­‐systolic	  volume	  (ml)	  Ejection	  fraction	  (%)	   -­‐22±23	  -­‐15±20	  5±10	   -­‐	  -­‐	  -­‐	  Bicudo	  et	  al.(71)	  	   End-­‐diastolic	  volume	  (ml)	  End-­‐systolic	  volume	  (ml)	  Ejection	  fraction	  (%)	   -­‐4	  0.3	  -­‐2	   -­‐	  -­‐	  -­‐	  Shimada	  et	  al.(56)	  	   End-­‐diastolic	  volume	  (ml)	  End-­‐systolic	  volume	  (ml)	  Ejection	  fraction	  (%)	   -­‐9.9	  -­‐4.7	  -­‐0.13	   -­‐	  -­‐	  -­‐	  
 
Abbreviations:	  2DE,	  two-­‐dimensional	  echocardiography;	  3DE,	  three-­‐dimensional	  echocardiography;	  CMR,	  cardiac	  magnetic	  resonance;	  SD,	  standard	  deviation.	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Mor-­‐Avi	  et	  al.	  (42),	  in	  a	  multicenter	  study	  comparing	  3DE	  and	  CMR	  to	  assess	  LV	  volumes,	  found	  that	  LV	  volumes	  were	  highly	  correlated	  	  with	  CMR	  (EDV:	  r	  =	  0.91;	  ESV:	  r	  =	  0.93),	  but	  were	  26%	  and	  29%	  smaller	  consistently	  across	  institutions,	  with	  the	  magnitude	  of	  the	  bias	  being	  inversely	  related	  to	  the	  level	  of	  experience	  of	  the	  operators.	  They	  found	  that	  the	  main	  reason	  for	  this	  underestimation	  was	  the	  limited	  spatial	  resolution	  of	  3DE,	  which	  cannot	  provide	  clear	  definition	  of	  endocardial	  trabeculae	  which	  are,	  therefore,	  included	  into	  the	  myocardium	  rather	  being	  part	  of	  the	  LV	  as	  it	  is	  done	  when	  tracing	  endocardium	  with	  CMR.	  	  Female	   gender	   and	   presence	   of	   cardiac	   disease	  were	   associated	  with	   a	   larger	   extent	   of	  underestimation.	  As	   a	   rule,	   good	   image	  quality	   is	   a	  prerequisite	   for	   an	  accurate	  quantitation	  of	   global	  LV	  function	   using	   semi-­‐	   or	   automated	   border	   detection	   algorithms.	   A	   manual	   editing	   of	   the	  automatically-­‐identified	  endocardial	  surface	  may	  be	  required	  in	  order	  to	  ensure	  an	  accurate	  quantitative	  analysis,	  particularly	  in	  patients	  with	  suboptimal	  image	  quality.	  (41,42,72)	  Some	  authors	  reported	  that	  LV	  volume	  measurements	  by	  3DE	  are	  smaller	  when	   less	   than	  60%	  of	  the	   endocardial	   border	   is	   visualized;	   (73)	   in	   this	   setting,	   the	   use	   of	   contrast	   agents	   may	  improve	  the	  accuracy	  and	  reproducibility	  of	  measurements.	  (74,75)	  	  Simultaneous	  LV	  shape	  analysis	  (i.e.	  3D	  sphericity	  index)	  is	  provided	  from	  the	  endocardial	  3D	  surface	  reconstruction:	  as	  the	  LV	  becomes	  more	  globular,	  the	  sphericity	  index	  approaches	  unity.	   In	   patients	   with	   acute	  myocardial	   infarction,	   3DE	   derived	   sphericity	   index	   has	   been	  demonstrated	   to	   be	   an	   earlier	   and	   more	   accurate	   predictor	   of	   LV	   remodeling	   than	   other	  clinical,	  ECG,	  and	  echocardiographic	  variable.	  (76)	  	  By	  adding	  an	  automated	  detection	  of	   the	  LV	  epicardial	  surface	  and	  applying	  3D	  speckle-­‐tracking	   analysis	   within	   the	   LV	   myocardial	   wall	   delimited	   between	   the	   endocardial	   and	  epicardial	   surfaces,	   additional	   parameters	   can	   be	   obtained	   from	   the	   same	   3D	   data	   set:	   LV	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mass	   (Figure	   4.5),	   as	   well	   as	   myocardial	   deformation	   components	   (longitudinal,	  circumferential,	  radial	  and	  area	  strain).	  (55)	  	  LV	   mass	   calculations	   by	   M-­‐mode	   and	   2DE	   are	   subject	   to	   the	   same	   limitations	   in	  reproducibility	   and	   accuracy	   affecting	   LV	   size	   and	   function.	   Several	   comparative	   studies	  (Table	  5.2)	  have	  proven	  that	  3DE	  is	  more	  accurate	  than	  M-­‐mode	  or	  2DE	  methods	  to	  calculate	  LV	   mass	   when	   CMR	   was	   used	   as	   reference	   standard.	   Inter-­‐observer	   and	   test/re-­‐test	  reproducibility	  were	  also	  improved	  by	  the	  3DE	  approach.	  (57)	  More	  accurate	  measurements	  of	   LV	   mass	   may	   facilitate	   its	   use	   as	   a	   surrogate	   outcome	   marker	   in	   trials	   involving	  antihypertensive	  medications.	  (77)	  
TABLE	  5.2	  -­‐	  Differences	  between	  left	  ventricular	  mass	  calculation	  by	  three-­‐dimensional	  echocardiography	  and	  conventional	  two-­‐dimensional	  echocardiography	  in	  comparison	  with	  cardiac	  magnetic	  resonance.	  	   	   Mean	  difference	  ±SD	  from	  CMR	  
Author	   3DE	   2DE	  Mor-­‐Avi	  et	  al.	  (78)	   -­‐4±17	   -­‐39±29	  Caiani	  et	  al.	  (79)	   -­‐2.1±11.5	   -­‐34.9±24.8	  Jenkins	  et	  al.	  (57)	   0±38	   16±57	  Qin	  JX	  et	  al.	  (80)	   -­‐9±33	   -­‐15±47	  Oe	  H.	  et	  al.	  (81)	   -­‐14.1±29.1	   -­‐10.7±83.7	  van	  den	  Bosch	  et	  al.	  (82)	   2±20	   -­‐	  Bicudo	  et	  al.	  (71)	  	   -­‐6	   -­‐	  Takeuchi	  et	  al.	  (83)	  	   -­‐2	   -­‐	  Pouleur	  et	  al.	  (69)	  	   1±3	   -­‐	  	  Abbreviations	  as	  in	  Table	  5.1.	  	  3DE	  provides	  new	  opportunities	  of	  assessing	  regional	  LV	  wall	  motion.	  Conventional	  2DE,	  being	   confined	   to	   several	   predefined	   views,	   actually	   shows	   only	   a	   very	   limited	   part	   of	   the	  whole	  LV	  myocardium.	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  Conversely,	  3DE	  can	  display	  the	  entire	  myocardial	  volume	  in	  a	  multi-­‐slice	  panel,	  allowing	  a	   comprehensive	   assessment	   of	   the	   whole	   LV	   circumference	   (Figure	   3.10).	   This	   display	  modality	  can	  improve	  the	  accuracy	  of	  visual	  regional	  wall	  motion	  assessment,	  because	  even	  limited	  wall	  motion	  abnormalities,	  localized	  in	  regions	  that	  are	  not	  apparent	  in	  conventional	  2D	   views,	   can	   be	   visualized.	   Furthermore,	  with	   3DE,	   a	   quantitative	   analysis	   of	   LV	   regional	  functional	   is	  possible	  by	  comparing	  regional	  volume	  variation	  of	  each	  pyramidal-­‐shaped	  LV	  segment	  during	  the	  cardiac	  cycle	  (Figure	  5.1).	  A	  good	  correlation	  of	  quantitative	  3DE	  analysis	  with	  2DE	  regional	  wall	  motion	  score(84)	  and	  CMR(85)	  has	  been	  reported.	  Very	  recently	  3D	  speckle-­‐tracking	   technology	   has	   been	   validated	   for	   regional	   wall	   motion	   analysis,	   (86)	  providing	   an	   additional	   quantitative	   tool	   to	   objectively	   assess	   segmental	   myocardial	  deformation.	  However,	   despite	   this	   impressive	   amount	   of	   data	   and	   the	   fact	   that	   both	   EAE	   and	   ASE	  recommend	   3DE,	   rather	   than	   2DE,	   for	   routine	   clinical	   assessment	   of	   LV	   geometry	   and	  function,	   (87)	   the	   adoption	   of	   3De	   into	   routine	   clinical	   practice	   is	   still	   limited.	   The	   limited	  availability	   of	   reference	   values,	   particularly	   the	   lack	   of	   gender-­‐	   and	   anthropometric-­‐based	  
	  
	  
Figure	  5.2.	  Limited	  actual	  visualization	  of	  left	  ventricular	  
myocardium	  with	  2DE.	  Schematic	  representation	  of	  the	  position	  of	  3	  apical	  views	  of	  left	  ventricle	  obtainable	  with	  conventional	  2D	  echocardiography.	  As	  shown,	  the	  3	  longitudinal	  slices	  cover	  only	  a	  very	  limited	  part	  of	  left	  ventricular	  circumference	  and	  cannot	  be	  changed	  anymore	  once	  acquired,	  if	  proven	  unsatisfactory	  or	  foreshortened.	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analysis	   have	   hindered	   the	   extensive	   use	   of	   3DE	   to	   assess	   the	   LV	   for	   clinical	   and	   research	  purposes.	  (87)	  
5.2	  Development	  of	  reference	  values	  for	  LV	  geometry	  and	  function	  by	  3DE	  Of	  the	  263	  healthy	  volunteers	  screened	  for	  eligibility,	  37	  (14%)	  were	  excluded	  for:	  unknown	  cardiac	  pathology	  detected	  by	  echocardiography	  (n=13),	  obesity	  (n=4),	  professional	  sport	  activity	  (n=3),	  elevated	  blood	  pressure	  levels	  at	  enrolment	  (n=4),	  premature	  ventricular	  contractions	  (n=2),	  pregnancy	  (n=1),	  right	  bundle	  branch	  block	  (n=1).	  Other	  7	  healthy	  subjects	  were	  excluded	  due	  to	  poor	  apical	  acoustic	  window	  and	  3	  due	  to	  technical	  inadequate	  3D	  LV	  data	  sets	  identified	  during	  image	  analysis.	  Thus,	  the	  overall	  feasibility	  of	  LV	  acquisition	  and	  quantitation	  by	  3DE	  in	  our	  study	  population	  was	  86%.	  	  Temporal	  resolution	  of	  3D	  data	  sets	  was	  34±5	  volumes/second,	  while	  for	  2DE	  data	  sets	  it	  was	  76±7	  frames/second.	  The	  quality	  of	  3DE	  data	  sets	  for	  LV	  quantification	  was	  judged	  subjectively,	  considering	  the	  signal-­‐to-­‐noise	  ratio,	  degree	  of	  blood-­‐tissue	  contrast	  and	  completeness	  of	  LV	  wall	  visualization;	  image	  quality	  was	  excellent	  in	  31%,	  good	  in	  45%,	  fair	  in	  20%	  and	  poor	  in	  4%	  of	  subjects.	  Manual	  optimization	  of	  endocardial	  border	  detection	  required	  the	  addition	  of	  a	  mean	  of	  one	  point	  (range	  0-­‐5)	  after	  automatic	  processing.	  Manual	  optimization	  of	  epicardial	  border	  detection	  for	  LV	  mass	  measurement	  required	  the	  addition	  of	  a	  mean	  of	  3	  points	  (range	  0-­‐7)	  after	  automatic	  processing.	  The	  quality	  of	  2D	  LV	  data	  sets	  for	  LV	  quantitation	  by	  disc-­‐summation	  method	  was	  verified	  by	  calculating	  the	  differences	  in	  the	  LV	  longitudinal	  axes	  in	  4-­‐	  vs	  2-­‐chamber	  views;	  less	  than	  10%	  difference	  was	  found	  in	  96%	  of	  subjects	  at	  end-­‐diastole	  and	  in	  90%	  of	  them	  at	  end-­‐systole.	  Table	  5.3	  summarizes	  the	  demographics	  and	  the	  3DE	  LV	  parameters	  of	  geometry	  and	  function	  in	  the	  study	  population	  taken	  as	  a	  whole	  and	  separately	  by	  gender.	  Subject	  age	  range	  was	  18-­‐76	  years,	  and	  45%	  of	  enrolled	  subjects	  were	  men.	  There	  was	  no	  difference	  in	  age	  or	  heart	  rate	  between	  men	  and	  women.	  However,	  women	  showed	  significantly	  smaller	  body	  size	  and	  lower	  blood	  pressure	  levels	  than	  men	  (Table	  5.3).	  	  
	   68	  
5.2.1	  3DE	  LV	  volumes	  and	  function	  LV	  volumes	  were	  larger	  in	  men	  than	  in	  women,	  even	  after	  normalization	  for	  BSA.	  Upper	  reference	  values	  (mean	  +	  2	  SD)	  for	  3D	  LV	  EDV	  and	  ESV	  were	  75	  ml/m2	  and	  34	  ml/m2	  in	  men,	  and	  72	  ml/m2	  and	  28	  ml/m2	  in	  women,	  respectively.	  
TABLE	  5.3	  -­‐	  Demographics	  and	  parameters	  of	  left	  ventricular	  geometry	  and	  function	  obtained	  by	  three-­‐dimensional	  echocardiography	  in	  the	  study	  population.	  
	   All	  (n=226)	   Men	  (n=101)	   Women	  (n=125)	   p	  Value	  Age	  (years)	   44±14	   43±14	   44±15	   0.584	  Height	  (cm)	   170±9	   177±7	   164±7	   <0.0001	  Weight	  (kg)	   68±11	   76±9	   61±8	   <0.0001	  Body	  mass	  index	  (kg/m2)	   23±3	   24±3	   22±3	   <0.0001	  BSA	  (m2)	   1.78±0.18	   1.93±0.13	   1.66±0.12	   <0.0001	  Heart	  rate	  (bpm)	   67±10	   67±11	   68±10	   0.338	  Systolic	  BP	  (mmHg)	   123±14	   128±12	   118±14	   <0.0001	  Diastolic	  BP	  (mmHg)	   74±8	   77±8	   71±9	   <0.0001	  LV	  EDV	  (ml)	   106±25	   123±25	   93±16	   <0.0001	  LV	  EDV/BSA	  (ml/m2)	   59±10	   63±11	   56±8	   <0.0001	  LV	  ESV	  (ml)	   39±11	   46±10	   33±7	   <0.0001	  LV	  ESV/BSA	  (ml/m2)	   22±5	   24±5	   20±4	   <0.0001	  LV	  SV	  (ml)	   68±15	   76±16	   60±12	   <0.0001	  LV	  SV/BSA	  (ml/	  m2)	   38±6	   39±7	   36±6	   0.001	  LV	  EF	  (%)	   64±4	   62±4	   65±4	   <0.0001	  LV	  mass	  (g)	   135±23	   150±22	   124±16	   <0.0001	  LV	  mass/BSA	  (g/m2)	   76±9	   77±10	   74±8	   0.023	  LV	  end-­‐diastolic	  sphericity	  index	  	   0.35±0.07	   0.35±0.07	   0.34±0.07	   0.838	  LV	  mass/EDV	  (g/ml)	   1.30±0.2	   1.24±0.18	   1.30±0.18	   <0.0001	  	  Data	  is	  expressed	  as	  mean±SD.	  	  
Abbreviations:	  BP,	  blood	  pressure;	  BSA,	  body	  surface	  area;	  EDV,	  end-­‐diastolic	  volume;	  EF,	  ejection	  fraction;	  ESV,	  end-­‐systolic;	  LV,	  left	  ventricular;	  SV,	  stroke	  volume.	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As	  expected,	  LV	  EDV	  and	  ESV	  calculated	  on	  2DE	  images	  were	  significantly	  smaller	  than	  those	  measured	  from	  3DE	  data	  sets.	  	  
 
TABLE	  5.4	  -­‐	  Comparison	  of	  parameters	  of	  left	  ventricular	  geometry	  and	  function	  obtained	  by	  three-­‐dimensional	  echocardiography	  with	  those	  derived	  from	  two-­‐dimensional	  echocardiography.	  	   	  
3DE	   2DE	   p	  Value	   3DE	  upper	  limit	  
2DE	  upper	  
limit	  EDV	  (ml)	   107±25	   97±25	   <0.0001	   157	   147	  ESV	  (ml)	   39±11	   35±11	   <0.0001	   61	   57	  Sphericity	  index	   0.35±0.07	   0.34±0.06	   0.35	   0.49	   0.46	  EF	  (%)	   64±4	   65±4	   <0.0001	   56*	   57*	  	  *lower	  limit.	  	  
Abbreaviations:	  3DE,	  three-­‐dimensional	  echocardiography;	  2DE,	  two-­‐dimensional	  echocardiography.	  Other	  abbreviations	  as	  in	  Table	  5.3	  	  
5.2.2	  Relationships	  with	  gender,	  age	  and	  body	  size	  LV	  EF	  was	  significantly	  higher	  in	  women	  (Table	  5.3).	  However,	  since	  LV	  volumes	  in	  women	  were	  smaller,	  LV	  SV	  in	  women	  was	  also	  found	  to	  be	  significantly	  smaller	  than	  in	  men	  and	  this	  difference	  persisted	  after	  normalization	  for	  BSA.	  Lower	  reference	  values	  (mean	  -­‐	  2SD)	  for	  LV	  EF	  were	  54%	  in	  men	  and	  57%	  in	  women,	  while	  for	  SV	  were	  25	  ml/m2	  and	  24	  ml/m2	  using	  BSA,	  respectively.	  LV	  EF	  was	  significantly	  smaller	  with	  3DE	  than	  with	  2DE,	  but	  this	  difference	  was	  clinically	  irrelevant	  (Table	  5.4,	  Figure	  5.3).	  LV	  SV	  measured	  with	  3DE	  was	  significantly	  lower	  than	  the	  LV	  SV	  calculated	  using	  conventional	  2D-­‐Doppler	  method	  (76±16	  ml	  vs	  94±20	  ml	  in	  men	  and	  60±12	  ml	  vs	  75±12	  ml	  in	  women,	  p<0.0001	  for	  both)	  (Figure	  5.3).	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Figure	  5.3.	  Bland-­‐Altman	  plots	  comparing	  left	  ventricular	  volumes,	  ejection	  fraction	  and	  stroke	  volume	  obtained	  by	  three-­‐	  and	  two–dimensional	  echocardiography.	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Figure	  6.4.	  Bland-­‐Altman	  plot	  comparing	  measurements	  of	  left	  ventricular	  mass	  with	  three-­‐	  dimensional	  and	  M-­‐mode	  echocardiography.	  	  




TABLE	  5.5	  -­‐	  Relationship	  between	  left	  ventricular	  parameters	  by	  three-­‐dimensional	  echocardiography	  and	  age	  for	  both	  genders.	  
	   Men	  	  (n=101)	   Women	  	  (n=125)	  	   r	   p	  value	   r	  	   p	  value	  EDV	  (ml)	   -­‐0.25	   0.014	   -­‐0.36	   <0.0001	  EDV/BSA	  (ml/m2)	   -­‐0.25	   0.012	   -­‐0.42	   <0.0001	  ESV	  (ml)	   -­‐0.28	   0.005	   -­‐0.44	   <0.0001	  ESV/BSA	  (ml/m2)	   -­‐0.28	   0.005	   -­‐0.49	   <0.0001	  SV	  (ml)	   -­‐0.20	   0.052	   -­‐0.20	   0.031	  SV/BSA	  (ml/	  m2)	   -­‐0.20	   0.053	   -­‐0.25	   0.005	  EF	  (%)	   0.18	   0.067	   0.28	   0.002	  Mass	  (g)	   0.01	   0.940	   -­‐0.18	   0.050	  Mass/BSA	  (g/m2)	   0.03	   0.749	   -­‐0.20	   0.024	  Sphericity	  index	  	   0.16	   0.107	   0.10	   0.256	  Mass/EDV	  (g/ml)	   0.32	   0.001	   0.29	   0.001	  
 Abbreviations	  as	  in	  Table	  5.2.	  	  Finally,	  Table	  5.6	  reports	  the	  reference	  values	  for	  LV	  geometry	  and	  function	  grouped	  in	  the	  young	  (18-­‐39	  years),	  middle	  age	  (40	  -­‐59	  years)	  and	  elderly	  (≥	  60	  years)	  cohorts.	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TABLE	  5.6	  -­‐	  Left	  ventricular	  geometry	  and	  function	  by	  three-­‐dimensional	  echocardiography	  presented	  by	  age	  groups	  in	  men	  and	  women.	  
 Data	  are	  reported	  as	  mean	  value±SD	  	  (upper	  or	  *lower	  limits	  of	  normality).	  	  Abbreviations	  as	  in	  Table	  5.2.
 18-39 years  
 
p Value 
40-59 years  
 
p Value 
≥60 years  











EDV (ml) 128±27 (182) 98±16 (130) <0.0001 119±21 (161) 94±16 (126) <0.0001 116±26 (168) 84±12 (108) <0.0001 
EDV/BSA (ml/m2) 66±11 (88) 60±8 (76) 0.001 61±9 (79) 56±8 (72) 0.021 62±12 (86) 51±7  (65) 0.001 
ESV (ml) 50±11 (72) 36±7 (50) <0.0001 44±9 (62) 33±5 (43) <0.0001 44±11 (66) 28±6 (40) <0.0001 
ESV/BSA (ml/m2) 26±5 (36) 22±4 (30) <0.0001 23±4 (31) 20±3 (26) <0.0001 23±5 (33) 17±4 (25) <0.0001 
SV (ml) 78±17 (44)* 62±10 (42)* <0.0001 75±13 (49)* 60±14 (32)* <0.0001 74±15 (44)* 56±9 (38)* <0.0001 
SV/BSA (ml/m2) 41±7 (27)* 37±5 (27)* 0.027 38±6 (24)* 36±6 (24)* 0.261 39±7 (25)* 34±5 (24)* 0.016 
EF (%) 61±4 (53)* 63±3 (57)* 0.016 63±3 (57)* 65±4 (57)* 0.009 63±3 (57)* 66±5 (56)* 0.008 
Mass (g) 149±22 (193) 124±15 (154) <0.0001 150±22 (194) 126±16 (158) <0.0001 150±23 (196) 118±19 (156) <0.0001 
Mass/BSA (g/m2) 78±9 (96) 75±8 (91) 0.250 76±11 (98) 75±8 (91) 0.450 79±10 (99) 72±10 (92) 0.027 
Mass/BSA  (g/m2) 112±16 (144) 96±11 (118) <0.0001 113±13 (139) 98±11 (120) <0.0001 113±15 (143) 92±14 (120) <0.0001 
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5.2.3.	  Comparison	  with	  previous	  studies	  Comparisons	  of	  our	  findings	  with	  the	  3D	  LV	  reference	  values	  from	  previous	  studies	  are	  reported	  in	  Table	  5.7.	  	  
TABLE	  5.7	  -­‐	  Data	  comparison	  with	  other	  two	  studies	  reporting	  left	  ventricular	  parameters	  obtained	  by	  three-­‐dimensional	  echocardiography	  in	  healthy	  subjects.	  	  
	  *<0.0001;	  †<0.05.	  Abbreviations	  as	  in	  Table	  5.1.	  
 
5.2.4	  Reproducibility.  Three-­‐dimensional	  LV	  parameters	  showed	  an	  excellent	  intra-­‐observer	  and	  inter-­‐observer	  reproducibility	  (Table	  5.8).	  In	  comparison	  with	  3D	  parameters,	  2D	  LV	  volumes	  and	  particularly	  2D	  LV	  EF	  showed	  more	  variability	  at	  repeated	  measurements:	  for	  2D	  LV	  EDV	  ICC	  were	  0.970	  and	  0.945;	  for	  2D	  LV	  ESV	  ICC	  were	  0.963	  and	  0.957;	  for	  2D	  LV	  ejection	  fraction	  ICC	  were	  0.741	  and	  0.742	  for	  intra-­‐	  and	  inter-­‐observer	  analysis,	  respectively. 
	  Author	  	  Echo	  machine	  
	  	  	  	  Present	  study(9)	  	  Vivid	  E9	  
	  	  	  	  	  	  	  Aune	  et	  al.	  (88)	  	  iE33	  
	  	  	  	  	  Fukuda	  et	  al.(	  89)	  	  Sonos	  7500/iE33	  Gender	  	  Sample	  size	  
Men	  	  	  (n=101)	   Women	  	  	  (n=125)	   Men	  	  (n=79)	   Women	  	  (n=87)	   Men	  	  (n=222)	   Women	  	  (n=134)	  	  EDV/BSA	  (ml/m2)	   63±11	   56±8	   66±10	   58±8	   50±12*	   46±9*	  ESV/BSA	  (ml/m2)	   24±5	   20±4	   29±6*	   23±5*	   19±5*	   17±4*	  SV/BSA	  (ml/m2)	   39±7	   36±6	   -­‐	   -­‐	   -­‐	   -­‐	  EF	  (%)	   62±4	   65±4	   57±4*	   61±6*	   61±4†	   63±4*	  Mass	  (g/m2)	   77±10	   74±8	   -­‐	   -­‐	   64±12*	   56±11*	  Mass/EDV	  (g/ml)	   1.24±0.18	   1.30±0.18	   -­‐	   -­‐	   1.3±0.3	   1.3±0.2	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TABLE	  5.8	  -­‐	  Reproducibility	  of	  left	  ventricular	  geometry	  and	  function	  parameters	  by	  three-­‐dimensional	  echocardiography	  in	  15	  healthy	  subjects.	  	  
	  *p<0.0001.	  CI,	  confidence	  interval;	  CR,	  coefficient	  of	  repeatability;	  ICC,	  intraclass	  correlation	  coefficient	  
 
5.3	  Discussion	  The	  present	  study	  provides	  a	  comprehensive	  analysis	  of	  LV	  geometry	  and	  function	  using	  3DE	  in	  a	  relatively	  large	  cohort	  of	  Caucasian	  healthy	  volunteers	  with	  a	  wide	  age	  range.	  The	  main	  results	  can	  be	  summarized	  as	  follows:	  (i).	  Reference	  values	  for	  LV	  volumes	  and	  mass	  by	  3DE	  were	  found	  to	  be	  significantly	  different	  from	  those	  obtained	  with	  conventional	  echocardiography,	  highlighting	  the	  importance	  of	  applying	  method-­‐specific	  reference	  values	  for	  a	  reliable	  identification	  of	  LV	  dysfunction;	  (ii).	  LV	  parameters	  measured	  by	  3DE	  had	  excellent	  reproducibility,	  and	  were	  more	  robust	  than	  2D	  indices	  (particularly	  regarding	  LV	  EF)	  at	  repeated	  measurements;	  (iii).	  Most	  LV	  indices	  should	  be	  defined	  according	  to	  age	  and	  gender,	  since	  indexing	  them	  only	  for	  BSA	  does	  not	  account	  for	  all	  variations	  in	  LV	  geometry	  and	  function.	  
	   Intra-­‐observer	   Inter-­‐observer	  CR	   ICC*	   95%	  CI	   	   	  	  	  	  	  	  	  	  CR	   ICC*	   	   95%	  CI	  EDV	  (mL)	   8.5	   0.998	  	  	   0.968-­‐0.996	   	   9.3	   0.990	  	  	   0.971-­‐0.997	  ESV	  (mL)	   5.5	   0.982	  	   0.947-­‐0.994	   5.4	   0.981	  	   0.944-­‐0.993	  EF	  (%)	   2.9	   0.906	  	   0.745-­‐0.968	   3.7	   0.816	  	   0.536-­‐0.934	  SV	  (mL)	   6.1	   0.980	  	   0.942-­‐0.993	   8.9	   0.967	  	   0.905-­‐0.989	  Sphericity	  index	  	   0.06	   0.878	  	   0.675-­‐0.957	   0.06	   0.914	  	   0.764-­‐0.970	  Mass	  (g)	   10.2	   0.863	   0.640-­‐0.952	   17.0	   0.875	   0.668-­‐0.956	  
	   76	  
	  
5.3.1	  Method-­‐specific	  reference	  values	  for	  LV	  geometry	  and	  function	  by	  3DE.	  	  LV	  volumes,	  EF	  and	  spherical	  shape	  are	  powerful	  predictors	  of	  morbidity	  and	  mortality	  in	  both	  clinical	  and	  population	  studies.	  However,	  LV	  parameters	  derived	  from	  conventional	  echocardiography	  (M-­‐mode,	  2DE	  and	  Doppler)	  are	  based	  on	  a	  limited	  number	  of	  actual	  measurements.	  In	  fact,	  they	  mostly	  derive	  from	  calculations	  involving	  several	  assumptions	  on	  LV	  geometry	  (i.e.	  LV	  wall	  thickness	  distribution,	  LV	  outflow	  tract	  circularity	  etc)	  and	  on	  their	  anatomically-­‐correct	  imaging	  by	  2DE,	  despite	  a	  significant	  error	  may	  result	  from	  restricted	  imaging	  capabilities	  inherent	  to	  a	  tomographic	  technique,	  foreshortening	  errors	  or	  insufficient	  experience	  in	  image	  acquisition	  or	  analysis.	  Hence,	  despite	  these	  LV	  indices	  are	  of	  utmost	  clinical	  importance,	  traditional	  echocardiographic	  methods	  are	  inherently	  flawed.	  This	  has	  been	  demonstrated	  by	  several	  studies	  comparing	  the	  accuracy	  of	  2DE	  with	  CMR	  or	  cardiac	  computerized	  tomography.	  (90)	  Since	  CMR	  and	  cardiac	  computerized	  tomography	  have	  also	  their	  own	  limitations	  such	  as	  limited	  availability,	  costs,	  time	  consumption,	  use	  of	  contrast	  agents	  and	  radiation	  exposure	  (for	  cardiac	  computerized	  tomography	  only),	  there	  is	  a	  need	  of	  a	  robust	  non-­‐invasive	  imaging	  modality	  to	  be	  routinely	  used	  to	  quantify	  LV	  performance	  and	  remodelling	  in	  patients	  with	  known	  or	  suspected	  cardiovascular	  disease.	  	  3DE	  measurements	  are	  neither	  affected	  by	  cardiac	  chamber	  foreshortening	  nor	  by	  any	  geometric	  assumptions.	  Specifically,	  previous	  studies	  have	  shown	  that	  3DE	  is	  not	  only	  accurate	  in	  measuring	  LV	  volumes	  and	  mass	  when	  compared	  with	  CMR,	  (1)	  but	  it	  is	  also	  more	  reproducible	  than	  2DE,	  demonstrating	  a	  low	  observer	  and	  test/re-­‐test	  variability.	  (57,69,87)	  However,	  the	  lack	  of	  specific	  reference	  values	  for	  3DE	  might	  have	  hindered,	  at	  least	  partially,	  the	  use	  of	  3DE	  in	  clinical	  practice	  and	  research.	  Available	  recommendations	  on	  LV	  quantification	  (38)	  rely	  either	  on	  2DE-­‐	  or	  M-­‐mode	  -­‐derived	  cut-­‐off	  values	  to	  define	  normality	  of	  LV	  volumes,	  EF	  or	  mass,	  and	  to	  date	  there	  is	  no	  clear	  evidence	  that	  these	  reference	  values	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can	  be	  extrapolated	  for	  3DE	  measurements.	  Studies	  comparing	  3DE	  and	  2DE	  with	  CMR	  in	  patients	  reported	  that	  LV	  volumes	  by	  3DE	  were	  significantly	  larger	  than	  those	  obtained	  with	  2DE	  (41,91),	  while	  3DE	  LV	  mass	  was	  larger	  than	  the	  value	  obtained	  by	  2DE	  (78)	  and	  smaller	  than	  the	  one	  calculated	  using	  cubed	  formula	  by	  M-­‐mode	  echocardiography.	  (92,93)	  Our	  findings	  in	  healthy	  subjects	  demonstrate	  that	  LV	  reference	  values	  from	  conventional	  echocardiography	  should	  not	  be	  used	  interchangeably	  with	  3D	  LV	  volumes	  and	  mass,	  emphasizing	  once	  more	  that	  method-­‐specific	  normality	  ranges	  should	  be	  applied	  for	  clinical	  decision-­‐making.	  In	  addition,	  an	  excellent	  intra-­‐	  and	  inter-­‐observer	  reproducibility	  for	  3DE	  parameters	  was	  confirmed	  in	  our	  study,	  as	  well	  as	  the	  superiority	  of	  3DE	  in	  comparison	  with	  2DE	  regarding	  LV	  volumes	  and	  ejection	  fraction	  measurement	  reproducibility.	  
	  
5.3.2	  Comparison	  with	  LV	  reference	  values	  from	  other	  3DE	  and	  CMR	  studies. To	  our	  knowledge,	  four	  studies	  have	  previously	  reported	  reference	  values	  for	  LV	  geometry	  and	  function	  in	  healthy	  subjects	  using	  3DE	  and	  all	  have	  used	  BSA	  to	  index	  LV	  volumes	  and	  mass.	  Aune	  et	  al.	  (88)	  studied	  166	  healthy	  Norvegian	  subjects	  (46%	  males,	  29-­‐80	  years)	  and	  found	  reference	  values	  very	  similar	  to	  ours	  (differences	  in	  upper	  limits	  of	  normality	  for	  end-­‐diastolic	  and	  end-­‐systolic	  LV	  volumes	  of	  2	  and	  1	  ml/m2,	  respectively).	  Kaku	  et	  al.	  (13)	  studied	  the	  effect	  of	  aging	  on	  LV	  geometry	  and	  function	  in	  	  280	  healthy	  US	  and	  Japanese	  subjects	  (49%	  men,	  age	  1-­‐88	  years).	  LV	  volumes	  and	  mass	  in	  their	  adult	  subgroup	  were	  very	  similar	  to	  the	  ones	  obtained	  in	  our	  cohorts.	  Finally,	  Fukuda	  et	  al.	  (89)	  recently	  reported	  reference	  data	  for	  the	  LV	  and	  LA	  obtained	  in	  222	  Japanese	  healthy	  subjects	  (61%	  me,	  age	  20-­‐69	  years).	  Their	  reference	  values	  for	  LV	  EDVs	  were	  smaller	  than	  ours	  (-­‐13	  ml/m2	  in	  men	  and	  -­‐10	  ml/m2	  in	  women),	  but	  they	  studied	  Japanese	  subjects	  with	  smaller	  BSA	  (1.8	  m2	  in	  men	  and	  1.5	  m2	  in	  women).	  It	  is	  possible	  that	  race	  or	  ethnicity-­‐specific	  3DE	  reference	  values	  for	  the	  LV	  need	  to	  be	  identified	  as	  well,	  however	  only	  a	  multicenter	  study	  specifically	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designed	  for	  this	  purpose	  or	  a	  meta-­‐analysis	  of	  existing	  data(94)	  could	  clarify	  for	  this	  aspect. Recently,	  Chahal	  et	  al.	  (95)	  reported	  average	  values	  of	  49±9	  ml/m2	  and	  42±8	  ml/m2	  for	  3DE	  LV	  EDVs	  in	  healthy	  European	  men	  and	  women,	  respectively.	  These	  volumes	  are	  significantly	  smaller	  than	  those	  reported	  in	  our	  study	  and	  by	  the	  other	  Authors	  who	  performed	  similar	  studies:	  66±10	  ml/m2	  and	  58±8	  ml/m2,	  respectively,	  found	  by	  Aune	  et	  al.	  (88);	  and	  55±7	  ml/m2	  and	  49±6	  ml/m2,	  respectively,	  reported	  by	  Kaku	  et	  al.	  (25)	  for	  the	  same	  age	  group.	  Even	  Fukuda	  et	  al.	  (89)	  in	  their	  Japanese	  population	  (significantly	  smaller	  body	  size	  than	  Europeans)	  found	  larger	  LV	  EDVs:	  50±12	  ml/m2	  and	  46±9	  ml/m2	  in	  men	  and	  women,	  respectively.	  Furthermore,	  the	  upper	  normal	  values	  (mean	  values+2	  SDs)	  for	  3DE	  LV	  EDVs	  and	  ESVs	  reported	  by	  Chahal	  et	  al.	  (95)	  (e.g.	  67	  ml/m2	  	  and	  29	  ml/m2	  in	  men)	  are	  	  smaller	  than	  the	  2DE	  upper	  normal	  limits	  reported	  in	  current	  guidelines	  (75	  ml/m2	  and	  30	  ml/m2,	  respectively)(38),	  contradicting	  all	  previous	  studies	  showing	  a	  larger	  underestimation	  of	  LV	  volumes	  measured	  by	  2DE	  than	  by	  3DE.	  Finally,	  making	  a	  simple	  calculation	  from	  the	  data	  in	  the	  Table	  1	  included	  in	  the	  paper	  by	  Cahal	  et	  al.	  (95),	  it	  seems	  that	  the	  European	  subjects	  were	  in	  low	  flow	  state	  (average	  SV	  index	  30	  ml/m2	  in	  men,	  and	  26	  ml/m2	  in	  women).	  These	  data	  raise	  the	  issue	  of	  the	  accuracy	  of	  the	  measurements	  performed	  in	  that	  study,	  particularly	  when	  no	  reference	  (or	  at	  least	  comparison)	  modality	  such	  as	  the	  simple	  SV	  measured	  with	  2DE	  and	  Doppler	  has	  been	  provided.	  	  One	  possible	  explanation	  of	  the	  underestimation	  of	  the	  LV	  volumes	  reported	  by	  Chahal	  et	  al.	  (95)	  may	  be	  the	  limited	  experience	  of	  the	  sonographers	  who	  performed	  measurements	  as	  acknowledged	  by	  the	  Authors	  (“…all	  underwent	  a	  4-­‐wk	  period	  of	  training	  in	  3DE	  volume	  acquisition	  and	  off-­‐line	  
analysis	  by	  the	  vendor	  representative	  at	  the	  beginning	  of	  the	  study”).	  (96)	  The	  effect	  of	  the	  reader	  experience	  on	  accuracy	  of	  3D	  LV	  volume	  measurements	  has	  already	  been	  documented.	  (42)	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Hudsmith	  et	  al.	  (97)	  have	  reported	  the	  upper	  normal	  limits	  (mean	  +	  2SD)	  for	  LV	  EDV	  and	  ESV	  by	  CMR	  in	  108	  apparently	  healthy	  subjects	  (58%	  men):	  106	  ml/m2	  in	  men	  and	  39	  ml/m2	  in	  women.	  The	  upper	  limits	  for	  LV	  volumes	  in	  the	  study	  of	  Hudsmith	  et	  al.	  (97)	  exceeded	  our	  corresponding	  values	  for	  LV	  EDVs	  with	  19%	  in	  men	  and	  34%	  in	  women,	  while	  ESVs	  were	  very	  similar.	  An	  underestimation	  of	  LV	  volumes	  obtained	  by	  3DE	  in	  comparison	  to	  CMR	  has	  also	  been	  documented	  by	  the	  recently	  performed	  meta-­‐analysis	  by	  Dorosz	  et	  al.	  (90)	  They	  reviewed	  data	  from	  23	  studies	  enrolling	  1,638	  echocardiograms	  and	  found	  pooled	  biases	  ±	  2SDs	  for	  3DE	  of	  -­‐19±34	  ml,	  -­‐10±30	  ml,	  and	  0.6±12%	  for	  LV	  EDV,	  ESV	  and	  EF,	  respectively.	  	  Mor-­‐Avi	  et	  al.	  (42),	  in	  a	  multicenter	  study	  comparing	  3DE	  and	  CMR	  found	  that	  3DE	  LV	  volumes	  were	  highly	  correlated	  with	  CMR	  measurements	  (EDV:	  r	  =	  0.91;	  ESV:	  r	  =	  0.93),	  but	  were	  26%	  and	  29%	  lower,	  consistently	  across	  institutions,	  with	  a	  bias	  magnitude	  inversely	  related	  to	  the	  level	  of	  experience	  of	  the	  operators.	  They	  found	  that	  the	  main	  reason	  for	  this	  underestimation	  was	  the	  limited	  spatial	  resolution	  of	  3DE,	  which	  cannot	  provide	  clear	  definition	  of	  endocardial	  trabeculae	  which	  are,	  therefore,	  included	  into	  the	  myocardium	  rather	  being	  part	  of	  the	  LV	  as	  it	  is	  done	  when	  tracing	  endocardium	  with	  CMR.	  Greater	  underestimation	  seems	  to	  occur	  for	  LV	  EDVs	  and	  this	  is	  consistent	  with	  the	  fact	  that	  our	  reference	  values	  for	  EDV	  were	  significantly	  lower	  than	  those	  reported	  by	  Hudsmith	  et	  al.	  (97)	  while	  ESVs	  were	  closer.	  The	  same	  issue	  about	  the	  underestimation	  of	  the	  LV	  EDVs	  with	  3DE	  has	  been	  reported	  by	  Aune	  et	  al.	  (88).	  This	  limitation	  may	  have	  contributed	  to	  the	  underestimation	  of	  the	  SV	  by	  3DE	  in	  comparison	  with	  conventional	  2D-­‐Doppler	  method	  in	  our	  study.	  	  In	  a	  recent	  meta-­‐analysis,	  Dorosz	  et	  al.	  (90)	  have	  also	  identified	  significantly	  larger	  biases	  and	  limits	  of	  agreement	  for	  2DE	  (-­‐48±56	  ml,	  -­‐28±46	  ml,	  and	  0.1±14%	  for	  LV	  volumes	  and	  EF)	  than	  3DE,	  when	  both	  were	  compared	  to	  CMR.	  These	  data,	  together	  with	  the	  superior	  reproducibility	  of	  3DE	  warrant	  its	  use	  as	  the	  preferred	  method	  to	  assess	  LV	  size	  and	  function	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by	  echocardiography.	  
	  
5.3.3	  Relationship	  with	  gender	  and	  age.	  	  Our	  findings	  show	  that	  reference	  values	  for	  most	  LV	  size	  and	  function	  parameters	  should	  be	  gender-­‐specific	  since	  the	  simple	  normalization	  of	  LV	  volumes	  by	  BSA	  does	  not	  eliminate	  gender	  differences	  for	  these	  parameters.	  These	  findings	  are	  consistent	  with	  the	  data	  reported	  by	  other	  similar	  studies(13,89,98).	  LV	  mass/volume	  ratio	  and	  ejection	  fraction	  were	  also	  significantly	  higher	  in	  women	  than	  in	  men.	  Conversely,	  LV	  sphericity	  index	  was	  similar	  in	  men	  and	  women.	  These	  gender	  differences	  in	  LV	  geometry	  and	  function	  are	  consistent	  with	  previous	  reports	  in	  which	  both	  3DE	  and	  CMR	  were	  used	  (13,97). It	  is	  widely	  accepted	  that	  age-­‐related	  changes	  in	  cardiovascular	  structure	  and	  function	  occur	  in	  healthy	  subjects.	  In	  our	  study	  population,	  LV	  size	  decreased	  with	  age,	  whereas	  LV	  mass	  and	  shape	  did	  not	  change.	  As	  a	  result	  the	  LV	  mass/volume	  ratio	  increased	  with	  age.	  These	  age-­‐related	  changes	  evolving	  as	  a	  concentric	  LV	  remodelling,	  and	  interpreted	  as	  a	  “physiological”	  response	  to	  increased	  arterial	  pressure	  and	  afterload	  with	  age	  (99,100),	  were	  particularly	  evident	  in	  women.	  LV	  volume	  reductions	  are	  compensated	  by	  an	  increase	  in	  LV	  ejection	  fraction	  (which	  was	  statistically	  significant	  in	  women	  in	  our	  study)	  to	  maintain	  cardiac	  output.	  Our	  findings	  are	  consistent	  with	  those	  reported	  by	  others	  who	  used	  either	  echocardiography(13)	  or	  CMR	  (91,99)	  to	  assess	  age-­‐related	  changes	  in	  LV	  morphology	  and	  function.	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CHAPTER 6 	  	  





6.1	  Background	  2DE	  quantification	  of	  RV	  size	  and	  function	   is	  challenging,	  due	  to	  the	  anterior	  position	  of	  the	  RV	  in	  the	  chest,	  its	  complex	  asymmetric	  geometry,	  irregularity	  of	  the	  highly	  trabeculated	  endocardial	  border,	  impossibility	  to	  visualize	  in	  the	  same	  view	  both	  inflow	  and	  outflow	  tracts	  and	   lack	   of	   realistic	   geometric	   models	   to	   use	   for	   volume	   calculation.	   (101)	   3DE	   has	   been	  demonstrated	  to	  have	  a	  good	  accuracy	  in	  measuring	  RV	  volumes	  compared	  to	  CMR.	  (102)	  A	   good	   correlation	   between	   CMR	   and	   3DE	   parameters	   reflecting	   RV	   geometry	   and	  function	   has	   been	   demonstrated,	   although,	   as	   for	   the	   LV,	   an	   underestimation	   of	   3DE	   RV	  volumes	  is	  often	  reported	  (Table	  6.1).	  	  Shimada	  et	  al.	  (102)	  reported	  that	  the	  underestimation	  of	  RV	  volumes	  occurs	  mainly	  with	  large	  EDVs,	  whereas	  an	  overestimation	  was	  more	  likely	  for	  smaller	  ESVs.	  Age	  accounted	  for	  a	  part	  of	  the	  error,	  RV	  volumes	  being	  overestimated	  and	  RV	  EF	  underestimated	  in	  the	  elderly.	  Possible	  reasons	  for	  this	  systematic	  bias	  may	  be	  the	  poorly-­‐defined	   endocardial	   border	   in	   a	   dilated	   RV,	   the	   non-­‐inclusion	   of	   RV	   outflow	   tract	   in	   the	  analysis	   and	   the	   limited	   temporal	   resolution.	   In	   a	   recent	   study,	   Tamborini	   et	   al.	   (103)	  proposed	   reference	   values	   for	   RV	   volumes	   and	   EF	   obtained	   from	   245	   normal	   subjects.	   RV	  volumes	  were	  significantly	  correlated	  with	  age,	  gender	  and	  BSA.	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TABLE	  6.1	  -­‐	  Differences	  between	  right	  ventricular	  volumes	  assessed	  by	  three-­‐dimensional	  echocardiography	  and	  cardiac	  magnetic	  resonance.	  	   	   	   Mean	  difference	  (95%	  CI)	  
from	  CMR	  
Author	   Parameter	   3DE	  Shimada	  et	  al.	  (102)	   End-­‐diastolic	  volume	  (ml)	  End-­‐systolic	  volume	  (ml)	  Ejection	  fraction	  (%)	  
-­‐14	  (-­‐18,	  -­‐10)	  -­‐6	  (-­‐8,	  -­‐3)	  -­‐1	  (-­‐2,	  -­‐0,1)	  Grapsa	  et	  al.	  (104)	   End-­‐diastolic	  volume	  (ml)	  End-­‐systolic	  volume	  (ml)	  Ejection	  fraction	  (%)	  
-­‐4	  (-­‐11,	  4)	  0	  (-­‐6,	  6)	  -­‐1	  (-­‐3,	  0)	  Sugeng	  et	  al.	  (105)	   End-­‐diastolic	  volume	  (ml)	  End-­‐systolic	  volume	  (ml)	  Ejection	  fraction	  (%)	  
-­‐14	  (-­‐28,	  0)	  -­‐9	  (-­‐19,	  1)	  -­‐2	  (-­‐4,	  0)	  Van	  der	  Zwaan	  et	  al	  (46)	   End-­‐diastolic	  volume	  (ml)	  End-­‐systolic	  volume	  (ml)	  Ejection	  fraction	  (%)	  
-­‐34	  (-­‐43,	  -­‐25)	  -­‐11	  (-­‐19,	  3)	  -­‐4	  (-­‐6,	  -­‐2)	  Leibundgut	  et	  al.	  (45)	   End-­‐diastolic	  volume	  (ml)	  End-­‐systolic	  volume	  (ml)	  Ejection	  fraction	  (%)	  
-­‐10	  (-­‐15,	  -­‐6)	  -­‐5	  (-­‐8,	  -­‐1)	  0	  (-­‐2,	  1)	  CI,	  confidence	  interval.	  Other	  abbreviations	  as	  in	  Table	  5.1	  	   Amaki	   et	   al.	   (106)	   demonstrated	   that	   RV	   quantification	   by	   3DE	   can	   be	   accurately	  performed	  also	   in	  patients	  with	  pulmonary	  hypertension.	  They	   reported	   that	   the	   abnormal	  end-­‐diastolic	  interventricular	  septal	  convexity	  visualized	  by	  3DE	  was	  a	  predictor	  of	  mortality.	  	  In	   congenital	   heart	   diseases,	   RV	   volumes	   are	   important	   predictors	   of	   patient	   outcome,	  may	  help	   in	  choosing	  the	  timing	  of	   interventions	  and	   in	  monitoring	  the	  post-­‐surgical	  result.	  An	  added	  value	  of	  3DE	  is	  the	  ability	  of	  quantificating	  RV	  function	  after	  surgery,	  when	  TAPSE	  and	   RV	   myocardial	   velocities	   by	   tissue-­‐Doppler	   are	   no	   longer	   reliable	   indicators	   of	   global	  systolic	  performance.	  (107,108)	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6.2	  Development	  of	  reference	  values	  for	  RV	  geometry	  and	  function	  by	  3DE	  
Analysis of 3D RV volumes and EF was feasible in 507 of the 542 healthy subjects enrolled in 
this multicenter study. The overall feasibility of 3DE was very similar among centers: 94% for 
Padua, 93% for Naples, and 93% for Milan. 
TABLE	  6.2	  -­‐	  Clinical,	  echocardiographic	  and	  demographic	  characteristics	  of	  the	  study	  population.	  	   All	  (n=507)	   Women	  (n=260)	   Men	  (n=247)	   	  p-­‐value	  Age	  (years)	   45±16	   47±16	   43±16	   <0.01	  Height	  (m)	   170±9	   164±6	   177±7	   <0.01	  Weight	  (kg)	   69±12	   61±9	   77±10	   <0.01	  BMI	  (kg/m2)	   23.8±3.3	   23.0±3.4	   24.7±3.0	   <0.01	  BSA	  (m2)	   1.79±0.19	   1.66±0.12	   1.93±0.14	   <0.01	  Systolic	  BP	  (mmHg)	   121±15	   117±14	   125±14	   <0.01	  Diastolic	  BP	  (mmHg)	   73±10	   71±10	   75±9	   <0.01	  Heart	  rate	  (bpm)	   68±11	   69±11	   67±11	   0.02	  RV	  systolic	  pressure	  (mmHg)	   24.5±5.4	   24.7±5.3	   24.2±5.6	   0.37	  TAPSE	  (mm)	   24.7±3.0	   24.5±2.8	   24.9±3.2	   0.22	  RV	  ED	  Area	  (cm2)	   18.0±4.2	   15.7±2.8	   20.8±3.9	   <0.01	  RV	  ES	  Area	  (cm2)	   9.2±2.6	   7.9±1.8	   10.8±2.6	   <0.01	  RV	  FAC	  (%)	   49±8	   50±7	   48±8	   <0.01	  LV	  EDV	  (mL)	   95±20	   83±13	   108±18	   <0.01	  LV	  ESV	  (mL)	   36±11	   30±8	   42±11	   <0.01	  LV	  EF	  (%)	   63±7	   64±7	   62±7	   <0.01	  p-­‐value	  refers	  to	  unpaired	  Student’s	  t-­‐test,	  Women	  vs	  Men.	  Abbreviations:	  bpm,	  beats	  per	  minute;	  BMI,	  body	  mass	  index;	  EDA,	  end-­‐diastolic	  area;	  ESA,	  end-­‐systolic	  area;	   FAC,	   fractional	   area	   change;	   RV,	   right	   ventricular;	   TAPSE,	   tricuspid	   annulus	   peak	   systolic	  excursion.	  Other	  abbreviations	  as	  in	  Table	  5.3.	  
 
The age of the study cohort ranged between 18 and 90 years, with a slight prevalence of women 
(51%). At least 37 subjects per age decade were included in the study (mean 85±27 subjects per age 
decade), having a similar gender distribution among age decades (p=0.13). All anthropometric 
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measurements were greater in men than in women. Male gender was associated with larger LV 
volumes and RV areas, and lower LV EF and RV FAC, while TAPSE, heart rate and RV systolic 
pressure were similar in men and women (Table 7.2). 
6.2.1	  3D	  RV	  Volumes	  and	  Function.	  	  
As expected, gender effect was largely significant in all age groups, with RV volumes larger in men 
than in women.  
TABLE	   6.3	   -­‐	   Normal	   ranges	   for	   3DE	   right	   ventricular	   end-­‐diastolic	   volume,	   end-­‐systolic	   volume	   and	   ejection	  fraction	   by	   gender	   and	   age	   decade.	   Unless	   otherwise	   stated,	   all	   Women	   vs	   Men	   comparisons	   are	   significant	  (p<0.01).	  	   	   RV	  End-­‐diastolic	  Volume	  (mL)	   	   RV	  End-­‐systolic	  Volume	  (mL)	  
Age	  (years)	   n	  (Women,	  Men)	   All	   Women	   Men	   	   All	   Women	   Men	  <30	   114	  (46,68)	   105	  (69,183)	   88	  (66,136)	   122	  (80,189)	   	   46	  (18,88)	   35	  (14,71)	   51	  (30,94)	  30-­‐39	   98	  (50,48)	   92	  (64,147)	   85	  (63,117)	   114	  (72,153)	   	   36	  (18,67)	   31	  (17,52)	   45	  (25,66)	  40-­‐49	   98	  (53,45)	   90	  (63,132)	   82	  (64,106)	   101	  (75,137)	   	   35	  (16,54)	   30	  (15,44)	   40	  (23,62)	  50-­‐59	   91	  (49,42)	   90	  (62,138)	   79	  (62,117)	   101	  (72,138)	   	   33	  (18,62)	   29	  (18,46)	   37	  (22,63)	  60-­‐69	   69	  (39,30)	   85	  (47,139)	   79	  (43,100)	   98	  (76,149)	   	   32	  (14,61)	   30	  (13,40)	   37	  (20,68)	  ≥70	   37	  (23,14)	   77	  	  (50,	  125)	   70	  (51,86)	   98	  (64,129)	   	   23	  (11,53)	   20	  (12,32)	   34	  (18,54)	  All	   507	  (260,247)	   91	  (61,150)	   81	  (58,120)	   107	  (74,163)	   	   35	  (16,72)	   30	  (15,52)	   44	  (22,80)	  	   	   RV	  Stroke	  Volume	  (mL)	   	   RV	  Ejection	  Fraction	  (%)	  
Age	  (years)	   n	  (Women,	  Men)	   All	   Women	   Men	   	   All	   Women	   Men	  <30	   114	  (46,68)	   63	  	  (41,95)	   56	  (42,77)	   69	  (41,101)	   	   58	  (42,75)	   60	  (45,80)	   56	  (42,68)	  30-­‐39	   98	  (50,48)	   60	  	  (36,	  93)	   56	  (38,72)	   68	  (37,97)	   	   61	  (48,76)	   63	  (52,77)	   60	  (48,72)	  40-­‐49	   98	  (53,45)	   56	  	  (37,82)	   51	  (39,71)	   63	  	  (39,86)	   	   63	  (51,79)	   65	  (50,79)	   61	  (51,75)	  50-­‐59	   91	  (49,42)	   56	  	  (35,78)	   50	  (35,68)	   63	  	  (44,84)	   	   62	  (46,75)	   62	  (47,76)	   62	  (45,73),	  p=0.51	  60-­‐69	   69	  (39,30)	   52	  	  (28,85)	   49	  (25,61)	   64	  	  (48,88)	   	   61	  (50,79)	   61	  (53,75)	   63	  (50,78),	  p=0.75	  ≥70	   37	  (23,14)	   54	  	  (31,77)	   49	  (31,64)	   61	  	  (45,79)	   	   68	  (56,81)	   71	  (60,81)	   65	  (56,75)	  All	   507	  (260,247)	   57	  	  (36,87)	   52	  (35,72)	   66	  	  (40,91)	   	   62	  (47,77)	   63	  (49,79)	   60	  (45,75)	  Data	  expressed	  median	  (5th,	  95th	  percentile).	  p-­‐value	  refers	  to	  unpaired	  Student’s	  t-­‐test,	  Women	  vs	  Men.	  Abbreviations	  as	  in	  Table	  6.2.	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Overall, RV EF was lower in men than in women, even if this difference was not significant in 
all age groups.  
RV EDV and ESV were significantly larger in men than in women and these differences persist 












6.2.2	  Relationship	  with	  age,	  gender	  and	  body	  size.  The	  relationship	  of	  RV	  measurements	  with	  age	  and	  anthropometric	  data	  was	  explored	  using	  bivariate	  and	  multivariate	  linear	  regressions.	  	  
TABLE	  6.4	  -­‐	  Results	  of	  the	  bivariate	  correlations	  (pearson	  correlation)	  between	  right	  ventricular	  volumes	  and	  ejection	  fraction,	  age,	  and	  body	  size	  parameters	  (i.e.	  height,	  weight,	  BMI	  and	  BSA)	  	   RV	  EDV	   RV	  ESV	   RV	  SV	   RV	  EF	  Age	   -­‐0.36*	   -­‐0.37*	   -­‐0.25*	   0.24*	  Height	  	   0.54*	   0.46*	   0.49*	   -­‐0.20*	  Weight	   0.47*	   0.38*	   0.44*	   -­‐0.16*	  BMI	   0.17*	   0.13*	   0.17*	   -­‐0.05	  BSA	   0.55*	   0.45*	   0.50*	   -­‐0.19*	  *:	  correlation	  is	  significant	  at	  the	  0.01	  level	  (two-­‐tailed	  t	  test)	  Abbreviations	  as	  in	  Table	  6.2.	  
	  
	  
Figure	  6.1.	  Right	  ventricular	  end-­‐diastolic	  (left	  panels)	  and	  end-­‐systolic	  (right	  panels)	  volume	  in	  absolute	  values	  (upper	  panels)	  and	  indexed	  to	  body	  surface	  area;	  values	  are	  shown	  as	  mean±SD,	  separately	  for	  women	  and	  men.	  The	  numbers	  indicate	  the	  number	  of	  patients	  in	  each	  age	  decade	  (women,	  men).	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RV volumes showed a progressive reduction with age in both genders, and this effect was more 
pronounced in women. Conversely, RV EF increased with age, and was inversely related to body 
size. Among body size measurements, BMI showed the weakest correlation with RV volumes, and 
no correlation with EF. For this reason, BSA has been preferred to BMI in multivariate analysis. 
Heart rate was found negatively associated with RV volumes (EDV, r=-0.16; ESV, r=-0.17; SV, r=-
0.09) and positively with EF (r=0.13). Multivariate	   analysis	  was	   performed	   introducing	   different	   sets	   of	   predictors:	  model	   AGr	  included	  age	  and	  gender;	  model	  AGBr,	  age,	  gender	  and	  BSA;	  model	  AGHWr	  considered	  age,	  gender,	   height	   and	   weight.	   The	   latter	   model,	   considering	   height	   and	   weight	   separately,	  avoided	  the	  assumptions	  proper	  of	  BSA,	  while	   it	  allowing	  to	  account	  for	  differences	   in	  body	  size.	  (7) Age and gender were independently associated with RV volumes and function.   
TABLE	   6.5	   -­‐	   Results	   of	   the	   multivariate	   linear	   regression	   for	   right	   ventricular	   measurements,	   adjusted	   for	  gender,	   and	   age	   (Model	  AGr,	   ratiometric),	   age	   and	  BSA	   (Model	  AGBr,	   ratiometric,	   or	  Model	  AGBa,	   allometric),	  age,	   height	   and	  weight	   (Model	  AGHWr,	   ratiometric).	  Data	  presented	   as	  model	   coefficient	   (β),	   95%	  confidence	  interval	  (CI),	  and	  Pearson’s	  correlation	  coefficient	  (r2).	  	  
RV	  EDV	  (ml)	   	   	   RV	  ESV	  (ml)	   	   	   RV	  SV	  (mL)	   	   	   RV	  EF	  (%)	   	  	   β	  (95%	  CI)	   r2	   	   β	  (95%	  CI)	   r2	   	   β	  (95%	  CI)	   r2	   	   β	  (95%	  CI)	   r2	  
Model	  AGr	   	   0.34	   	   	   0.29	   	   	   0.22	   	   	   0.10	  Constant	   108.2	  (101.6,	  114.7)*	   	   	   46.6	  (42.6,	  50.6)*	   	   	   61.6	  (57.6,	  65.5)*	   	   	   58.0	  (55.6,	  60.4)*	   	  Gender	   25.9	  (21.9,	  30.0)*	   	   	   13.3	  (10.8,	  15.7)*	   	   	   12.7	  (10.2,	  15.1)*	   	   	   -­‐3.4	  (-­‐4.9,	  -­‐1.9)*	   	  Age	  (years)	   -­‐0.53	  (-­‐0.66,	  -­‐0.40)*	   	   	   -­‐0.34	  (-­‐0.41,	  -­‐0.26)*	   	   	   -­‐0.19	  (-­‐0.27,	  -­‐0.12)*	   	   	   0.12	  (0.08,	  0.17)*	   	  
Model	  AGBr	   	   0.42	   	   	   0.34	   	   	   0.30	   	   	   0.10	  Constant	   15.7	  (-­‐9.6,	  41.0)	   	   	   7.1	  (-­‐8.9,	  23.2)	   	   	   8.6	  (-­‐6.8,	  23.9)	   	   	   62.0	  (52.0,	  71.9)*	   	  Gender	   11.4	  (5.9,	  17.0)*	   	   	   7.3	  (3.7,	  10.8)*	   	   	   4.2	  (0.8,	  7.6)*	   	   	   -­‐2.9	  (-­‐5.1,	  -­‐0.7)*	   	  Age	  (years)	   -­‐0.55	  (-­‐0.67,	  -­‐0.43)*	   	   	   -­‐0.35	  (-­‐0.43,	  -­‐0.27)*	   	   	   -­‐0.20	  (-­‐0.27,	  -­‐0.12)*	   	   	   0.13	  (0.08,	  0.18)*	   	  BSA	  (m2)	   56.2	  (41.5,	  70.9)*	   	   	   24.2	  (14.9,	  33.5)*	   	   	   32.0	  (23.1,	  40.9)*	   	   	   -­‐2.5	  (-­‐8.3,	  3.2)	   	  
Model	  AGHWr	   	   0.42	   	   	   0.34	   	   	   0.30	   	   	   0.10	  Constant	   -­‐15.5	  (-­‐66.8,	  35.9)	   	   	   -­‐0.2	  (-­‐32.8,	  32.4)	   	   	   -­‐15.2	  (-­‐46.4,	  15.9)	   	   	   55.8	  (35.7,	  76.0)*	   	  Gender	   11.2	  (5.4,	  16.9)*	   	   	   7.4	  (3.7,	  11.0)*	   	   	   3.8	  (0.3,	  7.3)*	   	   	   -­‐3.2	  (-­‐5.4,	  -­‐0.9)*	   	  Age	  (years)	   -­‐0.53	  (-­‐0.66,	  -­‐0.40)*	   	   	   -­‐0.35	  (-­‐0.43,	  -­‐0.27)*	   	   	   -­‐0.18	  (-­‐0.26,	  -­‐0.10)*	   	   	   0.13	  (0.08,	  0.18)*	   	  Height	  (cm)	   0.55	  (0.23,	  0.88)*	   	   	   0.19	  (0.01,	  0.40)*	   	   	   0.36	  (0.16,	  0.55)*	   	   	   0.03	  (-­‐0.10,	  0.16)	   	  Weight	  (kg)	   0.55	  (0.32,0.77)*	   	   	   0.25	  (0.11,	  0.40)*	   	   	   0.29	  (0.16,	  0.43)*	   	   	   -­‐0.05	  (-­‐0.14,	  0.04)	   	  
Model	  AGBa	   	   0.43	   	   	   0.35	   	   	   0.28	   	   	   0.11	  Constant	   4.79	  (4.56,	  5.02)*	   	   	   4.19	  (3.80,	  4.18)*	   	   	   4.01	  (3.76,	  4.26)*	   	   	   3.83	  (3.67,	  3.98)*	   	  Gender	   0.11	  (0.06,	  0.17)*	   	   	   0.18	  (0.09,	  0.27)*	   	   	   0.07	  (0.01,	  0.13)*	   	   	   -­‐0.05	  (-­‐0.08,	  -­‐0.01)*	   	  Age	  (years)	   -­‐0.24	  (-­‐0.29,	  -­‐0.19)*	   	   	   -­‐0.39	  (-­‐0.47,	  -­‐0.30)*	   	   	   -­‐0.14	  (-­‐0.20,	  -­‐0.09)*	   	   	   0.10	  (0.06,	  0.13)*	   	  BSA	  (m2)	   1.02	  (0.77,	  1.28)*	   	   	   1.23	  (0.80,	  1.66)*	   	   	   0.94	  (0.67,	  1.22)*	   	   	   -­‐0.08	  (-­‐0.25,	  0.09)	   	  
Normative	  equations	  
(ABGa)	  
	   	   	   	   	   	   	   	   	   	   	  Women	   120.4·Age-­‐0.24·BSA1.02	   	   	   66.2·Age-­‐0.39·BSA1.23	   	   	   55.2·Age-­‐0.14·BSA0.94	   	   	   45.9·Age0.10	   	  Men	   134.9·Age-­‐0.24·BSA1.02	   	   	   79.3·Age-­‐0.39·BSA1.23	   	   	   59.0·Age-­‐0.14·BSA0.94	   	   	   43.8·Age0.10	   	  *:	  p<0.01	  versus	  null	  coefficient.	  Abbreviations:	  BSA,	  body	  surface	  area;	  RV,	  right	  ventricular.	  Indexed	  RV	  measures	  can	  be	  obtained	  by	  applying	  the	  following	  formulas:	  AGr:	  RV	  index	  =	  RV	  parameter/(constantF/M	  +	  βAge	  ·	  Age)	  AGBr:	  RV	  index	  =	  RV	  parameter/(constantF/M	  +	  βAge	  ·	  Age	  +	  βBSA	  ·	  BSA)	  AGHWr:	  RV	  index	  =	  RV	  parameter/(constantF/M	  +	  βAge	  ·	  Age	  +	  βBSA	  ·	  Height	  +	  βWeight	  ·	  Weight)	  AGBa:	  RV	  index	  =	  RV	  parameter/(constantF/M	  ·	  AgeβAge	  ·	  BSAβBSA)	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Specifically, there was an average expected age-related decrement of 5 ml/decade for EDV, 3 
ml/decade for ESV and 2 ml/decade for SV Moreover, ageing was associated with a small (≈ 
1%/decade), but significant increase in RV EF. 
The inclusion of BSA (Table 6.5, Model AGBr) resulted in a significant improvement of the 
overall variation in RV volumes explained by the model (up to 40% for the EDV). BSA was 
associated with EDV, ESV and SV, with an expected increase of ≈ 5 ml, ≈ 2 ml and ≈ 3 ml 
respectively per each 0.1 m2 of BSA increase. The effects of age and gender persisted in Model 
AGBr, with coefficients similar to those derived in Model AGr. No significant improvement was 
observed when including BSA in the regression model for RV EF. Considering height and weight 
separately (Table 6.5, Model AGHWr) instead of their combination as BSA (Table 6.5, Model 
AGBr) did not lead to significant improvements in terms of R2, the two models showing similar 
values in terms of constant and coefficients for age and gender. For this reason, and also to avoid 
the possible issue of collinearity, multivariate regressions on log-log transformed variables were 
performed using BSA, and not height and weight separately. 
6.2.3	  Normative	  equations	  for	  3DE	  RV	  volume	  and	  EF.	  	  
Normative equations for RV parameters were obtained using linear regression, after log-
transforming dependent and independent variables, to allow allometric scaling  of RV volumes and 
function. (109) Gender was included as a dummy variable in the model, resulting in different 
intercepts for women and men. Derived normative equations for 3DE RV volumes and EF are 
reported in Table 6.5. To validate the 3DE normative equations, a split and sample approach was 
used. A comparison between the derived normative equations and those obtained in a similar 
population using CMR, (7) has been carried out applying the two sets of equations to our 
population. The difference between the two predicted values was investigated as a function of the 
mean expected value. 
 
 























Figure	  6.2.	  Comparison	  between	  the	  values	  of	  end-­‐diastolic	  volume	  (EDV)	  obtained	  applying	  to	  the	  study	  population	  the	  normative	  equations	  in	  Table	  6.5	  derived	  using	  3D	  echocardiography	  (gray	  surfaces)	  and	  EDVs	  obtained	  in	  the	  same	  population	  using	  normative	  equations	  developed	  for	  CMR	  (7)	  (red	  surface).	  Normative	  surfaces	  are	  shown	  as	  a	  function	  of	  BSA	  and	  age,	  separately	  for	  men	  (top	  right)	  and	  women	  (top	  left).	  	  Scatter	  plot	  (bottom	  represents	  the	  difference	  between	  the	  expected	  values	  (ΔEDVCMR-­‐3DE)	  as	  a	  function	  of	  the	  mean	  expected	  value	  (EDVavg).	  The	  r2	  value	  refers	  to	  the	  Pearson	  coefficient	  between	  ΔEDVCMR-­‐3DE	  and	  EDVavg.	  





Figure	  6.3.	  Comparison	  between	  the	  values	  of	  end-­‐diastolic	  volume	  (EDV)	  obtained	  applying	  to	  the	  study	  population	  the	  normative	  equations	  in	  Table	  6.5	  derived	  using	  3D	  echocardiography	  (gray	  surfaces)	  and	  EDVs	  obtained	  in	  the	  same	  population	  using	  normative	  equations	  developed	  for	  CMR	  (7)	  (red	  surface).	  See	  figure	  6.2	  for	  detailed	  description	  of	  the	  graphs.	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Figure	  6.4.	  Comparison	  between	  the	  values	  of	  end-­‐diastolic	  volume	  (EDV)	  obtained	  applying	  to	  the	  study	  population	  the	  normative	  equations	  in	  Table	  6.5	  derived	  using	  3D	  echocardiography	  (gray	  surfaces)	  and	  EDVs	  obtained	  in	  the	  same	  population	  using	  normative	  equations	  developed	  for	  CMR	  (7)	  (red	  surface).	  See	  figure	  6.2	  for	  detailed	  description	  of	  the	  graphs.	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Contrary to general assumptions about scaling effects, in our study 3D RV volumes and EF 
maintain significant residual correlations with both height and weight, even after indexing them to 
BSA or BMI.  
TABLE	  6.6.	  Pearson	  correlation	  coefficients	  for	  indexed	  right	  ventricular	  parameters	  with	  height	  and	  weight.	  
	  Abbreviations:	  Abs,	  absolute	  value;	  BMI,	  body	  mass	   index;	  BSA,	  body	  surface	  area;	  AGBa,	  adjusted	   for	  age	  and	  BSA	  (allometric);	  AGBr,	  adjusted	  for	  age,	  gender	  and	  BSA	  (ratiometric);	  AGHWr,	  adjusted	  for	  age,	  gender,	  height	  and	  weight	   (ratiometric);	  EDV,	   end-­‐diastolic	   volume;	  EF,	   ejection	   fraction;	  ESV,	   end-­‐systolic	   volume;	  RV,	   right	  ventricular,	  SV,	  stroke	  volume.	  *:	  correlation	  is	  significant	  at	  the	  0.01	  level	  (2-­‐tailed	  t-­‐test).	  
Parameter	   Model	   Height	   Weight	  
RV	  EDV	   RV	  EDVAbs	   0.54*	   0.47*	  	   RV	  EDVBSA	   0.29*	   0.16*	  	   RV	  EDVBMI	   0.52*	   0.12*	  	   RV	  EDVAGBr	   0.00	  (p=0.92)	   -­‐0.02	  (p=0.59)	  	   RV	  EDVAGHWr	   -­‐0.02	  (p=0.63)	   -­‐0.01	  (p=0.81)	  	   RV	  EDVAGBa	   0.02	  (p=0.62)	   0.01	  (p=0.88)	  
RV	  ESV	   RV	  ESVAbs	   0.46*	   0.38*	  	   RV	  ESVBSA	   0.29*	   0.18*	  	   RV	  ESVBMI	   0.45*	   0.16*	  	   RV	  ESVAGBr	   -­‐0.02	  (p=0.60)	   -­‐0.02	  (p=0.68)	  	   RV	  ESVAGHWr	   -­‐0.04	  (p=0.38)	   -­‐0.02	  (p=0.61)	  	   RV	  ESVAGBa	   -­‐0.01	  (p=0.80)	   -­‐0.01	  (p=0.89)	  
RV	  SV	   RV	  SVAbs	   0.49*	   0.44*	  	   RV	  SVBSA	   0.18*	   0.07	  (p=0.15)	  	   RV	  SVBMI	   0.45*	   0.04	  (p=0.37)	  	   RV	  SVAGBr	   0.01	  (p=0.82)	   -­‐0.03	  (p=0.56)	  	   RV	  SVAGHWr	   -­‐0.01	  (p=0.83)	   0.00	  (p=0.96)	  	   RV	  SVAGBa	   0.04	  (p=0.41)	   0.00	  (p=0.95)	  
RV	  EF	   RV	  EFAbs	   -­‐0.20*	   -­‐0.16*	  	   RV	  EFBSA	   -­‐0.59*	   -­‐0.63*	  	   RV	  EFBMI	   -­‐0.17*	   -­‐0.63*	  	   RV	  EFAGBr	   0.02	  (p=0.70)	   -­‐0.01	  (p=0.83)	  	   RV	  EFAGHWr	   0.00	  (p=0.95)	   0.00	  (p=0.99)	  	   RV	  EFAGBa	   0.03	  (p=0.52)	   -­‐0.01	  (p=0.84)	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Ratiometric scaling for RV parameters adjusted for age and BSA (AGBr), or age, height and 
weight (AGHWr) resulted in RV volumes and EF values independent of body size. Similarly, 
allometric scaling for normative equation listed in Table 6.5 (Model ABa) resulted in negligible 
residual correlations with height and weight. 
6.2.4	  Comparison	  with	  CMR-­‐derived	  normative	  equations.	  	  Comparison	  with	  normative	  equations	  derived	  from	  CMR	  (7)	  applied	  to	  our	  study	  population,	  showed	  a	  consistent	  underestimation	  of	  RV	  volumes	  calculated	  using	  3DE	  vs.	  CMR	  normative	  equations	  (Figures	  6.2	  and	  6.3).	  	  	  The	   differences	   between	   the	   CMR	   and	   3DE	   expected	   normative	   values	   showed	   a	   strong	  positive	  correlation	  with	  their	  average.	  For	  every	  10	  mL	  increase	  of	  average	  3DE	  and	  CMR	  RV	  volumes,	   there	  was	  an	   increase	   in	  the	   inter-­‐modality	  difference	  of	  approximately	  6	  ml,	  4	  ml	  and	   5	   ml,	   for	   EDV,	   ESV	   and	   SV,	   respectively	   (Figures	   6.2	   and	   6.3).	   Conversely,	   the	   inter-­‐modality	  difference	  of	  expected	  EF	  showed	  no	  correlation	  with	   the	  average	  expected	  value,	  resulting	  in	  a	  bias	  of	  6.7%	  at	  Bland-­‐Altman	  analysis	  (Figure	  4.4).	  
6.2.5	  Reproducibility.	  	  
Intra-observer analysis showed good to excellent reproducibility (R2 ranges between 0.76 to 
0.94), with negligible bias and narrow limits of agreement (4.3 ml for ESV at Padua, 11.5 for EDV 
at Milan). Inter-center measurements using the standardized method showed higher variability (R2 
between 0.43 and 0.87), with no significant biases (absolute values comprised between 2 and 9 ml) 
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TABLE	   6.7	   -­‐	   Results	   of	   intra-­‐operator	   and	   inter	   center	   reproducibility	   analysis,	   evaluated	   using	   Pearson	  correlation	  coefficient	  (r2)	  and	  Bland-­‐Altman	  analysis	  between	  repeated	  measurements.	  
	   	   EDV	  (ml)	   ESV	  (ml)	  
Intra-­‐operator	   Padua,	  PD	   0.6±5.1	  (0.94)	   0.7±4.3	  (0.92)	  	   Naples,	  NA	   0.4±5.8	  (0.96)	   1.2±5.2	  (0.91)	  	   Milan,	  MI	   0.3±11.5	  (0.91)	   1.5±8.5	  (0.76)	  
Inter-­‐center	   PD	  vs.	  NA	   -­‐9±33	  (0.58)	   -­‐3±13	  (0.60)	  	   PD	  vs.	  MI	   -­‐3±15	  (0.87)	   -­‐5±13	  (0.63)	  	   NA	  vs.	  MI	   6±33	  (0.58)	   -­‐2±17	  (0.43)	  	  Values	  expressed	  as	  bias±1.96	  SD	  (r2).	  
6.3	  Discussion	  
This is the first prospective multi-center study providing reference values for 3D RV volumes 
and EF, separately for age and gender. To foster the clinical application of 3DE in individual 
patients, a set of normative equations for RV volumes and EF was derived from this large cohort of 
healthy adults, taking into account demographic and anthropometric parameters. 
The main findings of this study can be summarized as follows: (i) the normal ranges of absolute 
and BSA-indexed values of RV volumes and EF measured using 3DE are now available separately 
for gender and age decades; (ii) demographic and anthropometric parameters were strong 
independent predictors of 3DE RV volumes at multivariate analysis; (iii) RV EF showed a weak 
correlation with age and gender, and no correlation with body size; (iv) normative allometric 
equations for 3D RV volumes and EF have been developed, effectively indexing RV parameters for 
body size; (v) a strong agreement between 3DE and CMR predicted normative values was found; 
(vi) individual reference values for RV size and function parameters calculated using 3DE 
normative equations were systematically lower than those calculated using CMR normative 
equations. 
Quantification of RV size and function with conventional echocardiography is challenging, due 
to the anterior position of the RV in the chest, its complex asymmetric geometry and highly 
trabeculated endocardial border, impossibility to simultaneously visualize both inflow and outflow 
tracts and lack of realistic geometric models for volume calculation. (101) 3DE has been 
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demonstrated to have a good accuracy in measuring RV volumes compared to CMR. (102) This, in 
conjunction with the availability of specifically designed software not requiring a priori modeling or 
geometric assumptions, (110) made 3DE a feasible, fast and accurate technique for RV assessment 
in different clinical settings. (45,111-113) 
6.3.1	  Influence	  of	  demographic	  parameters	  and	  body	  size	  on	  RV	  volumes	  
Several biological processes and anatomic structures, including cardiovascular structural and 
functional variables, scale with anthropometric and demographic data. (114) However, while 
scaling is commonly performed in pediatric medicine, allowing to eliminate the possible 
confounding effect of the rapid somatic growth process, the practice of indexing is less used in adult 
clinical cardiology. (109) The goal of scaling cardiac structure is to eliminate, or at least 
substantially decrease, the overlap between normal and abnormal ranges that could be influenced by 
body size. In the present study, besides providing normative values of RV volumes and ejection 
fraction stratified for gender and age, we also derived different models and normative equations to 
index RV values according to demographic and anthropometric parameters. Independently of the 
adopted model, aging was associated with a decrease of 5 ml/decade for EDV, 3 ml/decade for 
ESV, and 2 ml/decade for SV. Conversely, EF increased by 1%/decade. Body size was also 
significantly related with RV volumes. For every 0.1 m2 increase in BSA, there was an increase of 6 
ml, 2 ml and 3 ml in RV EDV, ESV and SV, respectively. Height and weight were also positively 
associated with RV volumes. However, their inclusion in the statistical model separately, and not 
merged into BSA, did not increase the predictive power of the model. 
We also demonstrated the importance of gender in all RV parameters: RV volumes were larger 
and EF lower in men than in women. Albeit these dissimilarities can be partially explained by 
different biometric characteristics between women and men, gender was a significant determinant 
of RV size even after scaling for anthropometric variables. 
From an empirical point of view, adequate model fitting should result in negligible residual 
association between the values indexed by body size (e.g. BSA) and the independent variables, 
	   95	  
specifically height and weight. (115) Our results showed a residual correlation with height and 
weight after ratiometric indexing (Table 6.6) suggesting that the assumption of linearity between 
3DE RV volumes and BSA is not completely satisfied, even after adjusting for age and gender. 
Furthermore, indexing RV ESV to Model AGBr overcompensated the association with 
anthropometric measures. Conversely, applying the allometric scaling led to the calculation of RV 
volumes which were independent of age and body size. These findings imply that simply indexing 
by BSA may be suboptimal, and the use of an exponential allometric model could be more 
appropriate to scale RV volumes and SV. Alternatively, ratiometric scaling for the Model AGHWr, 
considering height and weight separately and not in fixed proportion as in BSA calculated by Du 
Bois and Du Bois formula (37), resulted in RV volumes independent of body size. In addition, the 
appropriateness of normalization achieved via scaling ratiometrically to BSA may be questionable 
from a theoretical point of view. Indeed, the theory of similarity states that relative geometries 
determine in part the relationships between body size variables. As RV volume is proportional to a 
length measure raised to the third power, and BSA is proportional to a length raised to the second 
power, the scaling relationship is dimensionally not consistent. Thus, indexing to BSA, despite 
widely used in clinical practice in all cardiac imaging modalities, may be suboptimal in certain 
circumstances. (109) 
The observed association between RV size, demographic and anthropometric parameters has 
been previously reported in other studies, both using echocardiography and other imaging 
modalities. In a large series of subjects with normal echocardiographic findings, D’Oronzio et al. 
(116) concluded that gender and BSA are important determinants of 2D echocardiographic RV 
dimensions, and proposed to use gender-specific RV measures indexed to BSA for the assessment 
of RV in the clinical routine. Of note, D’Oronzio et al. (116) reported only a weak inverse 
association between aging and RV area, which may be due to the lower accuracy of 2D 
echocardiography in comparison with 3DE in assessing RV size (116). 
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Our study corroborate and extend the results of Tamborini et al. (103) to a larger population, 
investigating the demographic and anthropometric determinants of RV morphology and function in 
a multi-center setting. This is an important step towards the definition of clinically applicable 
reference ranges. Indeed, systematic biases among laboratories have been reported for left LV 
assessment by 3DE (115,117,118), and similar biases affecting RV measurements could not be 
excluded a priori. In this view, a multi-center design is crucial for identifying reliable normative 
values. 
6.3.2	  Comparison	  with	  CMR	  
Nowadays, CMR is considered the gold standard for the assessment of RV volumes and 
function, and different studies have reported RV reference values for this modality (119,120). Our 
findings confirm previous studies reporting a slight systematic underestimation of RV volumes by 
3DE in comparison with CMR (117,121). The potential source of bias has been documented in both 
in vivo and in vitro studies(102,105). Despite the bias in absolute values, the role of aging, gender 
and anthropometric variables as determinants of RV size and function demonstrated by Maceira et 
al. (119) using steady-state free precession CMR are in complete agreement with our findings. The 
comparison of normative non-linear equations obtained in our study with those presented by Kawut 
et al. (7) obtained in a similar number of subjects, represents an even more interesting parallelism 
between 3DE and CMR in the setting of RV evaluation. Indeed (as depicted in Figure 6.2 and 6.3) 
normative surfaces of the present study obtained applying the derived normative equations show 
similar behaviors, with exponential positive influence of both BSA and age on RV EDV, ESV and 
SV. Also, from the comparison of these two models we demonstrated that the bias between the 
predicted normal values by 3DE and CMR is not constant, but has a rather strong positive linear 
correlation with the average expected RV volume. Normative surfaces of RV EF were very similar, 
with a significant and constant underestimation of 3DE versus CMR (approximately 7%), with 
narrow limits of agreement. 
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6.3.3	  Reliability	  of	  3DE	  to	  quantify	  RV	  volumes	  
From a clinical standpoint, the reliability of a quantitative method is more important that its 
accuracy in comparison with the reference value obtained using a universally-accepted “gold-
standard”. Accordingly, for patient follow-up most clinicians would prefer to use a precise method 
with a reproducible bias, despite less accurate, instead of using a highly accurate method affected 
by large random error. (122) For the first time, we evaluated the inter-center reproducibility of 3DE 
RV volumes using different echocardiographic equipment and the same post-processing software. 
Interinstitutional variability constitutes a serious threat for measurement reproducibility and it is 
potentially the most serious source of bias in multicenter study. In agreement with previous study 
(123), we demonstrated that the definition of a standardized method by joint consensus significantly 
improved the inter-center agreement. We demonstrated that RV 3DE measurements are fairly 
robust and reproducible. However, the limits of agreements of measurements among different 
centers were still relatively high and, apart the described standardization of the image acquisition 
and post-processing steps, further technological advances towards a fully-automated quantitation of 
cardiac chamber volumes would be desirable to further improve the robustness of 3DE. 
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CHAPTER 7 	  	  





7.1	  Background	  A	  growing	   interest	  has	  been	  recently	  dedicated	   to	  atrial	   cavities	  due	   to	   their	  prognostic	  value	   in	   various	   cardiac	   diseases	   and	   the	   rapid	   development	   of	   cardiac	   interventional	  electrophysiology.	  	  Left	   atrial	   (LA)	   size	   assessment	   is	   clinically	   relevant	   in	   a	   comprehensive	   patient	  evaluation.	  The	  finding	  of	  an	  enlarged	  LA	  could	  be	  indicative	  of	  significant	  ventricular,	  (124-­‐126)	   atrial	   (127)	   or	   valvular	   disease,	   (52)	   being	   also	   a	   proved	   marker	   of	   adverse	  cardiovascular	  outcomes.	  (128,129)	  Even	  if	  LA	  size	  has	  been	  assessed	  using	  different	  parameters,	   it	  has	  been	  shown	  that	  LA	  volume	  is	  a	  more	  robust	  cardiovascular	  risk	  marker	  than	  LA	  area	  or	  linear	  dimensions.	  (129)	  The	  current	  guidelines	  recommend	  biplane	  calculation	  of	  LA	  volume	  using	  both	  Simpson’s	  or	  area-­‐length	   methods	   on	   2DE	   apical	   four-­‐	   and	   two-­‐chamber	   views.	   (38,129,130).	   Both	  algorithms	   are	   heavily	   dependent	   on	   geometric	   assumptions	   about	   LA	   geometry	   and	   have	  been	   shown	   to	   underestimate	   LA	   volumes	   measured	   with	   cardiac	   computed	   tomography	  (131)	  and	  CMR.	  (132)	  Recently,	  3DE	  has	  been	  incorporated	  into	  the	  clinical	  practice	  of	  many	  echocardiography	  laboratories.	  When	  3DE	  has	  been	  used	  to	  measure	  LA	  volumes,	  it	  showed	  significantly	  better	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agreement	   than	   2DE	   with	   other	   imaging	   modalities	   including	   computerized	   tomographic	  imaging	   (133)	   and	   CMR.	   (48,134)	   In	   addition,	   LA	   volume	   assessment	   by	   3DE	   has	   shown	  prognostic	   value	   for	   cardiovascular	   events,	   (135,136)	  which	  was	   incremental	   compared	   to	  2DE	  LA	  volumes,	  (137)	  and	  the	  most	  favorable	  test-­‐retest	  variation	  with	  the	  least	  intra-­‐	  and	  inter-­‐observer	   variability	   compared	   with	   other	   echocardiographic	   techniques.	   (138)	  However,	   implementation	   of	   3DE	   LA	   volume	   measurements	   in	   the	   routine	   of	   the	  echocardiographic	  laboratories	  requires	  the	  availability	  of	  reliable	  reference	  values.	  (130)	  At	  present,	   reference	   values	   about	   3DE	   LA	   volumes	   and	   phasic	   function	   parameters	   are	   very	  limited.	  (139)	  
7.2	  Development	  of	  reference	  values	  for	  LA	  geometry	  and	  function	  by	  3DE	  19	  volunteers	  met	  all	  criteria	  for	  inclusion	  but	  were	  excluded	  from	  enrolment:	  6	  because	  their	   acoustic	   window	   was	   inadequate	   for	   2DE	   and	   3DE	   analysis	   and	   13	   due	   minimal	  abnormal	  echocardiographic	  findings	  (e.g.	  interatrial	  septal	  aneurysm).	  Among	  the	  remaining	  244	  subjects,	  23	  could	  not	  be	  evaluated	  by	  3DE	  due	  to	  poor	  image	  quality.	  	  
	  
TABLE	  7.1	  -­‐	  Demographic	  Characteristics	  
 	   All	  (n=244)	   Men	  (n=103)	   Women	  (n=141)	   p*	  Age	  (years)	   43	  ±	  14	   42	  ±	  14	   44	  ±	  14	   NS	  Age	  range	  (years)	   18	  -­‐	  75	   18	  –	  74	   18	  -­‐	  75	   NS	  Heart	  rate	  (bpm)	   68	  ±	  12	   67	  ±	  12	   69	  ±	  11	   NS	  Height	  (cm)	   170	  ±	  9	   178	  ±	  6	   165	  ±	  7	   <	  0.001	  Weight	  (kg)	   67	  ±	  11	   76	  ±	  9	   61	  ±	  8	   <	  0.001	  Body	  mass	  index	  (kg/m2)	   23.1	  ±	  2.8	   24.1	  ±	  2.4	   22.3	  ±	  2.8	   <	  0.001	  Body	  surface	  area	  (m2)	   1.78	  ±	  0.18	   1.93	  ±	  0.13	   1.67	  ±	  0.13	   <	  0.001	  Systolic	  blood	  pressure	  (mmHg)	   121	  ±	  13	   126	  ±	  11	   117	  ±	  14	   <	  0.001	  Diastolic	  blood	  pressure	  (mmHg)	   74	  ±	  8	   77	  ±	  8	   71	  ±	  8	   <	  0.001	  	  *	  p	  values	  refer	  to	  gender	  differences	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Thus	   in	   our	   study	  population,	   the	   feasibility	   of	   3DE	   and	  2DE	  LA	   volume	  measurements	  were	  91%	  and	  96%	  (p=0.59).	  Temporal	  resolution	  of	  3DE	  LA	  data	  sets	  was	  44±10	  volumes/s.	  Fifty-­‐seven	  percent	  of	  study	  subjects	  were	  women.	  There	  were	  no	  differences	  in	  age	  and	  heart	   rate	   between	   men	   and	   women.	   Women	   showed	   significantly	   smaller	   body	   size	   and	  lower	  blood	  pressure	  compared	  to	  men.	   
7.2.1.	  3DE	  LA	  volumes	  and	  function	  and	  their	  relationship	  with	  gender	  LA	  size	  and	  function	  parameters	  obtained	  with	  3DE	  and	  2DE	  are	  summarized	  in	  Table	  7.2.	  Irrespective	   on	   the	   echo	   technique	   used,	   parameters	   of	   LA	   size	  were	   significantly	   larger	   in	  men	  than	  in	  women,	  but	  these	  differences	  disappeared	  for	  2DE	  Vmax,	  Vmin	  and	  Vpre	  A,	  and	  3DE	  Vmax	  and	  Vpre	  A	  after	  indexing	  for	  BSA.	  Upper	  limits	  for	  3DE	  LA	  Vmax,	  Vmin	  and	  VpreA	  were	  39	  ml/m2,	  17	  ml/m2	  and	  24	  ml/m2	   in	  men	  and	  36	  ml/m2,	  16	  ml/m2	  and	  23	  ml/m2	   in	  women.	   3DE	   LA	   total,	   passive	   and	   active	   EVs	   were	   larger	   in	   men,	   but	   these	   differences	  disappeared	   after	   indexing	   for	   BSA	   (Table	   7.2).	   Lower	   limits	   of	   normality	   for	   3DE	   total,	  passive	  and	  active	  LA	  indexed	  EV	  in	  men	  were	  9	  ml/m2,	  4	  ml/m2	  and	  1	  ml/m2,	  and	  in	  women	  10	   ml/m2,	   6	   ml/m2	   and	   1	   ml/m2	   respectively.	   3D	   LA	   total	   EmptFr	   was	   similar	   between	  genders	   while	   women	   showed	   higher	   passive	   EmptFrs.	   Lower	   limits	   of	   normality	   for	   3DE	  total,	   passive	   and	   active	   LA	  EmptFrs	  were	   46%,	   20%	  and	  16%	   in	  men	   and	  50%,	   27%	  and	  14%	  in	  women.	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TABLE	  7.2	  –	  Left	  atrial	  volumes	  and	  function	  by	  two-­‐	  and	  three-­‐dimensional	  echocardiography	  	  
 
2DE	  parameters	   Overall	  (n=	  235)	   Men	  (n=	  99)	   Women	  (n=	  136)	   p*	  	   	   Average	   Normal	  Limit	   Average	   Normal	  Limit	   	  Vmax	  (ml)	   43	  ±	  11	   47	  ±	  11	   69	  a	   41	  ±	  10	   60	  a	   <0.001	  Vmax/BSA	  (ml/m2)	   24	  ±	  5	   24	  ±	  5	   34	  a	   24	  ±	  6	   36	  a	   NS	  Vmin	  (ml)	   14	  ±	  6	   15	  ±	  7	   29	  a	   13	  ±	  6	   25	  a	   0.02	  Vmin/BSA	  (ml/m2)	   8	  ±	  3	   8	  ±	  3	   14	  a	   8	  ±	  3	   14	  a	   NS	  Vpre	  A	  (ml)	   26	  ±	  9	   29	  ±	  10	   49	  a	   24	  ±	  8	   40	  a	   <0.001	  Vpre	  A/BSA	  (ml/m2)	   14	  ±	  5	   15	  ±	  5	   25	  a	   14	  ±	  5	   24	  a	   NS	  Total	  EV	  (ml)	   29	  ±	  7	   31	  ±	  6	   19	  b	   27	  ±	  7	   13	  b	   <0.001	  Total	  EV/BSA	  (ml/m2)	   16	  ±	  3	   16	  ±	  3	   10	  b	   16	  ±	  4	   8	  b	   NS	  Passive	  EV	  (ml)	   17	  ±	  6	   17	  ±	  5	   7	  b	   17	  ±	  6	   5	  b	   NS	  Passive	  EV/BSA	  (ml/m2)	   10	  ±	  3	   9	  ±	  3	   3	  b	   10	  ±	  3	   4	  b	   0.01	  Active	  EV	  (ml)	   12	  ±	  4	   13	  ±	  5	   3	  b	   11	  ±	  4	  	   3	  b	   <0.001	  Active	  EV/BSA	  (ml/m2)	   7	  ±	  2	   7	  ±	  2	   3	  b	   6	  ±	  2	   2	  b	   NS	  Total	  EmptFr	  (%)	   68	  ±	  9	   69	  ±	  9	   51	  b	   69	  ±	  8	   53	  b	   NS	  Passive	  EmptFr	  (%)	   41	  ±	  11	   40	  ±	  11	   18	  b	   43	  ±	  11	   21	  b	   0.03	  Active	  EmptFr	  (%)	   47	  ±	  10	   48	  ±	  11	   26	  b	   46	  ±	  10	   26	  b	   NS	  Expansion	  index	  (%)	   237	  ±	  107	   235±105	   445a	   239±109	   457a	   NS	  
3DE	  Parameters	   Overall	  (n=	  221)	   Men	  (n=	  92)	   Women	  (n=	  129)	   p*	  	   	   Average	   Limit	   Average	   Limit	   	  Vmax	  (ml)	   48	  ±	  11	   53	  ±	  12	   77	  a	   43	  ±	  9	   61	  a	   <0.001	  Vmax/BSA	  (ml/m2)	   27	  ±	  5	   27	  ±	  6	   39	  a	   26	  ±	  5	   36	  a	   NS	  Vmin	  (ml)	   19	  ±	  6	   21	  ±	  6	   33	  a	   17	  ±	  4	   25	  a	   <0.001	  Vmin/BSA	  (ml/m2)	   10	  ±	  3	   11	  ±	  3	   17	  a	   10	  ±	  3	   16	  a	   0.03	  Vpre	  A	  (ml)	   27	  ±	  8	   30	  ±	  9	   48	  a	   24	  ±	  7	   38	  a	   <0.001	  Vpre	  A/BSA	  (ml/m2)	   15	  ±	  4	   16	  ±	  4	   24	  a	   15	  ±	  4	   23	  a	   NS	  Total	  EV	  (ml)	   29	  ±	  7	   32	  ±	  8	   16	  b	   27	  ±	  6	   15	  b	   <0.001	  Total	  EV/BSA	  (ml/m2)	   16	  ±	  3	   17	  ±	  4	   9	  b	   16	  ±	  3	   10	  b	   NS	  Passive	  EV	  (ml)	   21	  ±	  7	   23	  ±	  8	   7	  b	   20	  ±	  6	   8	  b	   <0.001	  Passive	  EV/BSA	  (ml/m2)	   12	  ±	  4	   12	  ±	  4	   4	  b	   12	  ±	  3	   6	  b	   NS	  Active	  EV	  (ml)	   8	  ±	  4	   9	  ±	  4	   1	  b	   7	  ±	  4	   1	  b	   0.002	  Active	  EV/BSA	  (ml/m2)	   5	  ±	  2	   5	  ±	  3	   1	  b	   5	  ±	  2	   1	  b	   NS	  Total	  EmptFr	  (%)	   61	  ±	  6	   60	  ±	  7	   46	  b	   62	  ±	  6	   50	  b	   NS	  Passive	  EmptFr	  (%)	   44	  ±	  10	   42±	  11	   20	  b	   45	  ±	  9	   27	  b	   0.02	  Active	  EmptFr	  (%)	   30	  ±	  7	   30	  ±	  7	   16	  b	   30	  ±	  8	   14	  b	   NS	  Expansion	  index	  (%)	   163±45	   158±48	   254a	   167±43	   253a	   NS	  
2DE: two-dimensional echocardiography; 3DE: three-dimensional echocardiography; BSA: body surface area; EmptFr: 
emptying fraction; EV: emptying volume; Vmax: maximum volume; Vmin: minimum volume; VpreA: preA volume; * p values 
refer to gender differences; a upper limit; b lower limit. 
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7.2.2.	  Relationships	  of	  3DE	  LA	  volumes	  and	  function	  with	  age	  Table	  7.3	   summarizes	   the	   relationships	   between	   age	   and	  3DE	  LA	   volumes	   and	   function	  parameters.	  Total	  and	  passive	  EV	  didn’t	  change	  significantly	  with	  age,	  but	  active	  EV	  increased	  with	   age.	   Total	   EmptFr	   decreased	   with	   age	   while	   passive	   and	   active	   didn’t	   change	  significantly.	  	  
	  
TABLE	  7.3.	  Relationship	  between	  age	  and	  left	  atrial	  volumes	  and	  function	  parameters	  measured	  by	  three-­‐dimensional	  echocardiography	  	  
 	   Overall	  (n=221)	  	   r	   p	  Vmax	  (ml/m2)	   .2	   0.004	  Vmin	  (ml/m2)	   .22	   0.001	  Vpre	  A	  (ml/m2)	   .22	   .002	  Total	  EV	  (ml/m2)	   .11	   NS	  Passive	  EV	  (ml/m2)	   .02	   NS	  Active	  EV	  (ml/m2)	   .15	   0.02	  Total	  EmptFr	  (%)	   -­‐.14	   0.03	  Passive	  EmptFr	  (%)	   -­‐.07	   NS	  Active	  EmptFr	  (%)	   -­‐.07	   NS	  	  Abbreviations	  as	  in	  Table	  8.2	  
 
7.2.3.	  Comparison	  between	  2DE	  and	  3DE	  LA	  volumes	  All	   parameters,	   excluding	   VpreA	   volume	   and	   total	   EV,	   calculated	   on	   2DE	   images	   were	  significantly	   different	   than	   those	   measured	   using	   3DE	   (Table	   7.4).	   In	   general,	   all	   2DE	  measurements	  were	  lower	  than	  those	  obtained	  by	  3DE,	  while	  active	  EV,	  and	  total	  and	  active	  EF	  were	  higher.	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TABLE	  7.4	  -­‐	  Comparison	  between	  three-­‐	  and	  two-­‐dimensional	  echocardiographic	  parameters	  of	  left	  atrial	  size	  and	  function	  
 	   3DE	   2DE*	   p	  Value	  Vmax	  (ml)	   48	  ±	  11	   43	  ±	  11	   <0.001	  Vmin	  (ml)	   18	  ±	  5	   14	  ±	  6	   <0.001	  Vpre	  A	  (ml)	   26	  ±	  8	   26	  ±	  9	   NS	  Total	  EV	  (ml)	   29	  ±	  7	   29	  ±	  7	   NS	  Passive	  EV	  (ml)	   21	  ±	  7	   17	  ±	  5	   <0.001	  Active	  EV	  (ml)	   8	  ±	  4	   12	  ±	  4	   <0.001	  Total	  EmptFr	  (%)	   61	  ±	  6	   68	  ±	  9	   <0.001	  Passive	  EmptFr	  (%)	   44	  ±	  10	   41	  ±	  11	   0.002	  Active	  EmptFr	  (%)	   30	  ±	  7	   47	  ±	  10	   <0.001	  Expansion	  index	  (%)	   163±45	   237	  ±	  107	   <0.001	  
Abbreviations	  as	  in	  Table	  7.2.	  
7.2.4.	  Reproducibility	  Interobserver	  reproducibility	  of	  3DE	  LA	  volumes	  was	  significantly	  better	  than	  that	  of	  2DE	  LA	  volumes.	  
TABLE	  	  7.5	  -­‐	  Intra-­‐	  and	  interobserver	  variability	  of	  two-­‐	  and	  three-­‐dimensional	  left	  atrium	  volumes	  	   	   Intraobserver	  variability	   Interobserver	  variability	  	   bias	   95%CI	   bias	   95%CI	  2DE	  Vmax	  (ml)	   1.37	   -­‐0.76	  –	  3.51	   0.89	   -­‐1.3	  –	  3.09	  2DE	  Vmin	  (ml)	   -­‐0.64	   -­‐1.79	  –	  0.51	   -­‐0.2	   -­‐1.88	  –	  1.5	  2DE	  VpreA	  (ml)	   -­‐0.55	   -­‐2.07	  –	  0.97	   2.58	   0.37	  –	  4.79	  3DE	  Vmax	  (ml)	   0.96	   -­‐0.81	  –	  2.75	   -­‐0.66	   -­‐1.7	  –	  0.37	  3DE	  Vmin	  (ml)	   0.38	   -­‐0.93	  –	  1.7	   -­‐0.07	   -­‐0.82	  –	  0.68	  3DE	  VpreA	  (ml)	   -­‐0.35	   -­‐2	  –	  1.3	   0.9	   -­‐0.06	  –	  1.86	  
Abbreviations	  as	  in	  Table	  7.2.	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7.3	  Discussion	  	   The	   present	   study	   provides	   normative	   values	   of	   3DE-­‐derived	   LA	   volumes	   and	   a	  comprehensive	   analysis	   of	   LA	   phasic	   function	   obtained	   from	   a	   large	   sample	   of	   healthy	  volunteers.	  Our	  main	  results	  can	  be	  summarize	  as:	  (i).	  Assessment	  of	  LA	  volumes	  and	  phasic	  function	  parameters	  with	  3DE	   is	   feasible	   and	   reproducible;	   (ii).	   LA	  volume	  values	  obtained	  with	   3DE	   cannot	   be	   used	   interchangeably	   with	   2DE-­‐derived	   volumes;	   and	   (iii).	   reference	  values	  of	  LA	  volumes	  indexed	  by	  BSA	  are	  similar	  between	  genders	  but	  they	  increase	  slightly	  with	  ageing.	  
7.3.1	  Prognostic	  value	  of	  LA	  volumes	  and	  functional	  parameter	  	   The	  degree	  of	  the	  enlargement	  of	  the	  LA	  caused	  by	  pressure	  and/or	  volume	  overload	  reflects	  severity	  and	  chronicity	  of	  underlying	  pathologic	  conditions	  rather	  than	  instantaneous	  left	   ventricular	   filling	   pressure.	   (140)	   Accordingly,	   several	   previous	   studies	   demonstrated	  that	   LA	   Vmax	   measured	   by	   2DE	   is	   a	   robust	   predictor	   of	   future	   cardiovascular	   events	   in	  various	   clinical	   scenarios.	   (128,129)	   Recently,	   many	   researchers	   have	   focused	   on	   the	  importance	   of	   assessing	   LA	   phasic	   function	   and	   not	   only	   Vmax,	   because	   of	   the	   close	  interdependence	   between	   LA	   and	   left	   ventricular	   function.	   (128)	   It	   is	   physiologically	  explained,	  as	  LA	  modulates	  left	  ventricular	  filling	  through	  its	  reservoir,	  conduit,	  and	  booster	  pump	   function,	   whereas	   left	   ventricular	   function	   influences	   LA	   function	   throughout	   the	  cardiac	  cycle.	  However,	  normal	  values	  of	  LA	  volumes	  available	  in	  current	  guidelines	  are	  only	  maximal	  LA	  Vmax	  and	  LA	  Vmax	  indexed	  to	  BSA.	  (38)	  Biplane	  2DE	  calculation	  of	  LA	  volume	  is	  the	  recommended	  method,	  which	  sometimes	  is	  inaccurate	  due	  to	  the	  complexity	  of	  LA	  shape	  and	   the	   inability	   to	   obtain	   optimal	   cutting	   planes.(38,141)	   Transthoracic	   3DE	   has	   been	  reported	  to	  be	  more	  accurate	  than	  2DE	  in	  assessing	  LA	  volumes	  because	  it	  does	  not	  rely	  on	  geometric	   assumptions	   about	   LA	   shape(48,133).	   Although,	   there	   are	   limited	   data	   about	  normal	  values	  of	  LA	  volumes	  (139)	  and	  no	  data	  about	  LA	  phasic	  function	  parameters	  obtained	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with	  3DE.	  
7.3.2	  Accuracy	  of	  2DE	  and	  3DE	  to	  assess	  LA	  volumes	  	   Our	   results	   showed	   that	   LA	   volumes	   obtained	   by	   3DE	   are	   significantly	   larger	   than	  those	  calculated	  by	  2DE,	  and	  relative	  cut-­‐off	  values	  to	  define	  LA	  enlargement	  cannot	  be	  used	  interchangeably.	  Other	  authors	  did	  not	   find	  significant	  difference	  between	  3DE	  and	  2DE	  LA	  volumes,	   which	   was	   probably	   due	   to	   the	   use	   of	   a	   software	   developed	   for	   LV	   volume	  measurements	   and	   never	   validated	   for	   the	   LA.	   (137,142)	   However,	   investigations	   showed	  that	   3DE	   LA	   volumes	   correlated	   much	   better	   with	   CMR-­‐derived	   LA	   volumes	   than	   2DE	   LA	  volumes.	   (143,144)	   Additionally,	   recent	   investigations	   revealed	   that	   3DE	   LA	   volumes	  correlated	   closely	   with	   64-­‐slice	   multidetector	   computed	   tomography	   with	   only	   8%	  underestimation.	   (133,145)	   Nevertheless,	   studies	   reported	   underestimation	   of	   LA	   volumes	  assessed	   by	   3DE	   in	   comparison	   with	   cardiac	   CMR.	   (144,146)	   In	   recently	   published	   meta-­‐analysis	   Shimada	   et	   al.	   revealed	   that	   underestimation	   of	   LA	   volume	   by	   3DE	   in	   comparison	  with	   cardiac	   CMR	   is	   -­‐9.4	   ml	   (95%	   confidence	   interval,	   -­‐13.2	   to	   -­‐5.6	   ml;	   p	   <	   0.001).	   (147)	  Authors	  claimed	  that	  underestimation	  is	  likely	  to	  increase	  in	  pathological	  conditions.	  (147)	  The	  LA	  phasic	  function	  is	  very	  important	  because	  it	  modulates	  LV	  function.	  Namely,	  early	  impairment	  of	  LV	  diastolic	  function	  increases	  LV	  filling	  pressure,	  which	  induces	  a	  reduction	  of	  LA	  passive	  emptying	  and	  a	  compensatory	  increase	  of	  the	  booster	  function	  to	  preserve	  cardiac	  output.	   (148)	   Recent	   study	   revealed	   that	   3DE	   LA	   Vmin	   was	   a	   better	   correlate	   of	   left	  ventricular	  diastolic	  function	  than	  3DE	  LA	  Vmax	  (126,137)	  	  since	  LA	  Vmin	  size	  is	  determined	  by	   the	   direct	   exposure	   of	   LV	   diastolic	   pressure	   and	   seem	   to	   reflect	   more	   reliably	   the	  underlying	   pathology	   by	   the	   influence	   of	   LV	   longitudinal	   systolic	   function	   on	   LA	   reservoir	  function.	  (126)	  Furthermore,	  Wu	  et	  al.	  demonstrated	  that	  3DE	  derived	  LA	  Vmin	  volume	  was	  a	  better	   predictor	   of	   cardiac	   death,	   whereas	   3DE	   LA	   Vmin	   and	   Vmax	   were	   independent	  predictors	  of	  major	  cardiovascular	  events.	  (137)	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By	  comparing	  2DE	  and	  3DE	  assessment	  of	  LA	  phasic	  function	  we	  found	  that	  LA	  reservoir	  and	  pump	  functions	  were	  significantly	  lower	  by	  3DE	  than	  2DE,	  whereas	  the	  estimation	  of	  the	  conduit	  function	  was	  independent	  of	  the	  echocardiographic	  technique.	  In	  agreement	  with	  other	  Authors	  (149),	  we	  found	  that	  3DE-­‐derived	  LA	  volumes	  increased	  with	  aging.  
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CHAPTER 8 	  	  





8.1	  Background	  The	  right	  atrium	  (RA)	  plays	  an	  integral	  role	  in	  cardiac	  performance	  by	  modulating	  RV	  function	  with	  its	  reservoir,	  conduit	  and	  contractile	  functions.	  (51)	  Recent	  reports	  have	  documented	  that	  RA	  size	  enlarges	  in	  patients	  with	  atrial	  arrhythmias,	  chronic	  heart	  failure,	  pulmonary	  hypertension	  and	  congenital	  heart	  diseases.	  (150-­‐152)	  Although	  data	  on	  clinical	  significance	  of	  RA	  enlargement	  are	  sparse,	  2DE	  RA	  area	  has	  been	  demonstrated	  to	  be	  a	  predictor	  of	  outcome	  in	  primary	  pulmonary	  hypertension	  and	  chronic	  heart	  failure.	  (151,153,154)	  Conventional	  assessment	  of	  RA	  size	  includes	  measurement	  of	  RA	  diameters	  and	  area	  on	  2DE	  4-­‐chamber	  apical	  view.	  (38,50)	  RA	  volumetric	  assessment	  is	  not	  currently	  recommended.	  (38,50)	  In	  addition,	  2DE	  calculation	  of	  atrial	  volume	  is	  limited	  by	  view	  dependency	  and	  geometric	  assumptions	  about	  atrial	  shape.	  However,	  atrial	  remodeling	  as	  a	  consequence	  of	  disease	  processes	  is	  often	  asymmetrical,	  rendering	  these	  assumptions	  inadequate.	  3DE	  overcomes	  these	  limitations	  enabling	  accurate	  RA	  volume	  measurement.	  (48,134)	  Moreover,	  3DE	  enables	  assessment	  of	  atrial	  phasic	  volume	  changes,	  permitting	  to	  describe	  atrial	  function	  over	  its	  size.	  (155)	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Knowledge	  of	  reference	  echocardiographic	  values	  of	  RA	  volumes	  and	  function	  is	  a	  prerequisite	  for	  the	  introduction	  of	  RA	  quantitation	  in	  the	  clinical	  routine.	  At	  present,	  only	  one	  study	  reported	  normal	  values	  of	  3DE	  RA	  maximal	  and	  minimal	  volumes,	  but	  it	  did	  not	  report	  phasic	  RA	  function	  parameters.	  (139)	  	  Accordingly,	  we	  have	  designed	  this	  prospective,	  observational	  study	  to:	  (i).	  determine	  the	  normative	  values	  for	  RA	  geometry	  and	  function	  in	  a	  large	  cohort	  of	  healthy	  subjects	  using	  3DE;	  (ii).	  analyze	  the	  effects	  of	  age	  and	  gender	  on	  these	  parameters;	  and	  (iii).	  compare	  the	  parameters	  measured	  by	  3DE	  with	  the	  same	  values	  calculated	  using	  2DE.	  	  
8.2	  Development	  of	  reference	  values	  for	  RA	  geometry	  and	  function	  by	  3DE	  Six	  volunteers	  met	  all	  criteria	  for	  inclusion	  but	  were	  excluded	  from	  enrolment	  because	  their	  acoustic	  window	  was	  inadequate	  for	  2DE	  and	  3DE	  analysis.	  Among	  the	  remaining	  204	  subjects,	  4	  could	  not	  be	  evaluated	  by	  3DE	  due	  to	  poor	  image	  quality.	  Thus	  in	  our	  study	  population,	  feasibility	  of	  RA	  3DE	  volume	  measurements	  was	  95.2%.	  Temporal	  resolution	  of	  2DE	  images	  was	  73	  frames/s,	  and	  that	  of	  3DE	  data	  sets	  was	  34±9	  volumes/s.	  	  
TABLE	  8.1	  -­‐	  Demographic	  characteristics	  of	  the	  study	  population	  	  
	   All	  (n=200)	   Men	  	  (n=87)	   Women	  (n=113)	   p	  Value*	  Age	  (years)	   43±15	   41±14	   45±14	   0.078	  Height	  (cm)	   170±10	   177±7	   164±8	   <0.0001	  Weight	  (kg)	   67±11	   76±9	   61±9	   <0.0001	  Body	  mass	  index	  (kg/m2)	   23±3	   24±2	   23±3	   0.001	  Body	  surface	  area	  (m2)	   1.78±0.19	   1.93±0.13	   1.67±0.15	   <0.0001	  Heart	  rate	  (bpm)	   68±11	   67±12	   69±11	   0.15	  Systolic	  blood	  pressure	  (mmHg)	   122±14	   127±11	   118±14	   <0.0001	  Diastolic	  blood	  pressure	  (mmHg)	   74±8	   76±7	   71±8	   <0.0001	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   Fifty-­‐six	  percent	  of	  study	  subjects	  were	  women.	  There	  were	  no	  differences	  in	  age	  and	  heart	  rate	  between	  men	  and	  women	  (Table	  8.1).	  Women	  showed	  significantly	  smaller	  body	  size	  and	  lower	  blood	  pressure	  compared	  to	  men	  (Table	  8.1).	  
8.2.1.	  3DE	  RA	  volume	  and	  function	  and	  their	  relationships	  with	  gender	  RA	  size	  and	  function	  parameters	  obtained	  with	  2DE	  and	  3DE	  are	  summarized	  in	  Table	  8.2.	  Irrespective	  on	  the	  echo	  technique	  used,	  parameters	  of	  RA	  size	  were	  significantly	  larger	  in	  men	  than	  in	  women,	  even	  after	  normalization	  for	  BSA.	  Upper	  limits	  for	  3DE	  RA	  Vmax,	  Vmin	  and	  VpreA	  were	  49	  ml/m2,	  20	  ml/m2	  and	  27	  ml/m2	  in	  men	  and	  38	  ml/m2,	  16	  ml/m2	  and	  22	  ml/m2	  in	  women.	  3DE	  RA	  total,	  passive	  and	  active	  EV	  were	  higher	  in	  men,	  but	  these	  differences	  disappeared	  after	  indexing	  for	  BSA	  (Table	  8.2).	  	  Lower	  limits	  of	  normality	  for	  3DE	  total,	  passive	  and	  active	  RA	  indexed	  EV	  were	  11	  ml/m2,	  6	  ml/m2	  and	  2	  ml/m2.	  3D	  RA	  total,	  passive	  and	  active	  EmptFrs	  were	  higher	  in	  women	  (Table	  8.2).	  Lower	  limits	  of	  reference	  values	  for	  3DE	  total,	  passive	  and	  active	  RA	  EmptFrs	  were	  44%,	  27%	  and	  18%	  in	  men	  and	  50%,	  22%	  and	  19%	  in	  women	  (Table	  8.2).	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TABLE	  8.2	  -­‐	  Right	  atrial	  size	  and	  function	  by	  two-­‐	  and	  three-­‐dimensional	  echocardiography	  and	  right	  atrial	  myocardial	  wall	  function	  by	  2D-­‐speckle	  tracking	  echocardiography	  in	  healthy	  subjects	  
	   All	  (n=200)	   Men	  	  (n=87)	   Women	  (n=113)	   p	  Value*	  RA	  max	  diameter	  (mm)	   46±5	   49±5	   44±4	   <0.0001	  RA	  min	  diameter	  (mm)	   38±6	   41±6	   36±5	   <0.0001	  RA	  area	  (cm2)	   15±3	   17±3	   13±2	   <0.0001	  RA	  area/BSA	  (cm2/m2)	   8.4±1.5	   8.9±1.6	   8.1±1.3	   <0.0001	  2D	  RA	  VMax	  (ml)	   41±14	   50±15	   35±10	   <0.0001	  2D	  RA	  Vmax/BSA	  (ml/m2)	   23±7	   26±7	   21±6	   <0.0001	  2D	  RA	  VMin	  (ml)	   17±7	   21±7	   14±5	   <0.0001	  2D	  RA	  Vmin/BSA	  (ml/m2)	   10±4	   11±4	   8±3	   <0.0001	  2D	  RA	  VpreA	  (ml)	   27±11	   33±11	   22±8	   <0.0001	  2D	  RA	  VpreA/BSA	  (ml/m2)	   15±5	   17±5	   13±4	   <0.0001	  3D	  RA	  Vmax	  (ml)	   52±15	   60±16	   45±11	   <0.0001	  3D	  RA	  Vmax/BSA	  (ml/m2)	   29±7	   31±8	   27±6	   <0.0001	  3D	  RA	  Vmin	  (ml)	   19±8	   24±8	   16±5	   <0.0001	  3D	  RA	  Vmin/BSA	  (ml/m2)	   11±4	   12±4	   9±3	   <0.0001	  3D	  RA	  VpreA	  	  (ml)	   28±10	   34±10	   24±7	   <0.0001	  3D	  RA	  VpreA/BSA	  	  (ml/m2)	   16±5	   18±5	   14±4	   <0.0001	  3D	  RA	  total	  EV	  (ml)	   33±10	   37±11	   30±8	   <0.0001	  3D	  RA	  total	  EV/BSA	  (ml/m2)	   18±5	   19±5	   18±5	   0.22	  3D	  passive	  EV	  (ml)	   24±9	   27±10	   22±8	   <0.0001	  3D	  passive	  EV/BSA	  (ml/m2)	   13±5	   14±5	   13±4	   0.34	  3D	  RA	  active	  EV	  (ml)	   9±4	   10±4	   8±4	   0.001	  3D	  RA	  active	  EV/BSA	  (ml/m2)	   5±2	   5±2	   5±2	   0.37	  3D	  RA	  total	  EmptFr	  (%)	   63±9	   61±8	   65±8	   <0.0001	  3D	  RA	  passive	  EmptFr	  (%)	   46±11	   44±10	   48±12	   0.013	  3D	  RA	  active	  EmptFr	  (%)	  	   31±8	   29±7	   33±9	   0.002	  Abbreviations:	  EmptFr=	  emptying	  fraction;	  EV	  =	  emptying	  volume;	  LS=	  longitudinal	  strain;	  LS,	  longitudinal	  strain;	  RA=	  right	  atrium;	  Vmax=	  maximum	  volume;	  Vmin=	  minimum	  volume;	  VpreA=	  preA	  volume	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8.2.2	  Relationship	  of	  3DE	  RA	  volumes	  anf	  function	  parameters	  with	  age	  Total	  EV	  didn’t	  change	  significantly	  with	  age,	  but	  passive	  EV	  decreased	  and	  active	  EV	  increased	  with	  age	  in	  both	  genders.	  Similarly,	  passive	  EmptFr	  decreased	  with	  age	  and	  active	  EmptFr	  increased	  with	  a	  mild	  decrease	  of	  total	  EmptFr	  in	  both	  genders	  (Table	  8.3).	  
	  
TABLE	  8.3	  -­‐	  Relationship	  between	  age	  and	  right	  atrial	  volumes	  and	  function	  parameters	  assessed	  by	  3DE	  
	   All	  (n=200)	   Men	  (n=87)	   Women	  (n=113)	  	   r	   p	  Value	   r	   p	  Value	   r	   p	  Value	  3D	  RA	  Vmax	  (ml)	   -­‐0.05	   0.52	   0.016	   0.88	   0.031	   0.75	  3D	  RA	  Vmin	  (ml)	   0.10	   0.14	   0.17	   0.12	   0.26	   0.005	  3D	  RA	  VpreA	  (ml)	   0.16	   0.026	   0.21	   0.05	   0.32	   <0.0001	  3D	  RA	  Total	  EV	  (ml)	   -­‐0.14	   0.05	   -­‐0.10	   0.34	   -­‐0.10	   0.26	  3D	  RA	  Passive	  EV	  (ml)	   -­‐0.26	   <0.0001	   -­‐0.23	   0.04	   -­‐0.25	   0.008	  3D	  RA	  Active	  EV	  (ml)	   0.25	   <0.0001	   0.31	   0.003	   0.27	   0.004	  3D	  RA	  Total	  EF	  (%)	   -­‐0.24	   0.001	   -­‐0.26	   0.015	   -­‐0.31	   0.001	  3D	  RA	  Passive	  EF	  (%)	   -­‐0.38	   <0.0001	   -­‐0.43	   <0.0001	   -­‐0.40	   <0.0001	  3D	  RA	  Active	  EF	  (%)	   0.15	   0.035	   0.04	   0.71	   0.17	   0.06	  
	  Abbreviations	  as	  in	  Table	  8.2	  	  
8.2.3.	  Comparison	  between	  2DE	  nad	  3DE	  RA	  volumes	  and	  function	  RA	  volumes	  calculated	  on	  2DE	  images	  were	  significantly	  smaller	  than	  those	  measured	  using	  3DE	  (Table	  8.4).	  Total	  and	  passive	  EV	  and	  EF	  obtained	  with	  2DE	  were	  lower	  than	  those	  obtained	  by	  3DE	  (Table	  8.4).	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TABLE	  8.4	  -­‐	  Comparison	  between	  3DE	  and	  2DE	  parameters	  of	  RA	  size	  and	  function	  
	   3DE	   2DE	   p	  	   Limit	  3D	   Limit	  2D	  Vmax	  (ml)	   52±15	   41±14	   <0.0001	   78§	   69§	  Vmin	  (ml)	   19±8	   17±7	   <0.0001	   36§	   33§	  VpreA	  (ml)	   28±10	   27±11	   <0.0001	   49§	   49§	  Total	  SV	  (ml)	   33±10	   24±9	   <0.0001	   17*	   11*	  Passive	  SV	  (ml)	   24±9	   14±7	   <0.0001	   10*	   4*	  True	  SV	  (ml)	   9±4	   10±5	   0.017	   4*	   3*	  Total	  EmptFr	  (%)	   63±9	   58±9	   <0.0001	   49*	   42*	  Passive	  EmptFr	  (%)	   46±11	   34±12	   <0.0001	   24*	   14*	  True	  EmptFr	  (%)	   31±8	   35±11	   <0.0001	   18*	   17*	  
	  §upper	  limit.	  *lower	  limit.	  	  	  Abbreviations	  as	  in	  Table	  8.2	  	  
	  
8.2.4.	  Reproducibility	  All	  three	  techniques	  showed	  very	  good	  intra-­‐	  and	  inter-­‐observer	  reproducibility	  (Table	  8.5).	  However,	  interobserver	  reproducibility	  of	  3DE	  RA	  volumes	  was	  significantly	  better	  than	  that	  of	  2DE	  RA	  volumes.	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TABLE	  9.5	  -­‐	  Intra-­‐	  and	  interobsever	  variability	  of	  two-­‐	  and	  three-­‐dimensional	  right	  atrial	  volumes	  and	  longitudinal	  strain	  	  	  	  
Intraobserver	  variability	   Interobserver	  variability	  	   bias	   95%CI	   ICC	   bias	   95%CI	   ICC	  
2DE	  Vmax	  (ml)	   -­‐1.2	   -­‐14.3	  ;	  11.9	   0.91	   -­‐1.3	   -­‐19.2	  ;	  16.6	   0.85	  
2DE	  Vmin	  (ml)	   -­‐0.2	   -­‐4.9	  ;	  4.5	   0.95	   -­‐5.3	   -­‐15	  ;	  4.3	   0.56	  
2DE	  VpreA	  (ml)	   -­‐1.7	   -­‐8.3	  ;	  4.9	   0.94	   -­‐5.3	   -­‐21.3	  ;	  10.8	   0.69	  
3DE	  Vmax	  (ml)	   0	   -­‐9.6	  ;	  9.7	   0.94	   3.7	   -­‐9.1	  ;	  16.5	   0.86	  
3DE	  Vmin	  (ml)	   1	   -­‐3.4	  ;	  5.5	   0.95	   -­‐1.5	   -­‐7.3	  ;	  4.4	   0.91	  
3DE	  VpreA	  (ml)	   -­‐0.2	   -­‐10.6	  ;	  10.2	   0.9	   -­‐1	   -­‐9.3	  ;	  7.2	   0.92	  
Abbreviations	  as	  in	  Table	  8.2	  
	  
8.3	  Discussion	  The	  present	  study	  provides	  the	  reference	  values	  for	  RA	  size	  and	  function	  measured	  by	  3DE	  in	  a	  relatively	  large	  cohort	  of	  healthy	  volunteers	  with	  a	  wide	  age	  range.	  We	  found	  that:	  (i).	  RA	  assessment	  with	  3DE	  is	  feasible	  and	  reproducible;	  (ii).	  3DE	  allows	  to	  assess	  not	  only	  RA	  volumes,	  but	  also	  its	  phasic	  function	  parameters;	  (iii).	  RA	  volume	  values	  obtained	  with	  3DE	  cannot	  be	  used	  interchangeably	  with	  2DE	  derived	  volumes;	  (iv).	  Reference	  values	  of	  RA	  volumes	  should	  be	  gender	  specific	  while	  reference	  values	  for	  RA	  function	  should	  be	  age	  specific.	  
8.3.1.	  Echocardiographic	  assessment	  o	  RA	  size	  and	  additional	  value	  of	  3DE	  There	  is	  increasing	  evidence	  that	  RA	  enlargement	  is	  an	  outcome	  predictor	  in	  pathologic	  conditions,	  such	  as	  primary	  pulmonary	  hypertension	  and	  chronic	  heart	  failure.	  (151-­‐153,156)	  However,	  before	  introducing	  RA	  size	  and	  function	  assessment	  in	  the	  routine	  of	  the	  echo	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laboratories,	  the	  reference	  values	  for	  these	  parameters	  should	  be	  identified.	  At	  present,	  diameters	  and	  area	  measured	  in	  a	  2DE	  apical	  4-­‐chamber	  view	  are	  the	  only	  recommended	  methods	  to	  assess	  RA	  size	  while	  RA	  volume	  computation	  is	  not	  included	  in	  routine	  echocardiography	  because	  of	  the	  lack	  of	  reference	  data.	  (38,50)	  In	  the	  present	  study,	  we	  used	  3DE	  to	  obtain	  reference	  values	  of	  RA	  volume	  and	  function	  because	  of	  recognized	  superiority	  of	  3DE	  over	  2DE	  in	  heart	  chamber	  measurement.	  (1)	  In	  particular,	  a	  previous	  study	  by	  Keller	  et	  al.	  (134)	  	  demonstrated	  that	  3DE	  measurement	  of	  RA	  volume	  is	  comparable	  to	  CMR	  and	  it	  is	  superior	  to	  current	  2DE	  techniques.	  In	  addition,	  the	  software	  we	  have	  used	  to	  quantitate	  3DE	  RA	  datasets	  has	  been	  recently	  validated	  against	  CMR	  in	  a	  multicentre	  validation	  study	  of	  3DE	  left	  atrial	  volumes.	  (48)	  Finally,	  our	  results	  about	  RA	  Vmax	  (upper	  limit	  49	  ml/m2	  vs	  50	  ml/m2,	  and	  	  38	  ml/m2	  vs	  41	  ml/m2,	  for	  men	  and	  women,	  respectively)	  and	  total	  EF	  (lower	  limit	  49%	  vs	  46%)	  are	  very	  similar	  to	  those	  previously	  reported	  by	  Aune	  et	  al.	  (139)	  Therefore,	  we	  are	  confident	  that	  our	  study	  has	  provided	  robust	  data	  about	  the	  reference	  values	  of	  RA	  size	  and	  function.	  	  
8.3.2	  Importance	  of	  assessing	  RA	  phasic	  function	  In	  addition	  to	  data	  reported	  by	  Aune	  and	  coworkers,	  the	  measurement	  of	  the	  RA	  Vprea	  allowed	  us	  to	  assess	  also	  the	  conduit	  and	  booster	  functions	  of	  the	  RA,	  providing	  a	  comprehensive	  assessment	  of	  RA	  phasic	  functions.	  	  Assessment	  of	  RA	  phasic	  function	  parameters	  is	  clinically	  important	  because	  the	  RA	  is	  a	  dynamic	  structure	  whose	  role	  is	  to	  assist	  filling	  the	  RV.	  The	  three	  components	  of	  RA	  function	  are:	  i.	  reservoir	  function,	  storing	  blood	  when	  the	  tricuspid	  valve	  is	  closed;	  ii.	  conduit	  function,	  passive	  blood	  transfer	  directly	  from	  the	  coronary	  and	  systemic	  veins	  to	  the	  right	  ventricle	  when	  the	  tricuspid	  valve	  is	  open;	  and	  iii.	  booster	  pump	  function,	  atrial	  contraction	  in	  late	  diastole	  to	  complete	  ventricular	  filling.	  (51)	  RA	  is	  able	  to	  modulate	  the	  relationship	  between	  reservoir	  and	  conduit	  function	  in	  a	  dynamic	  manner.	  The	  RA	  conduit-­‐to-­‐reservoir	  ratio	  is	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directly	  related	  to	  the	  right	  ventricular	  pressure-­‐RA	  pressure	  gradient	  at	  the	  time	  of	  maximum	  RA	  volume,	  with	  increased	  ventricular	  pressures	  favoring	  conduit	  function,	  but	  it	  is	  inversely	  related	  to	  cardiac	  output,	  with	  an	  increase	  in	  the	  reservoir	  contribution	  favoring	  improved	  cardiac	  output.	  (51)	  Since	  pathological	  conditions	  could	  affect	  and	  modify	  RA	  phasic	  functions,	  there	  is	  a	  need	  to	  know	  reference	  values	  of	  each	  phase	  to	  be	  able	  to	  understand	  the	  pathophysiology	  of	  RA	  function	  in	  various	  cardiac	  diseases.	  	  
8.3.3.	  Relationship	  of	  3DE	  RA	  volumes	  and	  function	  parameters	  with	  age	  and	  gender	  Our	  results	  showed	  significantly	  different	  RA	  volumes	  between	  men	  and	  women	  even	  after	  indexing	  for	  BSA,	  suggesting	  the	  need	  for	  gender-­‐specific	  reference	  values.	  These	  findings	  are	  consistent	  with	  data	  reported	  by	  Aune	  et	  al(139).	  RA	  EmptFr	  was	  also	  higher	  in	  women	  than	  in	  men.	  	  	   In	  our	  study	  there	  was	  no	  relation	  between	  age	  and	  Vmax	  and	  Vmin,	  confirming	  previous	  findings.	  (139)	  Conversely,	  VpreA	  increased	  significantly	  with	  age.	  This	  finding	  parallels	  the	  age-­‐related	  changes	  in	  RA	  function	  with	  a	  significant	  decrease	  in	  passive	  RA	  function	  parameters	  (passEV,	  passEmptFr,)	  associated	  with	  an	  increase	  in	  active	  RA	  function	  (ActEV,	  ActEmptFr)	  in	  order	  to	  maintain	  constant	  TotEV.	  These	  results	  are	  in	  agreement	  with	  the	  documented	  age-­‐related	  decrease	  of	  the	  tricuspid	  valve	  E/A	  ratio(50)	  and	  with	  previous	  reports	  showing	  an	  age	  related	  increase	  in	  active	  LA	  contraction	  in	  response	  to	  increased	  left	  ventricular	  stiffness.	  (157)	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9.1	  Study	  limitations	  3DE	  data	  set	  acquisitions	  have	  been	  performed	  using	  a	  single	  vendor	  platform	  which	  may	  have	   implications	   for	   the	  applicability	  of	   these	  reference	  values	  to	  volumetric	  data	  sets	   that	  are	   acquired	   with	   other	   vendor-­‐specific	   platforms.	   However,	   conversely	   from	   myocardial	  deformation	   measurements,	   (158)	   no	   significant	   intervendor	   inconsistency	   of	   cardiac	  chamber	  volume	  has	  ever	  been	   reported.	   In	  addition,	  quantification	  of	  3DE	  data	   sets	  of	   the	  RV,	  LA	  and	  RA	  have	  been	  performed	  using	  a	  vendor-­‐independent	  software	  using	  DICOM	  file	  which	  should	  ensure	  generalizability	  of	  our	  results.	  The	  generalizability	  of	  our	  research	  project	  results	  may	  be	  limited	  by	  the	  homogeneity	  of	  our	  study	  cohort	  with	  respect	  to	  race	  and	  ethnicity,	  too.	  	  The	   identification	   of	   ‘abnormal’	   relies	   on	   the	   definition	   of	   ‘normal’	   and	   needs	   to	  acknowledge	   normal	   physiological	   variation	   that	  may	   arise	   from	   factors	   such	   as	   age,	   body	  size,	   gender,	   and	   ethnicity.	   (11)	   So	   far,	   the	   studies	   that	   have	   been	   designed	   to	   obtain	   the	  normative	   values	   for	   echocardiographic	   measurements	   have	   related	   the	   measured	  parameters	   to	   subjects’	   age,	   height,	   weight,	   BSA	   and	   gender.	   Only	   a	   few	   have	   taken	   into	  account	   the	   role	   of	   ethnicity.	   As	   a	   result	   current	   guidelines	   for	   chamber	   quantification	   by	  echocardiography	   (38)	   contains	   reference	   values	   that	   have	   been	   obtained	   from	   European	  (Western	  Europe)	  and	  American	  (United	  States)	  Caucasian	  subjects.	  However,	  ethnicity	  is	  an	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important	  factor	  and	  studies	  which	  have	  compared	  measurements	  performed	  in	  Caucasians,	  Indians,	  Malaysian	  and	  Chinese	   (95,159),	   Japanese	   (89)	  or	  African	  American	   (160)	   subjects	  have	   shown	   significant	   differences	   in	  measurements	   between	   the	  different	   ethnical	   groups.	  Therefore,	  the	  use	  of	  the	  reference	  values	  reported	  in	  current	  guidelines	  to	  define	  normality	  or	  abnormality	  of	  cardiac	  chamber	  size	  and	  function	  in	  population	  others	  than	  European	  and	  White	  Americans	  may	  be	  misleading	  and	  bring	  to	  erroneous	  conclusions.	  This	   is	  not	  only	  a	  medical	  problem	  of	   the	  areas	  of	   the	  world	  non-­‐represented	   in	   current	  guidelines	   like	  Middle-­‐	  East,	  Asia,	  Africa	  or	  South	  America	  but,	  since	  more	  and	  more	  people	  move	  from	  their	  area	  of	  origin	  to	  different	  areas	  of	  the	  world	  for	  working,	  tourism	  either	  to	  escape	  from	  war	  or	  persecution	  this	  lack	  of	  proper	  reference	  values	  is	  becoming	  a	  worldwide	  medical	  problem.	  Accordingly,	  several	   initiatives	  have	  been	  undertaken	  to	  collect	  normative	  data	   from	   larger	  cohorts	  of	  normal	   subjects	  who	  may	   include	  different	  ethnicities.	   (94,161)	  The	   NORRE	   study	   is	   a	   large	   prospective,	   observational	   multicenter	   study	   in	   which	  transthoracic	   echocardiographic	   studies	  will	   be	   collected	   in	   22	   European	   EACVI	   accredited	  echo	  laboratories	  	  and	  in	  one	  US	  echocardiographic	  laboratory	  to	  obtain	  reference	  values	  for	  cardiac	  chamber	  geometry	  and	  function	  in	  normal	  subjects	  between	  25	  and	  75	  years	  of	  age.	  African	  American	  subjects	  will	  be	  enrolled	  by	  the	  US	  laboratory.	  The	  EchoNoRMAL	  study	  is	  an	  individual	   person	   data	   meta-­‐analysis	   of	   echocardiographic	   measurements	   obtained	   from	  healthy	  subjects	  aimed	   to	  re-­‐define	  normal	  echocardiographic	   reference	  ranges	   (for	   the	   left	  heart	   including	   dimensions,	   areas,	   volumes,	   and	   associated	   calculated	   variables)	   for	  populations	   across	   the	   world,	   and	   to	   do	   that,	   the	   organizing	   Institution	   (the	   University	   of	  Auckland,	   New	   Zealand)	   asked	   data	   from	   those	   populations	   to	   the	   different	   reasearchers	  around	  the	  world.	  (94)	  Another	   important	   limitation	   of	   this	   reaserach	   project	   is	   that	   the	   samples	   of	   men	   and	  women	  were	  not	  equal,	  particularly	  for	  the	  middle	  and	  advanced	  decades	  of	   life,	  raising	  the	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possibility	  that	  some	  gender	  differences	  may	  have	  been	  amplified	  or	  not	  adequately	  detected.	  In	   addition,	   the	   number	   of	   subjects	   older	   than	   60	   years	   of	   age	   was	   limited.	   Therefore,	  reference	  values	  in	  our	  elderly	  cohort	  (≥	  70	  years)	  should	  be	  considered	  cautiously,	  given	  the	  small	  size	  of	  this	  age	  group.	  Despite	  elderly	  patients	  are	  the	  majority	  of	  patients	  examined	  in	  our	  echocardiographic	  laboratories,	  specific	  reference	  values	  for	  the	  oldest	  decades	  (i.e.	  >70	  years)	   are	   lacking.	   However,	   the	   enrolment	   of	   truly	   healthy	   subjects	   at	   this	   age	   is	   rather	  difficult.	  	  The	  absence	  of	  a	  comparison	  with	  a	  reference	  standard,	  such	  as	  CMR,	  could	  be	  regarded	  as	  a	   limitation	   of	   this	   research	   project.	   However,	   several	   studies	   comparing	   3DE	   and	   CMR	   to	  assess	   LV,	   RV	   and	   LA	   volumes	   have	   documented	   the	   accuracy	   of	   3DE	   and	   consistently	  reported	  smaller	  volumes	  by	  3DE	  than	  by	  CMR	  in	  normal	  subjects,	  as	  well	  as	   in	  a	  variety	  of	  cardiac	  diseases.	  (1)	  There	  is	  now	  enough	  evidence	  that	  the	  two	  techniques	  are	  different	  and	  that	   specific	   references	   values	   are	   needed	   for	   each	   of	   them.	   Furthermore,	   the	   analysis	  algorithms	   used	   in	   this	   study	   has	   been	   extensively	   validated	   against	   CMR.	   (41,44,48)	  Moreover,	   limited	  availability	  and	  costs	  of	  CMR,	  as	  well	  as	  ethical	  reasons	  prevented	  its	  use	  for	  studying	  healthy	  subjects	  having	  no	  clinical	  indication	  for	  CMR	  examination.	  The	  inclusion	  of	  weight	  as	  a	  predictor	  may	  be	  questionable	  as	  it	  may	  change	  rapidly	  in	  adults.	  However,	  the	  exclusion	  of	  overweight	  subjects	  could	  have	  prevented	  this	  confounding	  factor.	  Finally,	   despite	   subjects	   fulfilled	   all	   the	   inclusion	   criteria	   as	   healthy	   adults,	   we	   cannot	  exclude	  the	  possibility	  of	  subclinical	  coronary	  artery	  disease,	  particularly	  in	  older	  subjects.	  
 
10.2	  Clinical	  implications	  3DE	  is	  a	  novel	  imaging	  technique	  based	  on	  acquisition	  and	  display	  of	  volumetric	  data	  sets	  in	   the	   beating	   heart.	   This	   permits	   a	   comprehensive	   evaluation	   of	   cardiac	   anatomy	   and	  function	   from	   a	   single	   acquisition	   and	   expands	   the	   diagnostic	   possibilities	   of	   non-­‐invasive	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cardiology.	   It	   provides	   the	   possibility	   to	   quantitate	   geometry	   and	   function	   of	   cardiac	  chambers	  without	  pre-­‐established	  assumptions	  regarding	  cardiac	  chamber	  shape	  and	  allows	  an	  echocardiographic	  assessment	  of	  the	  heart	  that	   is	   less	  operator-­‐dependent	  and	  therefore	  more	  reproducible.	  	  Further	   developments	   and	   improvements	   for	   widespread	   routine	   applications	   include	  higher	   spatial	   and	   temporal	   resolution	   to	   improve	   image	   quality,	   faster	   acquisition,	  processing	   and	   reconstruction,	   and	   easier	   approaches	   to	   quantitative	   analysis.	   At	   present,	  3DE	   complements	   routine	   2DE	   in	   clinical	   practice,	   overcoming	   some	   of	   its	   limitations	   and	  offering	   additional	   valuable	   quantitative	   and	   morphological	   information	   that	   has	   led	   to	  recommend	   its	   use	   for	   routine	   examination	   in	   selected	   fields.	   3DE	   is	   currently	   gaining	  popularity,	  as	  a	  more	  accurate	  and	  reproducible	  technique	  for	  cardiac	  chamber	  evaluation	  in	  various	   conditions	   and	   it	   is	   likely	   that,	   in	   the	   future,	   3DE	   may	   become	   the	   standard	  echocardiographic	  examination	  procedure.	  The	  availability	  of	  reference	  values	  obtained	  in	  a	  large	   population	   of	   healthy	   subjects	   is	   an	   important	   step	   towards	   the	   inclusion	   of	   3DE	   in	  everyday	  clinical	  practice.	  	  The	  present	   research	  project	   provides	   a	   comprehensive	  quantitative	   analysis	   of	   the	   four	  cardiac	   chamber	  geometry	  and	   function	  using	  3DE	   in	   a	   relatively	   large	   cohort	  of	  Caucasian	  healthy	  volunteers	  with	  a	  wide	  age	  range.	  The	  main	  results	  can	  be	  summarized	  as	  follows:	  (i).	  Cardiac	   chamber	  quantification	  with	  3DE	   is	   feasible	  and	  reproducible;	   (ii)	  Reference	  values	  for	  cardiac	  chamber	  size	  and	  function	  3DE	  were	  found	  to	  be	  significantly	  different	  from	  those	  obtained	   with	   conventional	   echocardiography,	   highlighting	   the	   importance	   of	   applying	  method-­‐specific	   reference	   values	   for	   a	   reliable	   identification	   of	   remodeling	   and/or	  dysfunction	  of	  cardiac	  chambers;	  (iii).	  Cardiac	  chamber	  parameters	  measured	  by	  3DE	  showed	  excellent	  reproducibility,	  and	  were	  more	  robust	  than	  2DE	  indices	  at	  repeated	  measurements;	  (iii).	  Most	  parameters	  describing	  cardiac	  chamber	  size	  should	  be	  defined	  according	  to	  age	  and	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gender,	  since	  indexing	  them	  only	  for	  BSA	  does	  not	  account	  for	  all	  the	  physiologic	  variations	  in	  geometry	  and	  function	  Availability	  of	  reference	  values	  and	  age-­‐	  and	  gender-­‐specific	  cut-­‐off	  values	  should	  facilitate	  the	  implementation	  of	  3DE	  to	  identify	  cardiac	  chamber	  remodelling	  and	  dysfunction	  in	  both	  clinical	  routine	  and	  research.	  (162)	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  after	  STEMI:	  which	  parameter	  is	  better?	  Eur	  Heart	  J	  2012;	  33	  (Abstract	  Supplement),	  167-­‐168	  	  44. 	  Muraru	  D,	  Badano	  LP,	  Ermacora	  D,	  Bellu	  R,	  De	  Lazzari	  M,	  Marra	  MP,	  Dal	  Bianco	  L,	  Peluso	  D,	  Boccalini	  F,	  Iliceto	  S.	  Two-­‐dimensional	  longitudinal	  strain	  is	  more	  accurate	  than	  three-­‐dimensional	  longitudinal	  strain	  to	  identify	  infarcted	  LV	  segments	  in	  STEMI	  patients.	  Eur	  Heart	  J	  2012;	  33	  (Abstract	  Supplement),	  672-­‐673	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45. 	  Muraru	  D,	  Badano	  LP,	  Bellu	  R,	  Ermacora	  D,	  De	  Lazzari	  M,	  Marra	  MP,	  Dal	  Bianco	  L,	  Peluso	  D,	  Cucchini	  U,	  Iliceto	  S.	  Predictive	  value	  of	  2D/3D	  deformation	  parameters	  and	  3D	  wall	  motion	  score	  to	  identify	  transmural	  myocardial	  necrosis	  in	  STEMI	  patients:	  a	  comparative	  study	  against	  cardiac	  magnetic	  resonance.	  Eur	  Heart	  J	  2012;	  33	  (Abstract	  Supplement),	  159	  46. 	  Muraru	  D,	  Badano	  LP,	  Ermacora	  D,	  Bellu	  R,	  De	  Lazzari	  M,	  Marra	  MP,	  Dal	  Bianco	  L,	  Peluso	  D,	  Cucchini	  U,	  Iliceto	  S.	  Two-­‐dimensional	  vs	  three-­‐dimensional	  deformation	  parameters	  to	  estimate	  infarct	  size	  and	  global	  left	  ventricular	  function	  after	  STEMI:	  which	  parameter	  is	  better?	  Eur	  Heart	  J	  2012;	  33	  (Abstract	  Supplement),	  167-­‐168	  47. Muraru	  D,	  Napodano	  M,	  Badano	  L,	  Tarantini	  G,	  Sarais	  C,	  Kocabay	  G,	  Isabella	  G,	  D’Onofrio	  A,	  Gerosa	  G,	  Iliceto	  S.	  Novel	  three-­‐dimensional	  transoesophageal	  echocardiography	  platform	  allows	  a	  fast	  and	  accurate	  assessment	  of	  aortic	  annulus	  size	  and	  shape	  before	  transcatheter	  aortic	  valve	  implantation.	  Eur	  Heart	  J	  Cardiovasc	  
Imaging	  2012	  48. 	  Muraru	  D,	  Cattarina	  M,	  Dal	  Bianco	  L,	  Peluso	  D,	  Zoppellaro	  G,	  Segafredo	  B,	  Calore	  C,	  Cucchini	  U,	  Iliceto	  S,	  Badano	  LP.	  Quantitative	  analysis	  of	  mitral	  valve	  geometry	  by	  transthoracic	  three-­‐dimensional	  echocardiography:	  reference	  values,	  feasibility	  and	  reproducibility.	  Eur	  Heart	  J	  Cardiovasc	  Imaging	  2012	  	  49. 	  Muraru	  D,	  Gripari	  P,	  Esposito	  R,	  Tamborini	  G,	  Galderisi	  M,	  Ermacora	  D,	  Maffessanti	  F,	  Santoro	  C,	  Pepi	  M,	  Badano	  L.	  	  Reference	  values	  for	  right	  ventricular	  geometry	  and	  function	  by	  three-­‐dimensional	  echocardiography.	  A	  multicenter	  study	  of	  a	  large	  cohort	  of	  healthy	  subjects.	  Eur	  Heart	  J	  Cardiovasc	  Imaging	  2012	  	  50. 	  Ippolito	  R,	  Gripari	  P,	  Muraru	  D,	  Esposito	  R,	  Kocabay	  G,	  Tamborini	  G,	  Galderisi	  M,	  Maffessanti	  F,	  Badano	  L,	  Pepi	  M.	  Age	  is	  an	  independent	  predictor	  of	  right	  ventricular	  geometry	  and	  function	  in	  males	  only.	  Eur	  Heart	  J	  Cardiovasc	  Imaging	  2012	  	  51. 	  Kocabay	  GK,	  Dal	  Bianco	  L,	  Muraru	  D,	  Peluso	  D,	  Segafredo	  B,	  Iliceto	  S,	  Badano	  L.	  Reference	  values	  for	  aortic	  diameters	  obtained	  using	  both	  inner-­‐edge-­‐to-­‐inner-­‐edge	  and	  leading-­‐edge-­‐to-­‐leading-­‐edge	  methods	  in	  190	  healthy	  subjects.	  Eur	  Heart	  J	  
Cardiovasc	  Imaging	  2012	  	  
Abstracts	  at	  national	  congresses	  (n=	  9)	  1. Cattarina	  M,	  Muraru	  D,	  Dal	  Bianco	  L,	  Peluso	  D,	  Kocabay	  G,	  Boccalini	  F,	  Sarais	  C,	  Iliceto	  S,	  
Badano	  LP.	  Accuratezza	  e	  riproducibilità	  dell’ecocardiografia	  transtoracica	  tridimensionale	  per	  l’analisi	  quantitativa	  della	  valvola	  mitrale:	  confronto	  con	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l’approccio	  ecocardiografico	  transesofageo	  3D.	  73°	  CONGRESSO	  NAZIONALE	  della	  Società	  Italiana	  di	  Cardiologia	  Roma,	  15	  –	  17	  dicembre	  2012	  2. Cattarina	  M,	  Muraru	  D,	  Dal	  Bianco	  L,	  Peluso	  D,	  Zoppellaro	  G,	  Segafredo	  B,	  Calore	  C,	  Cucchini	  U,	  Iliceto	  S,	  Badano	  LP.	  Analisi	  quantitativa	  della	  geometria	  della	  valvola	  mitrale	  tramite	  ecocardiografia	  transtoracica	  tridimensionale:	  valori	  di	  riferimento,	  fattibilità	  e	  riproducibilità.	  73°	  CONGRESSO	  NAZIONALE	  della	  Società	  Italiana	  di	  Cardiologia	  Roma,	  15	  –	  17	  dicembre	  2012	  3. Dal	  Bianco	  L,	  Muraru	  D,	  Badano	  LP,	  Ermacora	  D,	  Bellu	  R,	  De	  Lazzari	  M,	  Marra	  MP,	  Peluso	  D,	  Cucchini	  U,	  Kocabay	  G,	  Nour	  A,	  Iliceto	  S.	  Confronto	  tra	  i	  parametri	  di	  deformazione	  2D	  e	  3D	  nel	  stimare	  l’estensione	  dell’infarto	  miocardico	  e	  la	  funzione	  globale	  del	  ventricolo	  sinistro	  dopo	  STEMI:	  quale	  parametro	  è	  migliore?	  73°	  CONGRESSO	  NAZIONALE	  della	  Società	  Italiana	  di	  Cardiologia	  Roma,	  15	  –	  17	  dicembre	  2012	  4. Dal	  Bianco	  L,	  Muraru	  D,	  Badano	  LP,	  Bellu	  R,	  Ermacora	  D,	  De	  Lazzari	  M,	  Marra	  MP,	  Peluso	  D,	  Cucchini	  U,	  Kocabay	  G,	  Nour	  A,	  Iliceto	  S.	  Valore	  predittivo	  dei	  parametri	  2D/3D	  di	  deformazione	  miocardica	  e	  dell’indice	  di	  motilità	  3D	  nell’identificare	  l’estensione	  della	  necrosi	  transmurale	  in	  pazienti	  con	  STEMI:	  confronto	  con	  la	  RMC.	  73°	  CONGRESSO	  NAZIONALE	  della	  Società	  Italiana	  di	  Cardiologia	  Roma,	  15	  –	  17	  dicembre	  2012	  5. Dal	  Bianco	  L,	  Muraru	  D,	  Kocabay	  G,	  Zoppellaro	  G,	  Peluso	  D,	  Nour	  A,	  Segafredo	  B,	  
Badano	  LP,	  Iliceto	  S.	  Valori	  di	  riferimento	  per	  i	  diametri	  aortici	  ottenuti	  sia	  con	  metodo	  inner-­‐edge-­‐to-­‐inner-­‐edge	  (interno-­‐interno)	  che	  con	  metodo	  leading	  edge-­‐to-­‐leading	  edge	  (esterno-­‐interno)	  in	  190	  soggetti	  sani.	  73°	  CONGRESSO	  NAZIONALE	  della	  Società	  Italiana	  di	  Cardiologia	  Roma,	  15	  –	  17	  dicembre	  2012	  6. Ermacora	  D,	  Gripari	  P,	  Esposito	  R,	  Tamborini	  G,	  Galderisi	  M,	  Muraru	  D,	  Maffesanti	  F,	  Santoro	  C,	  Pepi	  M,	  Badano	  LP.	  Valori	  di	  riferimento	  della	  geometria	  e	  funzione	  del	  ventricolo	  destro	  ottenuti	  con	  ecocardiografia	  tridimensionale.	  Uno	  studio	  multicentrico	  su	  un’ampia	  coorte	  di	  soggetti	  sani.	  73°	  CONGRESSO	  NAZIONALE	  della	  Società	  Italiana	  di	  Cardiologia	  Roma,	  15	  –	  17	  dicembre	  2012	  7. Peluso	  D,	  Muraru	  D,	  Badano	  LP,	  Ermacora	  D,	  Bellu	  R,	  De	  Lazzari	  M,	  Marra	  MP,	  Dal	  Bianco	  L,	  Nour	  A,	  Sarais	  C,	  Cucchini	  U,	  Kocabay	  G,	  Iliceto	  S.	  Superiore	  accuratezza	  dello	  strain	  longitudinale	  2D	  rispetto	  a	  quello	  3D	  nell’identificare	  i	  segmenti	  coinvolti	  dalla	  necrosi	  nei	  pazienti	  con	  STEMI.	  73°	  CONGRESSO	  NAZIONALE	  della	  Società	  Italiana	  di	  Cardiologia	  Roma,	  15	  –	  17	  dicembre	  2012	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8. Peluso	  D,	  Muraru	  D,	  Badano	  LP,	  Bellu	  R,	  Ermacora	  D,	  De	  Lazzari	  M,	  Marra	  MP,	  Dal	  Bianco	  L,	  Zoppellaro	  G,	  Kocabay	  G,	  Sarais	  C,	  Cucchini	  U,	  Nour	  A,	  Iliceto	  S.	  Lo	  strain	  longitudinale	  2D	  e	  lo	  strain	  circonferenziale	  3D	  risultano	  predittori	  accurati	  di	  necrosi	  transmurale	  alla	  risonanza	  magnetica	  dopo	  uno	  STEMI.	  73°	  CONGRESSO	  NAZIONALE	  della	  Società	  Italiana	  di	  Cardiologia	  Roma,	  15	  –	  17	  dicembre	  2012	  9. Zoppellaro	  G,	  Ippolito	  R,	  Gripari	  P,	  Muraru	  D,	  Esposito	  R,	  Nour	  A,	  Tamborini	  G,	  Galderisi	  M,	  Maffesanti	  F,	  Badano	  LP,	  Pepi	  M.	  L’età	  è	  un	  predittore	  indipendente	  della	  funzione	  e	  geometria	  del	  ventricolo	  destro	  solo	  nel	  genere	  maschile.	  73°	  CONGRESSO	  NAZIONALE	  della	  Società	  Italiana	  di	  Cardiologia	  Roma,	  15	  –	  17	  dicembre	  2012	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non sarei mai riuscito a realizzare il laboratorio di eco-ricerca a Padova ed a renderlo così 
produttivo dal punto di vista scientifico e divulgativo.  
Senza saperlo, quando il prof Thiene mi offrì l’opportunità di entrare nella scuola di dottorato 
dell’Università di Padova, egli coronava il sogno di un giovane contadino e metteva il sigillo sul 
lavoro dei molti che ho ricordato in queste righe e dei moltissimi altri che mi hanno aiutato ed 
insegnato in tutti questi anni e che, per motivi di spazio, non ho potuto citare, ma a cui va il mio 
sentito ringraziamento. 	  	  	  
